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Cuffless blood pressure (BP) estimation devices are receiving considerable attention as tools for 
improving the management of hypertension, a condition that affects 1.13 billion people worldwide. It 
is an approach that can provide continuous BP monitoring, which is not possible with existing non-
invasive tools. Therefore, it yields a more comprehensive picture of the patient’s state. Cuffless BP 
monitoring relies on surrogate models of BP and the information encoded in alternative physiological 
measures, such as photoplethysmography (PPG) or electrocardiography (ECG), to continuously 
estimate BP. Existing models have typically relied upon pulse-wave delay between two arterial 
segments or other pulse waveform features in the estimation process.  However, the models available 
in the literature (1) provide an estimation of the systolic BP (SBP), diastolic BP (DBP), and mean BP 
(MAP) only, (2) are validated solely in controlled environments, and (3) do not assign a confidence 
metric to the estimates. At this point, cuffless methods are not used by clinicians due to their inaccuracy, 
the validation inadequacy, and/or the unevaluated uncertainty of the existing methods. 
The first objective of this thesis is to develop a cuffless modeling approach to estimate the BP 
waveform from ECG and PPG, and extract important BP features, such as the SBP, DBP, and MAP. 
Access to the full waveform has significant advantages over previous cuffless BP estimation tools in 
terms of accuracy and access to additional cardiovascular health markers (e.g., cardiac output), as well 
as potentially providing arterial stiffness. The second objective of this thesis is to validate cuffless BP 
estimation during activities of daily living, an uncontrolled environment, but also in more challenging 
physiological conditions such as during exercise. Such validation is important to increase confidence 
in cuffless BP monitoring, it also helps understand the limitation of the method and how they would 
affect clinical outcomes. Finally, in an effort to improve confidence in the cuffless BP estimation 
framework (third objective), a prediction interval (PI) estimation method is introduced. For potential 
clinical uses, it is imperative to assess the uncertainty of the BP estimate for acute outcome evaluation 
and it is even more so if cuffless BP is to be employed outside of the clinic. 
In this thesis, user-specific nonlinear autoregressive models with exogenous inputs (NARX) are 
implemented using an artificial neural network (ANN) to predict the BP waveforms using ECG and/or 
PPG signals as inputs. To validate the NARX-based BP estimation framework during activities of daily 
living, data were collected during six-hours testing phase wherein the participants go about their normal 
daily living activities. Data are further collected at four-month and six-month time points to validate 
long-term performance. To broaden the range of BP in the training data, subjects followed a short 
 
 v 
procedure consisting of sitting, standing, walking, Valsalva maneuvers, and static handgrip exercises. 
To evaluate the uncertainty of the BP estimates, one-class support vector machines (OCSVM) models 
are trained to cluster data in terms of the percentage of outliers. New BP estimates are then assigned to 
a cluster using the OCSVMs hyperplanes, and the PIs are estimated using the BP error standard 
deviation associated with different training data clusters. The OCSVM is used to estimate the PI for 
three BP model architectures: NARX models, feedforward ANN models, and pulse arrival time (PAT 
models). The three BP estimations from the models are fused using the covariance intersection fusion 
algorithm, which improves BP and PI estimates in comparison with individual model performance.  
The proposed method models the BP as a dynamical system leading to better accuracy in the 
estimation of SBP, DBP and MAP when compared to the PAT model. Moreover, the NARX model, 
with its ability to provide the BP waveform, yields more insight into patient health. The NARX model 
demonstrates superior accuracy and correlation with “ground truth” SBP and DBP measures compared 
to the PAT models and a clear advantage in estimating the large range of BP. Preliminary results show 
that the NARX models can accurately estimate BP even months apart from the training. Preliminary 
testing suggests that it is robust against variabilities due to sensor placement. The employed model 
fusion architecture establishes a method for cuffless BP estimation and its PI during activities of daily 
living that can be used for continuous monitoring and acute hypotension and hypertension detection.  
The NARX model, with its capacity to estimate a large range of BP, is next tested during moderate 
and heavy intensity exercise. Participants performed three cycling exercises: a ramp-incremental 
exercise test to exhaustion, a moderate and a heavy pseudorandom binary sequence exercise tests on an 
electronically braked cycle ergometer. Subject-specific and population-based NARX models are 
compared with feedforward ANN models and PAT (and heart rate) models. Population-based NARX 
models, when trained on 11 participants’ three cycling tests (tested on the participant left out of 
training), perform better than the other models and show good capability at estimating large changes in 
MAP. A limitation of the approach is the incapability of the models to track consistent decreases in BP 
during the exercise caused by a decrease in peripheral resistance since this information is apparently 
not encoded in either the forehead PPG or ECG signals. Nevertheless, the NARX model shows good 
precision during the whole 21 minutes testing window, a precision that is increased when using a shorter 
evaluation time window, and that can potentially be even further increased if trained on more data. 
The validation protocols and the use of a confidence metric developed in this thesis is of great value 
for such health monitoring application. Through such methodology, it is hoped that cuffless BP 
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Hypertension, commonly known as high blood pressure (BP), is a condition that affects 1.13 billion 
people worldwide [1] and is the cause of 9.4 million deaths worldwide every year, which accounts for 
half of the deaths associated with stroke and heart disease [2]. Hypertension is a major cardiovascular 
risk factor that is treatable, yet the detection and control rates are low [3], [4]; only 46% of individuals 
with hypertension have their condition under control, primarily due to inadequate treatment [5].  
Cuffless BP measurement devices are receiving considerable attention as tools to improve 
management of hypertension [6], since they require less cumbersome and expensive hardware [7] 
compared with cuff-based systems, which enables patient mobility, and eliminates the discomfort 
associated with the cuff [8]. Cuffless systems also have the potential to continuously monitor BP, which 
can be used to predict cardiovascular risks, such as short-term BP variability [9], and to better manage 
treatment [10]. Moreover, continuous BP monitoring can minimize false diagnoses due to isolated 
clinic hypertension (i.e., white-coat hypertension) [11].  
Generally speaking, cuffless BP relies on the information encoded in alternative physiological 
measures, such as photoplethysmography or electrocardiography, to continuously estimate BP. This 
requires surrogate models of BP, which have typically relied upon pulse-wave delay between two 
arterial segments [6] or other pulse waveform features [12] in the estimation process. Recently, a few 
studies reported the use of end-to-end deep learning to handle feature extraction with the aim to cope 
with the difficulty of designing hand-crafted features to characterize BP [13]. 
Existing models for cuffless BP monitoring only provide systolic (BP peak) and diastolic (BP 
trough) estimations, with a couple of noted exceptions that also enables the estimation of the mean 
arterial pressure (MAP) [14], [15] or the pulse pressure [16]. However, considerable clinically-relevant 
data are lost in such methods. To date, no model of the dynamics of BP has been reported to estimate 
the complete BP waveform, which also contains additional information of potential interest to 
physicians [17]. Specifically, in the case of hypertension, the waveform provides information on the 
underlying disease and mechanisms leading to high blood pressure [18]. For example, information 
regarding arterial stiffness, which can be extracted from the BP waveform [60], can inform optimal 
hypertension treatment. Another example is pulse diagnosis, which utilizes the blood pressure 
waveform to identify different cardiovascular diseases and track pathological changes [19]. Moreover, 
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the complete BP waveform could give access to other important continuous cardiovascular health 
measures, such as cardiac output [20] and stroke volume [21]. 
Cuffless BP monitoring aims to: 1) render more accessible discrete BP measurements usually 
obtained with an arm cuff, and/or 2) offer convenient access to continuous BP measurements. The 
method should ideally not require recalibration, or at the very least, the calibration should remain valid 
for several hours [22], [23]. To enable access to the continuous BP, the system can be calibrated on 
each user, after which the BP calibration device is removed (e.g., Finapres® NOVA) and beat-to-beat 
BP estimation is obtained from a surrogate signal (e.g., photoplethysmography). While many studies 
have demonstrated continuous BP monitoring, validation is often performed for time scales on the order 
of minutes in controlled environments [24]–[26]. To the author’s knowledge, there are only few noted 
exceptions in [15], [27], [28], wherein 24h BP estimation was performed by sampling BP every 30 
minutes; however, their estimates during daily activities were determined to lack sufficient accuracy 
for clinical use, and as such the results focused on rest periods at night. Therefore, estimation of BP 
during activities is lacking and would be clinically valuable. 
Another critical aspect of cuffless BP monitoring that has been overlooked thus far is the uncertainty 
associated with the estimation. The uncertainty in cuff-based measurements has been of concern for 
practitioners [29] which led to the development of methods for estimating uncertainty on such 
measurements [30]. The standard for expressing uncertainty for measurement devices [31] states that 
it should be applicable to a broad span of conditions. In practice, however, the uncertainty is obtained 
from a series of measurements under repeatable conditions, which do not necessarily capture every use 
case of the device. For instance, the British Hypertension Society and the Association for the 
Advancement of Medical Instrumentation (AAMI) have specific protocols for testing cuff-based BP 
measurement devices [32], which have been co-opted for cuffless BP estimation. However, the 
precision reported in specific tested situations, such as in-lab conditions, is unlikely to be reproducible 
in real-world conditions, which are potentially more challenging. Since continuous BP monitoring is 
likely to be employed outside of the clinic, it is imperative to assign a confidence metric to the estimates 
for outcome evaluation. 
1.1 Motivation and Objectives 
This Ph.D. thesis research aims to introduce a novel BP estimation strategy that overcomes the major 
hurdles associated with previously established techniques, namely the short prediction horizon (loosely 
captured in the ratio of required training time for a given prediction window) of deep machine learning 
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algorithms that renders them of questionable practical use [13], and the relatively poor performance of 
physiology-based models in comparison with medical standards [6]. More precisely, this work aims to 
combine knowledge in dynamical systems, physiology, and machine learning to develop a solution 
readily applicable to the real world. BP is a phenomenon with rich dynamics, yet existing models only 
provide SBP and DBP. It is hypothesized that by capturing subject-specific BP dynamics using data-
driven methods that estimation accuracy will be improved and the prediction horizon will be extended. 
However, the flexibility offered by complex data-driven modeling can have the cost of decreasing the 
confidence in the model, as black-box models might lead to suspicion in the results due to the loss of 
input to output interpretability, which is of great importance to clinical providers [33]. Therefore, to be 
adopted and fully utilized in clinical settings, practitioners need to be exceptionally confident in the 
data-driven model outputs used for BP monitoring. Most efforts to date in the field of cuffless BP 
monitoring have focused on algorithm development, with very little consideration for increasing the 
confidence in the models. Thus, it is presumed that incorporation of a confidence metric into a data-
driven model framework will increase the likelihood of clinical adoption of cuffless BP monitoring.  
To address the identified critical gaps in the state-of-the-art of cuffless blood pressure monitoring, 
the following research objectives are proposed:  
1. develop a data-driven model of BP dynamics to enable estimation of the complete BP 
waveform; 
2. validate the model architecture in real-world scenarios;  
3. incorporate an uncertainty measure into the modeling scheme. 
1.2 Outline of the Thesis 
The thesis is organized as follows. Chapter 2 presents a review of the literature pertinent to cuffless 
BP estimation. The core contributions of this thesis are presented in Chapters 3 to 6. In Chapter 3, the 
model architecture is introduced for accurate cuffless estimation of BP and tested for bed-ridden 
subjects. Chapter 4 presents a protocol to train the model architecture that enables BP estimation during 
activities of daily living from wearable sensors data as input. Chapter 5 deals with estimating the 
uncertainty associated with cuffless BP monitoring and improving BP estimates using estimation 
fusion. Chapter 6 considers the challenge of BP estimation during exercise using both subject-specific 
and population-based modeling approaches. Finally, Chapter 7 presents the major conclusions drawn 





This chapter introduces the concepts and theories needed to design and validate a cuffless BP 
monitoring system. It is organized as follows: first, an overview of the cardiovascular system focusing 
on BP is presented with a description of some common physiological sensors. Second, data-driven 
models are explained in the context of this research project. Finally, a review of cuffless BP monitoring 
literature is presented. 
2.1 Cardiovascular Physiology 
This section provides a brief introduction to cardiovascular physiology with an emphasis on BP and 
how it can be monitored. It is divided as follows: (1) a high level overview of the cardiovascular system 
is presented; (2) BP is described, including internal and external factors that affect it; (3) physiological 
parameters that can be extracted from the BP waveform are discussed; and (4) the main categories of 
physiological sensors, with the emphasis on blood pressure, blood pulse, and electrocardiogram 
measurements are presented. 
2.1.1 Cardiovascular System Overview1 
The cardiovascular system is comprised of two circulatory loops, the pulmonary and the systemic 
circulations. The pulmonary system sends deoxygenated blood from the right ventricle of the heart to 
the lungs, wherein the blood is oxygenated. The oxygenated blood then returns back to the left atrium 
of the heart. The left atrium feeds the left ventricle of the heart, which then pumps the oxygenated blood 
into the systemic circulation. The oxygenated blood travels through the arterial tree, delivering oxygen 
to the capillary networks of various organs and limbs of the body. The veins transport the deoxygenated 
blood back to the heart’s right atrium, which feeds the right ventricle, thus completing the circuit. 
A two-element Windkessel model is a simplified version of the cardiovascular system that relates 
the blood flow to BP, the mechanical force driving blood flow, by the main cardiovascular properties: 
arterial compliance and peripheral resistance. The former is modeled as a capacitor and the latter as a 
resistor in a parallel electrical circuit, see Figure 2.1. The dynamical equation relating the flow, I(t), to 
BP(t) is shown in equation (2.1. 
 




Figure 2.1 - Electrical analog of the 2-element Windkessel model 
The blood flow in the cardiovascular system is pulsatile in nature (half sin wave during 2/5 of the 
cardiac cycle, elsewhere 0 in a Windkessel model). From equation (2.1, for a given I(t), mean BP will 
increase with the peripheral resistance (R) and that the peak BP will decrease with an increase in arterial 
compliance (C). Other important variables characterizing the cardiovascular system are the stroke 
volume (SV) - the volume of blood ejected from the heart due to every contraction of the heart muscle, 
and the cardiac output (CO) - the amount of blood the heart pumps per minute. CO is usually expressed 
in litres per minute (L/min) and can be computed as CO = SV * heart rate [34]. The next subsection 
focuses on the physiology of BP and what affects its level. 
2.1.2 Blood Pressure 
The BP at various locations in the systemic circulatory system is shown in Figure 2.2, where the 
aorta is the artery fed by the left ventricle, and the vena cavae is the vein feeding the right atrium 
(returning the blood to the heart). The generic term blood pressure generally refers to arterial blood 
pressure (ABP), which is the complete waveform that is characterized by the change in pressure due to 
every heart contraction. This waveform has many characteristics, the most important of which are its 
maximum - the systolic (SBP), its minimum - the diastolic (DBP), the mean arterial pressure (MAP), 
and the pulse pressure (SBP-DBP). The normal ranges for SBP and DBP in the brachial artery (the 
location commonly measured by external BP cuffs; see Section 2.2.1.2) are 90-120 and 60-80 mmHg, 
respectively, in young, healthy normotensive persons but is elevated above this range in hypertension. 
[36]. The ABP is not to be confused with central venous pressure (CVP) that refers to the BP when the 
blood returns to the heart after flowing in the systemic circulation. A normal CVP is between 8 to 12 
mmHg in supine position, and is correlated with how much blood is going back to the heart [37]. 
Although the BP differs for different locations in the body, Figure 2.2 highlights that the BP is high on 













Figure 2.2 - Blood pressures in various parts of the cardiovascular system. The dashed line is 
the mean (average) blood pressure in the aorta, arteries, and arterioles. This figure was taken 
from Human Physiology: An Integrated Approach [35]. Note that pulse pressure should increase 
along the aorta, but this is not shown herein. 
BP level varies between individuals, and also changes over time. The former is characterized by the 
difference in cardiovascular properties between individuals, where the latter comes from the states of 
the body, e.g., posture and activity level, over time. The factors influencing BP level are important 
considerations for a cuffless BP monitoring system. 
2.1.2.1 Cardiovascular Properties Influencing Blood Pressure 
According to the American Heart Association, there are five blood pressure categories, ranging from 
normal to hypertensive crisis [38]. Hypotension, or low BP, which is associated with persistent 
tiredness, is excluded from this categorization since treatment is not suggested as either possible or 
necessary [39] when it is not associated with organ disfunction. The two main cardiovascular properties 
affecting BP level are arterial stiffness and peripheral resistance of the cardiovascular system [40]. The 
latter describes how the arteries changes in diameter to a change in BP. The former describes how 
difficult it is to pump blood in the cardiovascular system. 
Speculation continues as to whether an increase in arterial stiffness is a cause or a consequence of 
hypertension [41]. Nevertheless, this increase perturbs the natural mechanism, called impedance 
mismatch in the arteries, protecting the small capillaries from excessive pulsatility. This mechanism 
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changes the BP waveform as shown in Figure 2.3. In short, the pulse wave velocity (PWV) increases 
with stiffness, which increases progressively from the aorta to the large peripheral arteries. This, 
together with the tapering of the aortic diameter (impedance mismatch), induces wave reflections. 
These reflections are beneficial as they reduce the energy transmitted to the microcirculatory network, 
which is more fragile. With hypertension this stiffness gradient is reduced, see inversed, due proximal 
aortic stiffness increasing up to—and sometimes beyond—the level of aortic distal distal stiffness, 
leading to a higher PWV throughout the arteries. The reflected waves arrive at the central aorta in early 
systole and are superimposed on the incident pressure wave, a phenomenon which increases SBP, and 
therefore increases pulse pressure (SBP-DBP). It is to be noted that the complexity of different arterial 
sites and their varying distances from the aorta result in reflected waves with large phase differences, 
which tend to mitigate the cumulative effects of these waves on the central BP waveform [42]. 
Nevertheless, the overall BP waveform is a sum of reflected and forward traveling waves such that 
there is an increase in the observed aortic BP wave, as demonstrated in Figure 2.3, a condition that 
worsens with age and is correlated with arterial stiffness [41].  
 
Figure 2.3 - Upper left: the summation of a forward and a backward wave is responsible for 
the total blood pressure (BP) curve. Upper right: a schematic representation of the aortic BP 
curve with the definitions of augmentation index (AIx) and augmentation pressure. Lower half: 
the same mean arterial pressure (MAP) may correspond to different BP curves in younger (left) 




As mentioned above, hypertension is characterized by an increase in arterial stiffness, which implies 
an increase in pulse pressure. Hypertension however is also characterized by an increase in peripheral 
resistance, which increases mean BP [40]. Increases in peripheral resistance and arterial stiffness 
therefore result in an increase in both DBP and SBP, and a significant change in the BP waveform 
shape (Figure 2.3). This increase is natural with age although it can be accentuated by genetics, lifestyle, 
medication, and nutrition [44]. 
2.1.2.2 States Influencing Blood Pressure 
In this section, common states that cause BP to change that are encountered daily by humans are 
covered, which should be tractable by a cuffless BP measurement system. Herein, only body posture, 
motion, Valsalva maneuver, exercise and mental arithmetic are covered since they are encountered 
regularly by most individuals. Additional factors, such as ambient temperature, altitude, and noise are 
not covered; the reader is referred to [45] for additional details. 
Body posture, such as sitting, standing, and supine, significantly changes BP [46]. It has been 
reported that significantly different BP measurements are encountered while sitting posture with and 
without crossed legs [47], showing how small details can change BP. 
 
Figure 2.4 - Spectrum of normal and abnormal blood pressure (BP) and heart rate responses 
during the first 180 s after standing. Measurement of orthostatic BP with continuous noninvasive 
measurement in four subjects. The last 60 s in the supine position and 180 s of standing are 
illustrated. Dashed vertical lines indicate the onset of the active stand. Normal orthostatic BP 
recovery (a), initial orthostatic hypotension (systolic BP decrease >40 mmHg within 15 s of 
standing, with recovery to baseline within 30 s) [48]. 
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The studies [46] and [47] were done for steady-state BP in different body postures. However, a 
larger variation in BP is observed during postural transitions, such as the supine-to-stand transition 
shown in Figure 2.4, where the red and blue lines represent the SBP and DBP, respectively. This case 
shows a normal orthostatic BP recovery; how fast the recovery happens is, however, depending on the 
health of the person. Orthostatic hypotension is the result in a slow recovery of the BP that might result 
in fainting [48]. 
Activity level, in general, significantly changes BP. For instance, a simple activity such as walking 
not only it changes BP and heart rate due to the effort, it also highly distorts the BP waveform in 
different ways, partially due to the acceleration of the blood in the body [49].  This effect is amplified 
while running, as shown in Figure 2.5, the BP waveforms during running are complex due to the 
interaction between the heart’s pressure wave and the wave generated by the whole-body vertical 
movement. BP can be decreased with an asynchronous run, increased with a synchronous run, or highly 
variable beat-to-beat with unsynchronized running.  
 
Figure 2.5 - Pressure wave recordings during running in one subject (a) (Compressed time 
scale) when heart rate and step rate were not synchronised, (b) when heart rate and step rate 
were synchronised, with heart rate and body wave in phase, (c) with synchronised heart and step  




Static handgrip exercise increases BP drastically, as shown in Figure 2.6. This increase varies 
according to the percentage of maximum voluntary contraction [50]. There are two mechanisms 
involved in the cardiovascular response to a static handgrip exercise: central and peripheral neural 
mechanisms [50]. The former increases blood flow (increased cardiac output) and the latter refers to a 
vasoconstriction in some noncontracting tissues.  
 
Figure 2.6 - Blood pressure from a normal subject during static handgrip exercise [51]. 
Mental arithmetic increases BP more than postural changes, but less than static handgrip exercise 
[52]. Interestingly, the physiological response of mental arithmetic is similar to static handgrip exercise; 
both BP and heart rate are correlated, which is not the case for postural change [52]. Although mental 
arithmetic won’t be covered again in this thesis, any mental effort done during activities of daily living 
can change BP and should be tractable by a measurement device.  
The Valsalva maneuver is a technique that can be used for the evaluation of heart murmurs. It is 
also valuable in the evaluation of left ventricular function and autonomic dysfunction [53]. The 
maneuver is performed as follow: 
1- Deep inhalation and then the breath held. 
2- The chest and stomach muscles are very tight, and the person bears down as though straining to 
initiate a bowel movement. 
3- The position is held for a short time, usually about 10 seconds. 
4- Breathing out forcibly to release the breath rapidly. 
Although the Valsalva maneuver is not an activity per se, the BP response to the maneuver can resemble 
different activities experience daily, such as bowel movements or lifting heavy objects. A typical BP 





Figure 2.7 - A representative Valsalva maneuver: arterial blood pressure (BP; A ) and heart 
rate (in beats/min; B ). After inspiration, the subject blows against a resistance of 40 mmHg. This 
produces an initial brief increase in BP in phase I, a decrease in BP that is later restored in phase 
II, a brief decrease in BP with inspiration in phase III, and an overshoot in phase IV. Hypotension 
in phase II is associated with tachycardia, whereas hypertension in phase IV is associated with 
bradycardia [54]. 
2.1.3 Information in the Blood Pressure Waveform 
As introduced in Chapter 1, the BP waveform contains information that is physiologically 
meaningful to clinicians. Herein, the pulse pressure amplification, arterial stiffness, and stroke volume 
and cardiac output are discussed. 
2.1.3.1 Pulse Pressure Amplification 
In 2007, a consensus document on the role of central (aortic) BP in arterial hypertension was 
published [55]. It concluded that there is “mounting evidence suggesting that central BP and indices 
correlate more closely with intermediate markers of cardiovascular risk than brachial BP”.  One such 
marker is the pulse pressure amplification, a measure of the difference in pulse pressure (SBP-DBP) 
between two arterial sites, generally between the brachial (or radial) artery and the aorta [56]. The 
method generally applies measurement of the radial BP waveform and then the use of a generalized 
 
 12 
transfer function to recover the aortic BP [57]. The pulse pressure amplification is an independent 
predictor of all-cause and cardiovascular mortality [58], therefore an important parameter that can only 
be accessed through analysis of the complete waveform. 
2.1.3.2 Arterial Stiffness 
Although arterial stiffness cannot be computed directly from the waveform (in fact, it cannot be 
computed with any noninvasive method [59]), indirect indices that are correlated with arterial stiffness 
can be extracted [60]. The most commonly used surrogate of the arterial stiffness is the PWV, generally 
computed as PWV=ΔL/Δt, where ΔL is the distance between two measuring sites, and Δt is the time it 
takes for the arterial pulse to travel from the proximal to the distal measuring site [61]. However, as 
mentioned, this method needs two measuring sites. From the waveform only, the time delay between 
the SBP and the reflected wave can be extracted and is highly correlated with the PWV. Another metric 
that can be extracted from the waveform is the radial artery augmentation index, which is the ratio of 
the reflected wave pressure and the SBP. The radial artery augmentation index is correlated with age, 
therefore with stiffness as well [60]. 
2.1.3.3 Stroke Volume and Cardiac Output 
In this section, two different methods that compute CO and SV from the BP waveform are presented. 
One method to compute CO from the BP waveform is based on the two-element Winkessel model 
[62], see Section 2.1. This linear model represents fairly well the relationship between CO and the 
aortic BP despite its reliance on many assumptions. One important parameter that can be extracted from 
this model is the time constant, τ, which represents the exponential decay of the BP during the diastolic 
interval (between SBP and DBP). This time constant is, however, difficult to extract from a real BP 
waveform due its superposition with the reflected wave. The technique proposed by Mukkamala et al. 
[20] is to extrapolate the BP waveform after all reflected wave effects and then fit an exponential to the 
extrapolation to compute the time constant. To extrapolate the BP waveform, an autoregressive with 
exogenous inputs model (see Section 2.1.3.3) is fit between the pulse pressure spike train and the actual 
BP waveform. Once the model parameters are found, the BP waveform response to a single pulse 
pressure spike train is simulated for a long period of time (longer than one heartbeat) and τ is computed. 
Finally, the ratio of mean BP and τ is computed, which is proportional to CO. The proportional CO 
may be calibrated, if desired, with a single, absolute invasive CO measurement. 
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Another method to compute CO is called ModelFlow, which is a nonlinear three-element Windkessel 
model that computes an aortic blood flow waveform from the arterial pressure wave [21], see Section 
2.1 for the two-element model. The SV can be computed by integrating per beat the flow waveform 
and from the SV, and CO can then be computed by multiplying with the known heart rate. 
2.2 Useful Physiological Sensors for Blood Pressure 
This subsection focuses on identifying typical cardiovascular measurements used for cuffless BP 
monitoring. It is divided as follows: first, the different blood pressure measurement methods are 
discussed. Second, photoplethysmography is explained, followed by an explanation of 
electrocardiography. 
2.2.1 Blood Pressure Measurement 
In this section, the blood pressure measurement methods are discussed, which can be classified as 
invasive, non-invasive, and cuffless. Additional details on the latter are included in the cuffless blood 
pressure estimation section (Section 2.4). 
2.2.1.1 Invasive Measurement 
The gold standard method is invasive catheterization [63], which involves insertion of a catheter 
into the radial artery and pressure is measured by a pressure transducer [64]. This provides accurate, 
real-time, and direct measurement of the BP waveform, but tethers the patient to cumbersome 
equipment. 
2.2.1.2 Arm Cuff-Based Measurement 
Non-invasive BP monitoring techniques are widely used in healthcare and research for single time-
point blood pressure measures. Auscultation is a BP measurement method that uses Korotkoff sounds 
to detect SBP and DBP [65]. The brachial artery is compressed with a cuff and the pressure is slowly 
decreased until the Korotkoff sounds are heard (SBP) and decreased again until no sound is heard 
(DBP).  
Oscillometry generally detects the mean arterial pressure (MAP) from the pressure oscillation of the 
brachial cuff and uses algorithms, such as experimental ratios, to get the SBP and DBP (Figure 2.8) 
[66], [67]. In Figure 2.8, the envelope of the oscillation amplitude is extracted then the experimental 
ratios are used to compute the time at which SBP and DBP were measured with the cuff. These 
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algorithms, however, vary from machine to machine resulting in slightly different interpretations of the 
pressures [68].  
 
Figure 2.8 - Oscillometric method for non-invasive blood pressure measurement. (a) Cuff 
pressure during cuff inflation and deflation. (b) Estimation of SP (SBP), DP (DBP), and MAP 
(mean arterial pressure) from cuff pressure oscillations via fixed-ratio method and maximum 
oscillation amplitude [69].   
Due to the different machine designs and algorithms used in oscillometric BP measurements, 
validation has always been of concern. In 1986, the Association for the Advancement of Medical 
Instrumentation (AAMl) published a standard for automated blood pressure measuring devices that 
included a protocol for the evaluation of device accuracy [70]. The ANSI/AAMI/ISO standard, referred 
herein simply as the AAMI standard, requires a minimum of 85 participants and a minimum of three 
paired tests compared with auscultation by a certified professional. The acceptable error distribution 
between the reference and test blood pressure value is characterized by a mean of 5 mmHg and standard 
deviation of 8 mmHg. In 1990, another protocol was developed,   protocol  by  the  British Hypertension  
Society  (BHS), which used error-bands to quantify the error distribution of a medical grade automated 
blood pressure measuring devices [70]. This required that 60% of the cumulative readings fall within 5 
mmHg, 85% within 10 mmHg, and 95% within 15 mmHg [71]. Later, the BHS protocol was replaced 
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by the European Society of Hypertension (ESH) protocol that requires 33 instead of 85 subjects [72]. 
It has, however, been discontinued because of concerns regarding its statistical power [73]. Finally, it 
has recently been chosen to design a new joint protocol of AAMI and ESH, in which mean and standard 
deviation are the preferred outcome for quantifying the error distribution of measurements [74]. 
One downside of arm cuff-based BP measurements is that SBP, DBP, and MAP are not measured 
during the same heartbeat due to the time delay between the measurement of each. This, however, is 
usually negligible for a person at rest. Another downside is isolated clinic hypertension, commonly 
referred to as white-coat hypertension [11]. It was shown that the use of a cuff increases anxiety, which 
subsequently creates a peak BP response in the measurement (range, 4-75 mm Hg systolic and 1-36 
mm Hg diastolic) [75]. This can be minimized by consecutive measurements [76]. 
2.2.1.3 Finger Cuff-Based Measurement 
Volume clamping measures the finger BP waveform by controlling a constant blood volume at the 
fingertip (see Figure 2.9) [77], [78]. A photoplethysmography sensor (discussed in 2.2.2) is used to 
measure the volume of blood and a cuff controls the pressure such that the volume of blood stays 
constant. The resulting controlled pressure is equal to the finger BP waveform.  
 
Figure 2.9 – Principle of volume clamp method for blood pressure measurement [79]. 
The finger BP waveform is, however, different from the brachial BP waveform, see Figure 2.10. To 
improve this measurement technique a generalized transfer function, followed by a level correction, 
and finally level calibration are applied to the finger BP [80]. Similar approaches can be used for 
recovering the aorta BP waveform [57].  
As seen in Figure 2.10, the finger BP waveform is composed of higher frequency components than 
the brachial artery waveform. The relationship between the two waveforms can be modeled using a 
generalized transfer function from brachial to finger [81], shown in equation (2.2. 
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where 𝑖 = √−1. This model is equivalent to a gain (𝐾), a second-order aperiodic high emphasis section 
at frequency 𝑓 , followed by a second order underdamped low pass section at resonance frequency 𝑓 , 
with a damping factor D < 1. The transfer function is forced to unity transfer at high frequencies by 
linking 𝑓  and 𝑓  using equation (2.3. 
The free parameters of the transfer function (𝑓 , 𝐾, and 𝐷) are found based on the best fit for each 
individual in the study. The parameters are then averaged across individuals to get the generalized 
transfer function. The inverse transfer function is used to find the brachial BP waveform from the 
measured finger waveform. 
 
Figure 2.10 - Demonstration of the process of inverse modeling and level correction on a 
waveform of a 53-year-old subject. The original finger pressure (top panel) is distorted with 
respect to brachial (thin curve), and lower in level. After general inverse modelling (middle panel) 
the waveforms are nearly identical, but the level is still different. Level correction (bottom panel) 
shifts the waveform down by 7 mmHg in this case, after which it is nearly correct. The delay 
between waveforms was not modelled and, thus, not corrected, explaining the unchanged delays 
in the finger pressure derived waveforms [81]. 
The inverse generalized transfer function succeeds in removing the high frequency content but still 
overpredicts the mean BP due to neglecting frictional losses between the brachial artery and the finger 
𝐻(𝑓) = 𝐾
(1 + 𝑖 𝑓 𝑓⁄ )
1 + 2𝑖𝐷 𝑓 𝑓⁄ − (𝑖 𝑓 𝑓⁄ )
 (2.2) 
𝑓 = 𝑓 √𝐾 (2.3) 
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artery, which requires a pressure gradient to overcome. To compensate for those, a level correction is 
applied based on SBP and DBP [81] as shown in (2.4. 
where the coefficients were found using linear regression based on the collected data. Since the level 
correction is applied on a beat-to-beat basis, it decreases not only the measurement bias, but also the 
variance. 
The level correction increased the accuracy and precision of the measurement technique. However, 
the precision of the measurements does not meet the AAMI requirements. To improve the precision, a 
return-to-flow (RTF) calibration was developed. In short, an arm cuff inflates to stop the flow in the 
arm, then slowly deflates and return of the flow is measured using the finger cuff. This value of pressure 
corresponds to the SBP. This P  can then be used in equation (2.5 [82] to compute a correction 
factor (Corr) to the BP waveform as a function of the finger SBP (FP ) and the finger DBP (FP ). 
In equation (2.5, the coefficients of the equation were computed to minimize the error the the estimated 
waveform from their collected dataset. Although Corr only decreases the intra-individual measurement 
bias, it results in a decrease of the group-level error standard deviation (precision) [83]. 
An alternative to the BP measurement techniques mentioned above is cuffless BP monitoring, which 
is non-invasive and requires no pressurization mechanism [8]. These techniques are based on a 
surrogate model of the BP from other physiological sensors. Cuffless techniques are discussed in 
Section 2.4, but knowledge on data-driven modeling and on useful physiological sensors is required to 
understand better the different cuffless techniques. 
2.2.2 Photoplethysmography 
Photoplethysmography (PPG) is a low cost-optical technique that detects blood volume changes in 
the microvascular bed of tissues under the probe head [84]. A typical PPG sensor emits light at the 
tissue site with one or more LEDs. A photodiode measures the intensity of the non-absorbed light 
reflected or transmitted from the tissue [85]. A typical signal of a PPG sensor is pulsatile, where the 
main frequency of the AC component is related to the heart rate. The signal also has a quasi-DC 
component, which is related to tissues properties and average blood volume [86]. 
Heath monitoring using wearable sensors has gained attention in the past few years causing PPG to 
increase in popularity because of its low cost [87]. Most common monitoring applications are BP [12], 
pulse oximetry, heart rate, and screening of various cardiovascular-related diseases [85]. However, 
∆BP = −13.3 − 0.194SBP − 0.574DBP (2.4) 
Corr = 18.7 + 0.44 ∗ P  − 0.36 ∗ FP − 0.34 ∗ FP  (2.5) 
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many practical aspects need to be considered when using the sensor. For instance, one downside is that 
the signal is susceptible to motion artefacts, which are difficult to filter out [12]. Also, sensor placement 
affects the signals [84]. Using a PPG sensor to monitor heart rate is accurate, when monitoring average 
heart rate, but has been challenging on a beat-to-beat basis [86]. The main cause of error is the time for 
the pulse to travel from the heart to the arm, referred to as pulse transit time, which varies with posture 
and blood pressure, which can vary on a beat-to-beat basis. Another practical consideration when using 
a PPG sensor for cuffless BP monitoring is that the contact pressure affects the signal as observed in 
Figure 2.11 [88]. Despite all the practical challenges of using a PPG sensor for health monitoring, it is 
a relevant sensor to use when estimating BP from wearables, since they are highly correlated. 
 
Figure 2.11 – Representative example of all measurements from a subject. As expected, the 
PPG amplitude and shape markedly varied with the contact pressure (CP) [88]. 
2.2.3 Electrocardiography 
An electrocardiogram is a recording of the electrical signals generated by the heart. 
Electrocardiography (ECG) signals are generated by depolarization and repolarization of the heart 
muscles, which reflects the contraction of the heart [34]. However, the mechanical movement of the 
heart lags slightly its corresponding electrical signal as the contraction of a single cardiac muscle cell 
follows its action potential. The resulting pressure as a function of time in shown in Figure 2.12, 
wherein it can be observed that the pressure starts increasing with the QRS complex, but there is a time 
lapse between the peak pressure and the QRS complex. 
ECG signals can be measured using many different methods. The most common configuration uses 
three electrodes, one positive, one negative, and one ground, which are to be positioned on the right 
arm, the left arm and the left leg. However, the electrodes are generally placed on the trunk close the 
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reference position. A three-lead ECG measures three bipolar leads (referred as ECG I, ECG II, and 
ECG III) depending on which probe is the ground.  
Nowadays, ECG is used as a wearable as it is easily integrated into textiles [89] and is a signal 
commonly used in cuffless BP monitoring [6]. 
 
 
Figure 2.12 - When the ventricles depolarise, the ventricular muscles contract and rapidly 
builds up systolic pressure. When left ventricular pressure exceeds that of the aorta, the aortic 
valve opens and blood ejects out to circulate in the body [90]. 
2.2.4 Ballistocardiogram and Seismocardiogram 
The ballistocardiogram (BCG) is a measurement of the recoil forces of the body in reaction to 
cardiac ejection of blood into the vasculature, which is generally measured with a force plate. The 
seismocardiogram (SCG) represents the local vibrations of the chest wall in response to the heartbeat, 
which is generally measure with accelerometers [91]. Although the exact physiological significance of 
the waveforms are unknown [91], they have been useful in estimating BP [92], [93]. 
2.3 Data-Driven Models 
Most cuffless BP monitoring approaches use data-driven modeling to find the relationship between 
exogenous measurements and BP. Data-driven models can be used to tackle three main problems: 
regression, classification, and clustering. The two former are part of supervised learning problems, 
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where the model is built from data with known desired input and output pairs, and the latter is an 
unsupervised technique, where the desired output of the model is unknown [94]. Classifiers 
(classification models) and regression models are differentiated by their outputs. In regression, models 
are used to approximate continuous output variables, whereas classifiers approximate discrete output 
variables, taking the form of labels [95]. Clustering techniques are used to form groupings within data. 
The focus of this section is on regression models applied to dynamical systems, which is the approach 
taken to model BP, and on a clustering technique, the approach used to estimate the uncertainty of the 
model. 
2.3.1 Autoregressive Models2 
Autoregressive models (AR) are linear discrete-time models that allow the representation of the 
frequency domain of a dynamical system. AR models can be written using a discrete-time transfer 
function as seen in equation (2.6.: 
but the most common notation for AR models is the difference equation (equation (2.7). 
where 𝑘 is the time step (where the time 𝑡 = 𝑘𝑇, with 𝑇 being the sampling period), 𝑦 is the output 
times series, 𝑦(𝑘) is the 𝑘th sample of that time series, 𝑣(𝑘) is the noise at instant k, 𝑧 is the delay 
operator, 𝐴(𝑧) is the denominator polynomial of the transfer function associated with the poles of the 
system, and the number of coefficients 𝑚 is the order of the system. An AR model without any noise 
input can model, for example, the free vibration of a structure in the discrete time domain. 
The most widely used linear dynamic model for time series is the autoregressive with exogenous 
input (ARX) model. ARX models are extensions of AR models where an external input 𝑢(𝑘) is added. 
The complex notation is shown in equation (2.8.  
Again, the most common notation for ARX models is the difference equation (equation (2.9). 
 













𝑦(𝑘) = 𝑏 𝑢(𝑘 − 1)−. . . −𝑏 𝑢(𝑘 − 𝑛) − 𝑎 𝑦(𝑘 − 1)−. . . −𝑎 𝑦(𝑘 − 𝑚) + 𝑣(𝑘) (2.9) 
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where 𝐵(𝑧) is the polynomial of the numerator associated with the zeros of the system transfer function. 
There are other AR models such as AR moving average (ARMA) and ARMA with exogenous input 
(ARMAX) that will not be discussed here. ARMA and ARMAX are basically extensions of AR models 
that incorporate the noise dynamics [94].  
AR models are general linear discrete time models, where the coefficients of the equation can be 
found from different methods. For instance, a known continuous time system dynamical equation can 
be discretized by replacing dt by Δt. However, the most common approach is to find the coefficients 
from data, which is a quadratic optimization problem in this case. For such quadratic problems, the 
most common technique employed is the ordinary least squares estimate (LSE). In the case of an ARX 
problem, the LSE equation is as shown in equation (2.10. 
where 𝑦 is the vector of the data points of the output time series, X is the regression matrix, each row 
being all the 𝑢(𝑘 − 1), . . . , 𝑢(𝑘 − 𝑛), 𝑦(𝑘 − 1), . . . , 𝑦(𝑘 − 𝑚) with respect to its 𝑦(𝑘), where 𝑘 goes 
from 1 to the length of 𝑦, and 𝜃 is the optimal estimate of the ARX coefficients  𝑏 , . . . , 𝑏 , 𝑎 , . . . , 𝑎  
in equation (2.9. The best estimate of 𝑦 in the least square sense is 𝑦 = 𝑋𝜃. However, inverting the 
Hessian (𝑋 𝑋) requires large computer memory when the number of coefficients 𝑏 , . . . , 𝑏 , 𝑎 , . . . , 𝑎  
is large, since the size of (𝑋 𝑋) is (𝑚 + 𝑛) ×  (𝑚 + 𝑛). In that case, iterative methods, such as gradient 
descent (also called steepest descent) can be used [94]. The idea is to use the local gradient of the error 
function and update the coefficient of the equation such that it goes in the direction of the negative 
gradient. This process is done iteratively until an acceptable error is reached. 
 
Figure 2.13 – Bias/variance tradeoff. The model error can be decomposed into bias and variance 
part: a) relatively high variance error, b) lower variance due to more data or less noise than in a) 
[94]. 
𝜃 = (𝑋 𝑋) 𝑋 𝑦 (2.10) 
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There are a variety of tools to aid in choosing the embedding dimensions (𝑚 and 𝑛) for a given 
system/dataset, such as autocorrelation, cross-correlation, and mutual information [96]; however 
successively embedding in higher dimensions and looking at consistency of the results is the method 
generally employed [96]. Model generalization power, which is directly related to embedding 
dimension, is a tradeoff between bias and variance, where one might want to choose a model complexity 
(embedded dimensions) that minimizes the mean square error (MSE) between any of the real system 
outputs and the AR output ( Figure 2.13). In practice, a large bias refers to “underfitting”, where the 
error is similar for the training data (data used for LSE) and the new data. A large variance is referred 
to “overfitting”, meaning that the error for the training data will be small; however, the model will have 
a large error for a new dataset. For example, for a small noisy dataset being fitted with more parameters 
than needed the non-important parameters will be used to fit the noise. This leads to an estimate with 
large variance. 
2.3.2 Artificial Neural Networks  
The ARX models are limited to linear dynamics problems. However, the same architecture embeds 
nonlinear functions for building nonlinear ARX (NARX) models. The nonlinear functions can be 
implemented within an artificial neural networks (ANN), which is a universal function approximator 
[97]. One of the most commonly used feedforward ANN architectures is the multilayer-perceptron 
(MLP) shown in Figure 2.14 for a multi-input/multi-output configuration [98]. 
 
Figure 2.14 - A multi-layer perceptron with one hidden layer (adapted from [98]). 
The outputs of the MLP are computed using equation (2.11). 
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where 𝑤( ) denotes a weight of the MLP, which belongs to the kth neuron in layer 𝑙, associated with the 
jth neuron of the layer 𝑙-1. The fucntions 𝑔(. ) and ℎ(. ) are called the activation function, which are 
sometimes different from one layer to the next; they are generally sigmoidal or hyperbolic tangent 
functions in the hidden layers and linear functions at the output layer for regression problems. In deep 
neural networks (more than one hidden layer), however, the rectified linear (ReLu) activation function 
is more common [99].  
In ANN, the weights 𝑤( ) are the coefficients of the equation that are modified to fit the training 
data. Error backpropagation is an adaptation of the (stochastic) gradient descent to ANN, where the 
weights 𝑤( ) are updated at each iteration in the direction of the negative gradient of the loss function. 
However, due to the loss function of an ANN, the optimization would not usually guarantee a global 
minimum of the error norm since it can converge to local minima. It is not a problem for the engineering 
field, as long as this minimum achieves the error requirement prescribed a priori. See [94] for a 
complete derivation of error backpropagation for single and multiple hidden layer MLP models. 
The learning rate 𝜂 is the variable used to quantify the rate of change of the weights of the ANN 
proportional to the gradient of the error function at each iteration (equation (2.12)).  
where  is gradient of the loss function computed from the backpropagation. A fixed learning rate 
would results in a tradeoff between fast convergence of the optimization and the model error at 
convergence. The former can be visualized by a change in the weights that is too large which results in 
missing the optimal value than is situated between 𝑤  and 𝑤 . For that reason, the learning rate is 
generally adaptive. There are many training methods that adapt the learning rate, such as the Levenberg-
Marquardt, which is a combination of gradient-based methods and nonlinear least square, whereby 
convergence can be achieved in a lower number of iterations in comparison to stochastic gradient 
descent, but each iteration is more time consuming [94]. 
Another consideration for training an ANN is how the training data are fed to the model since it 
affects the training convergence. Common methods include  one-shot batch adaptation,  pure stochastic 
gradient descent, and  minibatch adaptation. One-shot batch adaptation updates the weights over the 




𝑥  (2.11) 






entire dataset, averaging over a large amount of information. It has generally faster convergence, but it 
is more susceptible of getting stuck in a local minima. In pure stochastic gradient descent (sample 
adaptation), on the other hand, the weights of the ANN are updated on every single instance of the 
dataset. Since it's based on one random data point, it's very noisy and may go off in a direction far from 
the batch gradient. However, the noisiness is needed in non-convex optimization, because it helps 
escaping local minima [100]. The disadvantage of sample adaptation is that it is inefficient and many 
iterations over the entire dataset are needed. The minibatch method is a compromise between injecting 
noise to each weight’s update and achieving a relative speedy convergence. It can even be an optimal 
choice when combined with batch normalization techniques [101]. 
When training an ANN, one way to deal with the bias/variance tradeoff, including the previously 
discussed method, is to use cross-validation and early stopping. The idea is shown in Figure 2.15, where 
the ANN is trained only on a portion of the data and uses another portion to test the accuracy of the 
ANN on unseen data (generally called the validation dataset). The training can be stopped such that the 
error is minimized on the validation portion. One must be careful not to report the error on the validation 
portion as being the MSE of the ANN. This MSE is biased towards the validation data and minimized 
in the training process, so should provide an optimistic estimate of MSE. Generally, a third data split is 
used to really test the accuracy of the ANN. 
 
Figure 2.15 - Learning curves for the training and the test data (C= MSE) [98]. 
So far, only static ANNs were explained, meaning that there is no feedback between the input layer 
and the output layer of the ANN. When an ANN is dynamic, there is a feedback loop of the output layer 
to the input layer with a delay. These so-called recurrent neural network (RNN) are a form of NARX 
models [94]. Those models can be used in one-step-ahead prediction, where the prediction output 𝑦(𝑘) 
is a function of the previous measurements 𝑦(𝑘 − 1), … , 𝑦(𝑘 − 𝑚). NARX models can also be used in 
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simulation mode, where the previous predicted outputs 𝑦(𝑘 − 1), … , 𝑦(𝑘 − 𝑚) are used to predict the 
output 𝑦(𝑘). Both, one-step-ahead prediction and simulation mode NARX models, can generally be 
trained as a static ANN, where the measurements are used in the input layer and the estimation output 
is compared with the measured input. However, simulation mode can sometimes benefit from a more 
sophisticated training method called backpropagation-through-time (BPTT). The idea is the same as 
backpropagation but the model is unfold with time (the output at one time step is connected to the input 
at the next time step), becoming similar to ANN with multiple hidden layers (called deep neural 
networks). However, BPTT is practically difficult because of the vanishing gradient problem [102] like 
deep neural networks. For instance, the hyperbolic tangent function have gradients in the range (0,1], 
and backpropagation computes gradients by the chain rule (  in equation (2.12 depends on the 
derivative of the deeper layers). In an n-layer network, this means that the gradient decreases 
exponentially with n resulting in the early layers training very slowly and at one point the weights stop 
changing. Nevertheless, NARX model can have good simulation accuracy without BPTT when using 
the good inputs [103]. 
2.3.3 Support Vector Machines 
Support vector machines (SVM), like ANNs, are data-driven models that tune their parameters 
according to a cost function. SVM are applicable to regression and classification problems, as well as 
outlier detection, which will be discuss in Section 2.3.3.1. In this section, a brief overview of 
classification using SVM is provided, which is then transposed to outlier detection using one-class 
SVM (OCSVM). 
The general idea of SVM is to find the hyperplane that splits data into two classes. Since there are 
many of them, SVMs are trained to find the hyperplane with the optimal margin, i.e., the hyperplane 
with the largest distance to the closest datapoints, called support vectors [104]. The previous definition 
is called hard margin SVM since it considers that the two classes are perfectly separable. Most of the 
time, SVMs are used with soft margins, which permit some data to be within the margin or to be 
misclassified by the means of slack variables (see 𝜉  in equation (2.14). The tradeoff between a large 
margin and misclassification rate is generally dealt with a tunable parameter such as C in C-SVM [105] 
or ν in ν-SVM [106]. This is equivalent to the bias-variance tradeoff discussed in Section 2.3.2. 
SVM are a kernel-based learning algorithm [104], meaning that the input data is transformed, using 
a kernel, into a high-dimensional space (feature space), and the learning is performed in the feature 
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space. The most versatile kernel is the Gaussian kernel, since it is equivalent to projecting the data into 
an infinite dimensional space [104], is defined in equation (2.13. 
where c is a tunable parameter that controls how much overfit to data there is (larger c means more 
overfit), and 𝑥  and 𝑥  are the input vectors. 
The hyperplane separating the data into two categories (𝑦 = 1 on one side and 𝑦 = −1 on the other) 
is define as 𝑤 ∙ 𝑘(𝑥 , 𝑥 ) + 𝑏, where w and 𝑏 are the weights and the bias of the hyperplane to be 
learned from the data. This hyperplane has a soft margin 𝜌, in which some of the training data can lie 
(or even be misclassified) if their respective slack variables 𝜉 >0. 
Putting everything together for the ν-SVM algorithm [106], the hyperplane parameters can be found 
by selecting a value for the free parameter 𝜈 and by solving the primal optimization problem on the 
training data as follow:  
subject to 
 
where 𝑥 is the input data, 𝑦 the data label (1 or -1), 𝑚 is the number of training datapoints, 𝜉  is a slack 
variable, w and 𝑏 are the parametrization of the hyperplane, ρ is the margin parameter, and ν is a 
variable to be optimized (or chosen), which will be explained more in detail in the context of outlier 
detection (Section 2.3.3.1).  
2.3.3.1 One-Class Support Vector Machines 
When dealing with unlabelled data, OCSVM can be used to find the underlying distribution of the 
data. In this scenario, equation (2.16 is modified such that the data can be separated in two categories 
(1 or -1) according to the free parameter ν, instead of separating labels (see equation (2.17)) [107]. 
subject to 
𝑘(𝑥 , 𝑥 ) = 𝑒 ‖ ‖ /  (2.13) 
min
, , ,
𝜋(𝑤, 𝜉, 𝜌) =
1
2
‖𝑤‖ − 𝜈𝜌 +
1
𝑚
𝜉  (2.14) 
𝑦 (𝑤 ∙ 𝑘(𝑥 ) + 𝑏) ≥ 𝜌 − 𝜉  (2.15) 
𝜉 ≥ 0, 𝜌 ≥ 0 (2.16) 
min
, ,






𝜉 − 𝜌 (2.17) 
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Once solved, the decision function applied to new data points is the following: 
The primal formulation can become difficult to solve if the dimension of the input 𝑥 is large. A 
solution to this curse of dimensionality is to solve the dual problem, which is derived by using the 
Lagrangian of the primal problem: 
subject to 
Once solved, the decision function applied to new data points is the following: 
where n is the number of support vectors, which represents the number of non-zero 𝛼’s found in 
equation (2.20. The margin 𝜌, which acts as an offset in a one-class problem, can be recovered from 
any support vector 𝑥  by summing proportionally the kernel with respect to 𝑥 . 
The free parameter ν has the following properties [107]: 
1. (0 < ν ≤ 1) 
2. ν is an upper bound on the fraction of outliers, that is, training points outside the estimated 
region. 
3. ν is a lower bound on the fraction of support vectors. 
In other words, a small value of ν leads to fewer support vectors and, therefore, a smooth, crude 
decision boundary. Property 2 only holds if 𝜌 is computed from equation (2.22. However, the margin 
𝜌 can be iteratively selected in order to have a known fraction of outliers in the training data [108]. 
2.4 Cuffless Blood Pressure Estimation 
Cuff-based BP monitoring techniques (introduced in Section 2.2.1), are uncomfortable and 
disruptive [30], and consequently, negatively impact patient compliance, despite the fact that 
(𝑤 ∙ 𝑘(𝑥 )) ≥ 𝜌 − 𝜉 , 𝜉 ≥ 0 (2.18) 




𝛼 𝛼 𝑘(𝑥 , 𝑥 )
,
 (2.20) 
0 ≤ 𝛼 ≤ , ∑ 𝛼 = 1 (2.21) 
𝑓(𝑥) = sign((∑ 𝛼 𝑘(𝑥 , 𝑥) − 𝜌)  




continuous BP monitoring can result in better treatment management [10]. An alternative to cuff-based 
systems is cuffless BP monitoring, which requires less cumbersome and expensive hardware [7], 
enables mobility for the patient, and eliminates discomfort associated with the cuff-based monitoring 
[8]. Cuffless BP monitoring relies on the information encoded in an alternative physiological measure, 
generally PPG (see Section 2.2.2), coupled with a surrogate model of BP. In this section, three main 
cuffless BP estimation methods to estimate SBP and DBP are covered, namely: pulse transit time (PTT) 
based, feature extraction of the PPG waveform, and end-to-end machine learning. But first, how models 
are generated and calibrated will be introduced, since it is applicable to all BP estimation methods. 
2.4.1 Model Generation, Calibration, and Monitoring Phase3 
The first step of cuffless BP monitoring is the initialization phase in which a parametric model is 
selected and then calibrated using data. In this initialization context, calibration refers to fitting a model 
to data, e.g., linear regression or training an artificial neural network. Once calibration is done, the 
second and final step of cuffless BP is the monitoring part in which the calibrated model uses as input 
the measurement of the features and outputs an estimation of BP. Calibration data should include 
matching input-output pairs, e.g., measurements of relevant features of the surrogate signals and 
measurements of BP. This calibration process can be person-specific, population-based, or hybrid. 
Person-specific calibration relies solely on data from the individual for which the model will 
subsequently be used. Population-based models are calibrated on the data of many individuals and 
imply that the model should perform well on different individuals likely not included in the calibration 
data. Hybrid calibration is the process of calibrating a population-based model to a specific person.  
When calibrating a BP model, the data need to cover a large range of BP in order to be well 
calibrated. In the case of population-based models, the range of BP generally comes from the spread in 
BP between individuals, i.e., hypotensive, normal BP, and hypertensive individuals. In the case of 
calibrating person-specific models, it is suggested to impose a change in BP through interventions, such 
that the calibrated model is able to generalize well in the monitoring phase in which the person’s BP 
will change constantly depending on their activities of daily living. 
 
3 The content of this section is primarily from [109] 
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2.4.2 Pulse Transit Time 
Pulse transit time (PTT) is the time delay for the pressure wave to travel between two arterial sites 
[6]. PTT is inversely related to BP as described by the Moens-Korteweg equation (equation (2.23), 





PTT = 𝑙 PWV⁄  (2.24) 
where E is the elastic modulus of the artery, h is its wall thickness, r is the vessel radius, and ρ is the 
blood density. 
This rather simplified model is the base for most of the physical models used to develop the 
mathematical relationship between PTT and BP, in which an assumed function that relates E to BP is 
used. The most common physical models are logarithmic PTT, computed as [111]: 
BP = 𝑎ln(PTT) + 𝑏 (2.25) 




+ 𝑏 (2.26) 
Other relationships have been developed based on experimental PTT–BP data, such as linear PTT 
[113]: 
BP = 𝑎PTT + 𝑏 (2.27) 




+ 𝑏 (2.28) 
Some models even included other physiological parameters, such as inverse quadratic PTT with a linear 




+ 𝑏HR + 𝑐 (2.29) 
where the user-specific coefficients 𝑎, 𝑏, and 𝑐 are determined using regression techniques based on 
measurements of subject-specific PTT-BP pairs. 
Typical PTT-based methods use a PPG combined with another signal, such as another PPG at a 
different peripheral site [116], [117], ECG (see Section 2.2.3) [16], [113], [118], a ballistocardiogram 
(see Section 2.2.4) [119]–[121], or a seismocardiogram (see Section 2.2.4) [91], [93], [122]. The time 
delay between the ECG waveform and the PPG waveform is called the pulse arrival time (PAT), which 
is equal to the sum of PTT and the pre-ejection period (PEP) of the cardiac cycle [6]. The PAT is often 
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used as a surrogate for PTT, the latter of which is not always practical. PAT has been defined in many 
ways over the years; the most common are the time delay between the ECG peak and the PPG foot, 
maximum slope, peak, or the PPG intersecting tangent method to name a few [6].  
Estimating BP from PTT or PAT is physiologically meaningful, which explains the considerable 
efforts to date in pursuing these methods for cuffless BP estimation. However, using PTT or PAT means 
that at least one PPG sensor is usually employed and these sensors are known to be susceptible to 
motion artefacts [84], [123]. Even though, various definitions have been compared and the intersecting 
tangent method revealed the best PTT–BP correlation and robustness to artefact [6], extracting accurate 
PTT is still difficult. Moreover, there are no consensus as where PAT or PTT should be measured for 
BP estimation. For instance, in one study comparing ear PAT, toe PAT, finger PAT, ear-toe PTT, ear-
finger PTT, and finger-toe PTT, toe PAT was significantly more correlated with SBP (ρ ≈ - 0.6) [124]. 
On the other hand, other studies shows that PAT is not an adequate surrogate for PTT as a marker of 
BP [125]. Therefore, there is a lot of variability in results in the literature. Another downside of PTT-
based methods is that calibration models are user-specific, and are reliable for only minutes to hours 
[6]. 
2.4.3 PPG Waveform Features 
The second set of cuffless BP methods uses a set of features extracted from the PPG waveform. The 
methods can be split into two different categories: physiological-based models and non-physiological-
based models [12]. Although the difference is not clear cut, the former relies on extracting specific 
physiological parameters, such as instantaneous heart rate, and systolic and diastolic periods [12], 
whereas the latter do not rely solely on physiological parameters. For physiological-based methods, BP 
is then estimated using the extracted parameters and a parametric model, such as the Windkessel model 
[126], regression of long-term and short-term features [127], or the pulse transport theory-based model 
[128]. Despite physiological-based models being intuitive and computationally less expensive, those 
models are not common in the literature due to their inaccuracy and their reliance on frequent 
calibration [12].  
Non-physiological-based models generally use a larger extracted feature pool from the PPG 
waveform. These features, which are not necessarily physiologically meaningful, are then fed into a 
machine learning-based algorithm to predict BP. Some common physiological features of the PPG 
waveform are [22]: 
 Augmentation Index (AI): a measure of the wave reflection on arteries [129]. 
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 Large Artery Stiffness Index (LASI): an indicator of the arterial stiffness [22]. 
 Inflection Point Area Ratio (IPA): can be considered as an indicator of the total peripheral 
resistance [129].  
Other features, such as pulse amplitude [130],  peak-to-onset interval [131], pressure index [132], 
heart rate and modified normalized pulse volume [8], along with other time and frequency domain 
features, can also be extracted from the PPG waveform [133]. There are too many existing features to 
make an exhaustive list. For instance, in [134], 153 features were extracted from the PPG waveform 
only. Moreover, these PPG features are sometimes combined with PTT to improve the accuracy [22], 
[24], [135]. Another set of common features used to estimate BP comes from the double time derivative 
of the PPG signal (sometimes called accelerated PPG), since the waveform is related to blood 
circulation [129].  
Once selected features are extracted, they are fed into a machine learning algorithm to predict the 
BP. The different PPG waveform features methods used for cuffless BP monitoring found in the 
literature can be person-specific, population-based, or hybrid.  The difficulty in this approach lies in 
the feature extraction from the morphology of PPG as it is highly susceptible to noise or artefacts [84], 
[123], but also because some morphologies do not fit in the typical mold [22]. This makes it difficult 
to apply the methods without manually tuning the algorithms. This is one motivation to used end-to-
end learning, which is the topic of the next section. 
2.4.4 End-to-End Machine Learning 
End-to-end machine learning or deep learning, in contrast to typical machine learning, learns to 
extract the relevant features from raw inputs as well as learning their relationships [99]. Deep learning 
can therefore handle feature extraction and the learning, which copes with both the inadequacy of pre-
determined (hand-crafted) features to fully characterize BP and the difficulty of extracting them using 
algorithms [13]. Many deep learning approaches to estimate BP have been developed and a recent 
review of the available models can be found in [13]. To the author’s knowledge, all end-to-end models 
were developed for population-based or hybrid calibration. 
The main characteristic of end-to-end BP models is that they use raw signals, such as ECG and PPG, 
as inputs. The various works in the field have tesed different deep learning architectures, such as 
convolutional neural network [136], long short-term memory network [137], auto-encoder [138], etc. 
Second, different inputs are used, such as 10 seconds of continuous ECG and PPG signals [139], single 
heartbeat PPG and its frequency domain information [140], PPG and personal information [141], etc. 
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Another difference between studies is the data used. The most common datasets are the MIMIC II [142] 
and the Queensland [143] databases, but some studies used their own collected data [141]. 
Nevertheless, the data used is heterogenous due to the difficulty of getting good data in databases. For 
instance, the number of subjects used in different studies varies widely from 15 [144] to 1557 [145]. 
The validation of end-to-end models are also largely heterogenous. Some studies split the data into 
training, validation, and testing [136], or used k-fold cross validation where all the data from different 
subjects are shuffled together [139], [145]. Those studies generally result in low error and high 
correlation estimation due to the fact that the models are already trained to estimate a given individual’s 
BP, sometimes for only a couple of seconds [145]. This kind of method is part of the family of hybrid 
calibration models, since they use population data plus some of each individual’s data to calibrate the 
model. Other studies used data in which some subject’s data are left out for further validation [141]. 
This refers to population-based calibration and those models have larger estimation error but are more 
applicable to real world BP measurement. 
2.4.5 Fusion of Models 
The method of combining models is generally referred to as estimation fusion, information fusion, 
data fusion, of sensor fusion, among other names [11]. One well established definition of data fusion 
was provided by the Joint Directors of Laboratories (JDL), establishing five levels of data fusion [12]. 
Herein, the important levels to distinguish are the sensor level and the track level [13]. Sensor level 
fusion refers to the use of multiple sensors and combining their information to improve estimation 
performance. Sensor fusion has been employed previously to improve BP estimates. For instance, using 
multiple PPG sensors and a seismocardiogram [146], using multiple bioimpedance sensors [147] to 
better estimate PTT, and using ECG and two pulse pressure waveform sensors to extract more features 
for BP estimation [135], [148]. Track fusion, which combines multiple BP estimates to improve 
accuracy, has also been considered [149], but the uncertainty of the estimation has not been explored, 
which is a benefit of using track fusion algorithm [150]. 
2.5 Conclusion 
BP is largely variable from one individual to another, due largely to differences in physiology 
(arterial stiffness and peripheral resistance), but it also varies continuously due to body posture and 
activity in general. Existing BP measurement techniques are cumbersome and do not provide 
continuous measurement of BP conveniently. An interesting alternative to measure BP is cuffless BP 
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monitoring. Existing models for cuffless BP monitoring, however, only provide SBP and DBP 
estimations, with a couple of noted exceptions that also enables the estimation of the mean arterial 
pressure (MAP) [103], [106] or the pulse pressure [87]. The estimation of the blood pressure waveform 
can give access to additional health markers such as arterial stiffness, pulse wave amplification, and 
stroke volume and cardiac output. Dynamical modeling approaches such as NARX with ANN are well 
suited for estimating the BP waveform due to the dynamic change in BP beat-by-beat. PPG and ECG 
signal have shown their potential as BP surrogate signals and end-to-end learning can help to cope with 
the difficulty of extracting features from them. Developing a cuffless BP monitoring technique that has 
the capabilities tracking SBP and DBP within the AAMI standard during activities of daily living, that 
gives access to the pulse pressure amplification, and that can monitor BP estimation uncertainty has 





Modeling the Blood Pressure Waveform4 
In this chapter, a modeling approach is proposed to accurately estimate the blood pressure (BP) 
waveform and extract important BP features, such as systolic BP (SBP), diastolic BP (DBP), and mean 
arterial BP (MAP). Access to the full waveform has significant advantages over previous cuffless BP 
estimation tools in terms of accuracy and access to additional cardiovascular health markers (e.g., 
cardiac output [20], [21]), as well as potentially providing arterial stiffness [60] and identifying different 
cardiovascular diseases [18]. Nonlinear autoregressive models with exogenous input (NARX) are 
implemented using an artificial neural network (ANN) to predict the BP waveforms using 
electrocardiography (ECG), and/or photoplethysmography (PPG) signals as inputs. Once the ANN is 
trained on a time series, the BP monitoring can be removed and the future BP can be estimated using 
only the exogenous inputs (ECG and/or PPG). We hypothesize that modeling the dynamics of the BP 
and estimating its complete waveform using the proposed NARX model can improve the accuracy of 
SBP, DBP, and MAP estimations. 
3.1 Method 
3.1.1 Model Architecture 
The ANN used by the NARX model was a multilayer Perceptron with one hidden layer of 10 
neurons in every case. Hyperbolic tangent and linear activation functions were used for hidden neurons 
and output neurons, respectively. The NARX model was used to predict the complete time series of the 
BP, from which the SBP, DBP, and MAP were also extracted.  
Three different exogenous inputs were explored: ECG, PPG, and both simultaneously. In its general 
form, the ANN inputs consisted of 1 and 2 time-step delays of the BP and 1 to n time-step delays of the 
exogenous input. The output layer generated the current BP estimate. The model architecture is 
 
4 Parts of this chapter have been adapted from the following publication: 
C. Landry, S. D. Peterson, and A. Arami, “Nonlinear Dynamic Modelling of Blood Pressure Waveform: Towards 




summarized in Figure 3.1. A feedforward ANN was trained on the exogenous inputs and the BP 
measurements (Figure 3.1.a). Then, the trained ANN was used to estimate the BP on the test data, where 
a feedback loop with delay was implemented to provide the ANN with the estimates of the required 
delayed BPs (Figure 3.1b).  
 
Figure 3.1 - Schematic of the NARX model used for a) training of the ANN as a feedforward 
ANN, and b) estimation and testing the BP using a recurrent ANN. 
 
Figure 3.2 - Typical ECG, PPG, and BP signals illustrating the potential temporal delays 
between signals. 
Figure 3.2 shows representative examples of typical ECG II, finger PPG, and radial artery BP 
waveforms, highlighting that a delay can appear between the peaks of the exogenous input and the BP 
pulse arrival at a peripheral measurement location. In this example, the ECG peak appears before the 
BP peak, whereas the PPG peak is located after due to the measurement site being located further down 
the arm (fingertip vs radial artery). Depending on the peripheral measurement site and the sampling 
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than the maximum delay between the BP peak and the input peak. This ensures that the peak of the 
exogenous input is fed into the ANN when predicting the BP peak.  
3.1.2 Training 
The delayed exogenous inputs and the delayed BP measurements were used as inputs for the training 
of the ANN (Figure 3.1.a). White Gaussian noise (Mean = 0 and Variance = 1 mmHg2) was added to 
the BP time series to enrich the training data and improve the model robustness to input noise. Error 
backpropagation was used with the Levenberg-Marquardt optimization algorithm to minimize the norm 
of the difference between the predicted and measured values of the BP. A training stop condition was 
defined as an increase of the mean square error on the validation dataset in six consecutive epochs.  
Two different data splits were used in training and testing the ANNs. Interval training mode, shown 
in Figure 3.3, used eight minutes at the beginning (A) and eight minutes at the end of the time series 
(C). The remaining data (B) were used for testing the accuracy of the trained model’s estimation. Only 
70% of the 16-minute training data were used for training the weights of the ANN, while 15% were 
used for validation (to check the training stop condition) and 15% for testing of estimation performance 
in a one-step-ahead prediction. The mean square error of the 15% test data was used as a threshold; if 
it was 20% higher than the mean square error on the training or the validation data, the ANN was 
retrained. 
Predictive training mode only uses the first eight minutes of the dataset, part (A), and tests the model 
on Part B (Figure 3.3). 
 
Figure 3.3 - Schematic of data split for the Interval training mode. Parts A and C were 
randomly split into training, validation, and test datasets. Part B is the sub dataset used for 
comparing the performance of the models. Only part A was used to train for the Predictive mode. 
A B C 
8 min 8 min 54 - 320 min 




70 % 15 % 15 % 
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3.1.3 Subject Selection and Preprocessing 
Patient data for this study were extracted from the MIMIC II database [151]. The database contains 
clinical signals, such as time-stamped nurse-verified physiological measurements, and vital signs time 
series obtained from a diverse population at an intensive care unit. The physiological waveforms from 
the MIMIC II database used in this study were obtained from the CareVue Clinical Information System 
(models M2331A and M1215A; Philips Healthcare, Andover, MA), which includes synchronized ECG 
(II, III or V), finger PPG, and invasive arterial BP from one of the radial arteries sampled at 125 Hz. 
PhysioBank ATM was used to extract data from 15 different patients from the database to assess 
the performance of the NARX models [152]. The inclusion criterion for patients was the access to at 
least an hour of clean data, defined as a time span without abrupt changes in the ECG, PPG, and BP 
waveforms. The dataset lengths for the selected subjects ranged from 70 min to 336 min, with a mean 
and standard deviation of 160±84 min. The record numbers of the selected subjects are included in the 
Appendix. 
Time points within each dataset that were corrupted by noise were removed from the dataset prior 
to model training. To find the noisy portions, double derivatives of the PPG and BP signals were 
computed. If the amplitude was outside +/- 5 standard deviations of the double derivative signals, the 
heartbeat was removed from the dataset. Outlier removal was double checked by a visual inspection of 
the data. It was observed that for subjects 3900975m and 3903773m, using +/- 5 standard deviation of 
the double derivative signals removed too much uncorrupted data. Therefore, 6 standard deviation was 
used for those subjects. Nevertheless, the removed time points generally spanned no more than a few 
heartbeats and may have arrived from temporary motion artifacts or minor signal loss/corruption. For 
all datasets employed no more than 7.2% of the data were removed for any subject, with an average 
and standard deviation of 2.6±2.2%. 
The general architecture of the model (Figure 3.1.a, b) was adapted to the MIMIC II database, where 
specific measurement locations were used (three leads ECG, finger PPG, and radial artery BP). The 
delay between the ECG peak and the BP peak was smaller than 0.8 seconds. Zero to 99 time-step delays 
were used to ensure that the ECG peak was fed into the ANN when the output should be the BP peak. 
The NARX model with ECG inputs (ANNECG) used the following inputs to estimate BP(k): 




PPG was measured further downstream than the BP (fingertip versus radial artery in the present 
study), resulting in a delay between the signals which is apparent in the measurement peaks (Figure 
3.2). Thus, 1 to 100 future time-step delays of the PPG was used in the ANN (ANNPPG) to estimate the 
BP(k): 
ANNPPG input layer: BP(k-1), BP(k-2), PPG(k+101), …, PPG(k+1) (3.2) 
 
Finally, the ANN model used to estimate BP(𝑘) from the ECG and PPG waveforms (ANNECG+PPG) 
was a combination of the two previous models with the following input layer: 
ANNECG+PPG input layer: BP(k-1), BP(k-2), ECG(k), …, ECG(k-99), 
PPG(k+101), …, PPG(k+1) 
(3.3) 
3.1.4 Pulse Arrival Time Model 
Subject-specific PAT models were implemented to facilitate direct comparison with this established 
cuffless BP monitoring method. Specifically, SBP and DBP estimates were computed as [118]: 
SBP = 𝑎 PAT + 𝑏 HR + 𝑐  
DBP = 𝑎 PAT + 𝑏 HR + 𝑐  
(3.4.a) 
(3.4.b) 
where the linear coefficient 𝑎 , 𝑏 , and 𝑐  were patient-specific. The coefficients were determined 
using the Least Square Estimate method for each training dataset [118]. The model was implemented 
with both PATf and PATp, computed as the time difference between the ECG peak and the foot PPG or 
its peak respectively (Figure 3.2). The heart rate (HR) was computed from the ventricular contraction 
peaks (R-R interval) of the ECG signal. The MAP estimates were computed as [14]: 
MAP = (SBP + 2 (DBP))/3 (3.5) 
3.1.5 Data Analysis 
For each NARX model, a cross-correlation analysis was performed to quantify any delay between 
the predicted and the measured BP. The mean and variance of the models’ error, which can describe its 
bias and precision, were assessed via scatterplots and Bland-Altman plots, where ±1.96 SD was used 
for a 95% confidence interval. The SBP, DBP, MAP and the BP waveform estimations for the four 
different models (three NARX and one PAT) were benchmarked against BP error standards from the 
Association for the Advancement of Medical Instrumentation (AAMI) protocol, which requires that a 
device must achieve within the limits of 5 mmHg bias and 8 mmHg precision [153]. The mean of the 
subjects’ mean error and standard deviation error were used for the comparison. Furthermore, the mean 
absolute error (MAE) and the Pearson correlation coefficient (𝑟) were used to compare the models. 
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Moreover, different visual comparisons of the measured BP and estimated BPs are made by plotting 
the SBP (SBP has a larger variance than DBP and MAP) to understand how well the model can estimate 
changes in BP on different time scales (beat-to-beat, minute-scale, and hour-scale). The CPU training 
time and the training epochs were compared for each NARX model.  
Friedman tests (α=0.05) was used to identify any statistical difference at the group level (comparing 
more than two distributions). If a difference was observed at the group level, the Friedman test was 
followed by Wilcoxon rank sum tests (p=0.05) with Bonferroni corrections to identify any statistical 
differences between the models. Those statistical tests are non-parametric, and there is no underlying 
assumption regarding the distributions of the tested samples. Comparing four different models (three 
NARX and one PAT), we used six pair-wise comparisons on each metric (e.g., mean errors) based on 
the data of 15 individuals. 
3.2 Results 
3.2.1 Model Performance Overview 
Representative samples of predicted BP waveforms using ANNECG in both training modes at early 
and late times of segment (B), see Figure 3.3, are benchmarked against the measured BP in Figure 3.4 
for three subjects with qualitatively different waveform characteristics. For all 15 subjects, no delay 
was observed in the closed-loop predicted waveform based on the cross correlation analysis, as can be 
observed in Figure 3.4. The other models (ANNPPG and ANNECG+PPG), while not presented in this figure, 
yield similar results characteristics. 
The ANNECG error evolution and overlayed linear regression over a period of 55 minutes (the 
shortest sample length across all subjects; subject 3000860m) is presented for all 15 subjects in Figure 
3.5. The red lines are the subjects with the largest positive or negative error at the end of the interval. 
This figure shows the error evolution obtained for models trained under both training modes. It can be 
observed that the Interval training mode has lower model drift compared to the Predictive training 
mode, which is consistent with qualitative observations in Figure 3.4. Moreover, the drift of the error 





Figure 3.4 - Comparison of actual versus predicted BP waveforms for subject (a) 3002090m, 
(b) 3000480m, and (c) 3000989m, see Appendix for details. The BP waveforms show considerable 
qualitative differences in shape and heart rate variability. 
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Figure 3.5 - Filtered BP error and linear fit for the 15 subjects for (a) Interval training, and 
(b) Predictive training for the first 55 min of testing data for each subject. Grey dashed lines are 
raw data, blue lines are linear regressions for each subject, and red lines are linear regressions of 
the subjects with the highest error at the end of the interval, (positive or negative). 
The mean and standard deviation of the absolute error averaged over all subjects is presented in 
Figure 3.6.  Time is normalized by the total signal length for each subject, which is used to bin the data 
prior to averaging. For the Interval training mode the expected absolute error is relatively constant over 
the entire prediction time; on the contrary, error tends to increase over time when Predictive training is 
employed. The standard deviation of error is similarly constant for Interval training and increases for 
Predictive training over time.  






































Figure 3.6 - Mean of the 15 subjects mean absolute error over time with the error bars 
representing the standard deviation. For each subject the mean absolute error is taken over 20 s 
of estimation. 
 
Figure 3.7 - Scatterplots of (a) SBP and (b) DBP for Interval training mode. The solid line is 
the regression line through all data Bland–Altman plots of (c) SBP and (d) DBP. The solid line 
and dashed lines represent fixed bias (M) and M ± 1.96 standard deviation range, respectively. 
Average = (estimated + measured)/2, Difference = measured – estimate. Subjects are color coded 
as defined in the Appendix. 
Figure 3.7 presents scatterplots of the measured versus estimated SBP and DBP extracted from the 
BP waveform estimates with ANNECG for all subjects for Interval training. Bland-Altman plots of the 
SBP and DBP are also presented to highlight the bias and variance in the estimates. The data were 
sampled at equal intervals; 3000 data points (part B) for each subject were used, which is the largest 
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common number of data points for the subjects. The linear fit between estimated and measured SBP 
and DBP showed high coefficients of determination, R2=0.87 and R2=0.93, respectively. SBP and DBP 
were accurately estimated, where the errors fall within the 95% confidence interval of 0.4±12.0 mmHg 
and 0.5±5.8 mmHg, respectively. 
Similarly, scatterplots and Bland-Altman plots for Predictive training mode are presented in Figure 
3.8. The estimated SBP and DBP exhibit good correlation with the measurements, R2=0.76 and 
R2=0.86, respectively. Furthermore, SBP and DBP were estimated with 95% of confidence within -
1.2±17.8 mmHg and -0.6±8.4 mmHg, respectively.  
 
Figure 3.8 - Scatterplots of (a) SBP and (b) DBP for Predictive training mode. The solid line 
is the regression line through all data Bland–Altman plots of (c) SBP and (d) DBP. The solid line 
and dashed lines represent fixed bias (M) and M ± 1.96 standard deviation range, respectively. 
Average = (estimated + measured)/2, Difference = measured – estimate. Subjects are color coded 
as defined in the Appendix. 
3.2.2 Model Comparison 
To compare both PAT models (PATp and PATf) the mean value of the intra-subject mean error, the 
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estimates were used in both training modes (Interval or Predictive).  There were no statistical 
differences between any of the distributions (Wilcoxon test p≥0.45). 
The expected value and standard deviation of the MAE computed across the 15 subjects for SBP, 
DBP, and MAP in both training modes are shown in Figure 3.9 for PATp and PATf. The results exhibit 
mild differences, with PATp yielding lower mean MAE in all cases. Given the slightly better 
performance, PATp was used as a reference to compare the NARX models within this section.  
 
Figure 3.9 - Comparison of mean absolute error between different PAT models estimates and 
the BP measurements. The results are shown for SBP, DBP, and MAP for both the Interval and 
Predictive training modes. Bars represent the mean of all subjects and the error bars show ± 
standard deviation. 
The absolute value of the mean error, |𝜇 |, (expected value and standard deviation) computed on 
the 15 subjects is presented in Figure 3.10.a for SBP, DBP, MAP, and the full BP waveform (BPW) 
for both training modes and all input signals considered. For the PAT model, the three outputs (SBP, 
DBP, and MAP estimates) are shown. The absolute errors were used to enable plotting in one quadrant, 
which is computed after performing all other calculations. The horizontal dashed line in Figure 3.10.a-
b indicates the AAMI requirement limit. All models meet the AAMI requirement of less than 5 mmHg 
bias. When comparing the bias results for the four models, there is no group-level statistical difference 
(Friedman test p≥0.282).  
The standard deviation of the error, 𝜎 , of each model with its expected value and standard deviation 
computed on the 15 subjects is shown in Figure 3.10.b. All expected standard deviations meet the 
AAMI standard deviation requirement of 8 mmHg and are at least one standard deviation lower than 
the AAMI limit. Moreover, ANNECG+PPG estimates of the BPW when trained with the Interval mode 

























Figure 3.10 - Comparison of (a) the absolute value of the mean error (b) standard deviation of 
the error (c) mean absolute error, and (d) the Pearson correlation coefficient between different 
models estimates and the BP measurements. The results are shown for SBP, DBP, MAP and BPW 
for the Interval training and the Predictive training modes. Bars represent the mean of all 
subjects and the error bars show ± standard deviation. Legend: * p<0.05/6, † p<0.05/3. 
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The MAE is computed on the 15 subjects and illustrated in Figure 3.10.c. The MAE is lower for all 
NARX models compared to the PAT model, except for ANNECG estimates of SBP, when trained in the 
Predictive mode. Moreover, the ANNECG+PPG always has the lowest absolute error among the models; 
it is significantly lower than the PAT model for DBP and MAP when trained with the Interval mode 
(Wilcoxon test p<0.007). ANNPPG also has a significantly lower MAE for DBP than the PAT model 
when trained with interval mode (Wilcoxon test p=0.006). 
Figure 3.10.d presents the average Pearson correlation coefficient, 𝑟, between the estimated and 
measured SBP, DBP, MAP, and BPW for all 15 subjects. The correlation coefficients obtained with 
the NARX models are always higher than the PAT model (Wilcoxon test p≤0.005). Moreover, the 
ANNECG+PPG trained with the Interval mode statistically outperformed the ANNPPG for the BPW 
prediction (Wilcoxon test p=0.006). 
Changes in BP happen over different time scales as shown in Figure 3.11. This figure compares the 
representative samples of measured SBP with the estimations on the test data obtained by different 
models tuned using Interval training. Figure 3.11.a shows that NARX models are more suitable than 
PAT for estimating large beat-to-beat BP variability observed for this subject. The MAEs (mean ± 
standard deviation) for this specific subject are 2.34±2.80, 2.11±2.77, 2.06±2.54, and 3.25±4.17 mmHg 
for ANNECG, ANNPPG, ANNECG+PPG, and PAT, respectively. 
Figure 3.11.b presents 10-beat moving averaged results of each model that better highlight the 
Mayer wave, which is characterized by a fluctuation in blood pressure related to vascular sympathetic 
activity at a frequency ranging from 0.03 to 0.15 Hz depending on the subject [154]. The selected 
exemplar subject has large Mayer wave compared to the others in this dataset. The NARX models are 
more accurate than PAT for estimating BP with a large Mayer wave and yield to the same results for 
smaller ones. The MAEs on the 10-beat moving averaged estimates for this subject are 3.91±4.90, 
2.59±3.21, 3.05±3.81, and 4.20±5.01 mmHg for ANNECG, ANNPPG, ANNECG+PPG, and PAT 
respectively.  
Figure 3.11.c shows 300-beat moving average (approximately 5 min) results to highlight slow 
changes in BP. This subject exhibited the largest slow changes in mean SBP (from 108 to 134 mmHg) 
among the subjects selected for this study. The MAEs on the 300-beat moving averaged data for this 
subject are 4.36±4.41, 3.45±4.37, 3.55±4.26, and 4.55±5.54 mmHg for ANNECG, ANNPPG, 
ANNECG+PPG, and PAT, respectively. Even though the slow changing SBP estimation exhibits relatively 
large errors, the NARX SBP estimates are highly correlated with the measured one. The Pearson 
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correlation coefficients are 0.72, 0.85, 0.91 and -0.57 for ANNECG, ANNPPG, ANNECG+PPG, and PAT, 
respectively. 
 
Figure 3.11 - Comparison of actual versus the four model estimations of SBP for subject (a) 
3000989m, (b) 3001689m, and (c) 3901339m, showing BP changes on different time scales. In (a), 
the SBP is plotted for each heartbeat. In (b), the SBP is averaged over 10 heart beats. In (c), the 
SBP is average over 300 heart beats. 
Slow changing SBP can be well modeled as it is observed in Figure 3.12. The MAEs on the 300-
beat moving averaged data for this subject are 5.28±4.02, 2.20±2.61, 2.39±2.18, and 4.27±3.36 mmHg 
and Pearson correlation coefficients of 0.64, 0.85, 0.92 and 0.56 for ANNECG, ANNPPG, ANNECG+PPG, 
and PAT, respectively. 
A source of error for the models is that the SBP range covered in the training data was different 
from the one in the test data. The difference in the maximum SBP in the training data for a subject 


























































compared to their test data was -2.76 ± 4.97 mmHg, and the difference in the minimum SBP was 5.21 
± 4.77 mmHg. The SBP in the test data that was outside the SBP training range was in average 1.2 ± 
1.7% and ranged from 0 to 5.1 %. 
 
Figure 3.12 - Comparison of actual versus the four model estimations of SBP for subject (a) 
3903867m. The SBP is average over 300 heartbeats. 
The training CPU time and the number of epochs required for convergence of the NARX models’ 
weights are compared for each input and training mode depicted in Table 3.1. The times presented are 
using MATLAB 2016b on a computer housing four i7-3770 3.4 GHz cores and 16 GB RAM.  
Table 3.1 - Training average CPU time and the number of epochs for every input and training 
mode. Legend: * p<0.05/3 in comparison with ANNECG, † p<0.05/3 in comparison with ANNPPG. 
Input Interval 
training time 



















ANNECG 6.8 ± 3.7 58 ± 32 2.0 ± 1.2 36 ± 23 
ANNPPG 13.2 ± 10.6* 123 ± 100* 4.2 ± 2.4* 78 ± 47* 
ANNECG+PPG 14.6 ± 7.6* 44 ± 33† 4.3 ± 0.6* 20 ± 3†* 
3.3 Discussion 
The model architecture presented in this chapter enables the estimation of the complete BP 
waveform only using the ECG or peripheral PPG signals. To the best of our knowledge, this is the first 
such demonstration. The estimation of the BP waveform, our main contribution, can be used by 
clinicians to gain additional insights into patient health conditions; for instance, access to an estimation 






























of the cardiac output [20], stroke volume [21], and arterial stiffness, which provides information on the 
mechanisms leading to high blood pressure [18] and can provide a guideline for enhanced hypertension 
treatment [60]. Moreover, this work introduces a novel approach to modeling BP, wherein it is 
considered as a dynamical system that changes over time as a function of the heart signal (ECG and/or 
PPG), and thus offers a new cuffless BP monitoring methodology, which has contributed to improving 
the accuracy of the SBP, DBP, and MAP estimations.  
The NARX model is easy to implement and train; only simple pre-processing, such as adding white 
noise to the BP training data and data normalization, are employed. No complicated feature extraction 
and computations are needed as in other machine learning based studies [155], [156]. Furthermore, the 
model is flexible to input signal type, so long as it carries information about BP, making the 
applicability less dependent on the hardware available. In addition, the low complexity of the ANN 
used in the model architecture (one hidden layer of 10 neurons) makes the training relatively fast, which 
has been an issue with other deep learning models [12]. Note that while for this study we performed 
some preprocessing to remove erroneous outlier segments, in practice this step is not necessary, as the 
model will re-establish fidelity once the input signal recovers.  
The method developed herein could be used in practice in two scenarios. In scenario 1, the 
exogenous input data are collected using a typical three-lead ECG and a finger-mounted PPG. The BP 
waveform for training the model is collected using a volume clamping method [77], [78]. Once eight 
minutes of BP data are collected, BP measurement equipment is removed, and the dataset can be used 
to train the ANN (Predictive training mode). Next, future ECG and/or PPG data are used as input to the 
trained ANN to estimate BP. In scenario 2, after the first eight-minute data collection including BP, 
ECG and/or PPG is collected for several hours, followed by an additional eight minutes of BP data 
(Interval training mode). Both eight minutes datasets are used to train the ANN, where the BP in the 
multi-hour interval can be retrieved using the trained ANN and the ECG and/or PPG data. 
3.3.1 Interpretation of the Results 
The good performance of the NARX models employed with the proposed input layer herein 
indicates that BP can be modeled with a nonlinear second-order system (two time-step delays of the 
BP), with some history of an exogenous input. This nonlinear second-order model is able to estimate a 
variety of BP waveform shapes (Figure 3.4.a, b), which are known to be descriptive of physiological 
factors, such as arterial stiffness, as well as measurement location [157], and is robust to changes in BP 
magnitude and heart rate over the time scale of a single beat (Figure 3.4.c). Longer time-scale variations 
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in the vascular system, such as blood redistribution during digestion, can result in drift of the NARX 
model estimates. This was observed in the case of Predictive training mode, and is also found in the 
literature for PAT/PTT models [118], [158], wherein recalibration was used to compensate for that 
drift. Herein it was shown that longer time-scale changes in the cardiovascular system can be 
accommodated by training the NARX on two temporally separated portions of a time series and 
estimating the BP in the interval. The improved accuracy of this training mode over the Predictive 
training mode has practical implications, as it would enable clinicians to correct recorded data post hoc. 
The two training modes affect the model outputs differently. Interval training reduced model bias 
for every output estimation (SBP, DBP, MAP, and BPW). This suggests that the PAT model can also 
benefit from this type of training and post hoc correction can improve the overall performance. The 
standard deviation of the error is not much influenced by the training mode. This suggests that the 
difference in MAE between both modes is mainly due to the model mean error drift for the Predictive 
training mode. Finally, Interval training results exhibit better overall correlation to the measured BP. 
This implies that if precise information is to be mined from the BP waveform for additional health 
monitoring insights, Interval training is preferred.  
The  SBP and DBP of the subjects ranged between 80 and 170 mmHg and from 30 to 90 mmHg, 
respectively, which spans the range of hypotension to hypertension for individuals at rest [8], [159]. 
The accuracy of the present model was not dependent on the amplitude of the BP; there are no 
indications that higher BPs result in any performance degradation given the nonlinear capacity of the 
NARX model; this is not necessarily the case for linear models [111]. 
Different definitions of PAT have been used in the literature for estimating BP [6]. Some studies 
have compared different definitions, but the results are inconclusive [160]–[162]. Nevertheless, to have 
a fair comparison for the NARX models, two PAT definitions, PATp and PATf, were implemented. The 
results show no statistical difference between the two PAT approaches, but PATp yielded a slightly 
better overall accuracy for BP estimates on this dataset, which is in accordance with some of the 
previous work on other datasets [159], [160]. 
The prediction of the SBP and DBP with the NARX model is not made at the expense of predicting 
all the waveforms when compared with the PAT model. On the contrary, the NARX models have lower 
error and higher correlation with the measured BP when compared with the PAT model, with the 
exception of SBP estimation based on ECG data when using Predictive training mode. The ANNECG+PPG 
exhibited a significantly lower MAE on the DBP than the PAT model when trained using Interval mode. 
Moreover, the correlation between the DBP signals and the estimates using all NARX models, and 
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correlation for the SBP using the ANNPPG and the ANNECG+PPG are significantly higher when compared 
to the PAT model. The computed MAP from the complete waveform estimates is significantly better 
correlated to the measured MAP for all NARX model when trained with the Interval method and leads 
to better MAE using the ANNPPG and ANNECG+PPG,. Moreover, ANNECG+PPG is trending towards a lower 
MAP error standard deviation than the PAT model (p-value = 0.009). ANNECG+PPG always yields the 
best results in terms of model bias, error standard deviation, mean absolute error, and correlation 
coefficient; it is significantly better than ANNPPG for prediction of the waveform in terms of precision 
and correlation when trained using Interval mode.  
It was shown that BP changes over different time scales can be well modeled by NARX models, 
mostly for beat-to-beat scale (Figure 3.11.a) and the minute-scale (Figure 3.11.b). As for the hour-scale, 
ANNECG seems to be performing poorly for all subjects (Figure 3.11.c and Figure 3.12). However, for 
ANNPPG and ANNECG+PPG, the accuracy of estimations varies from one subject to another. The 
difference in results can be attributed to the difference in the training data of subjects. For example, the 
training data from subject 3903867m (Figure 3.12) had the SBP ranging from 95 to 135 mmHg while 
the trained model was used to estimate SBP ranging from 89 to 137 mmHg. This can explain why 
ANNPPG and ANNECG+PPG are predicting the maximum SBP but failed to predict the minimum SBP due 
to lack of similar data in the training set. Similarly, the training data from subject 3901339m (Figure 
3.11.c) ranged from 109 to 132 mmHg but the trained model was used to estimate SBP with a larger 
range of 97 to 147 mmHg, leading to both poor estimations in the high BP and low BP range. This was 
the case for most of the current subjects, where the range of SBP in training data was generally smaller 
than the one in the test data. The range of training SBP combined with the edge effect, i.e., less training 
data closer to the extremum values resulting in poorer model performance close to the extremum, can 
explain why, in Figure 3.7, even though the 95% confidence interval is quite narrow, the difference of 
estimates can be quite large (> 60 mmHg); depending on the training data, the model can perform 
poorly on unseen high BP and/or low BP data. This indicates a limitation of the current study that can 
be addressed in the future by collecting rich training data, such as by including measurements of BP in 
relaxed (to decrease its BP) and exercise (to increase the BP) conditions. 
Using two sensors may not always be possible or convenient; for example, PPGs suffer from motion 
artifact [84], [123], so they may be less desirable for ambulatory monitoring. If a single sensor is to be 
implemented, ANNECG generally leads to better estimation of the DBP and the BPW, where its BP 
estimation is not statistically different from the ANNECG+PPG. The ANNPPG showed better results in 
terms of SBP estimation, though not statistically different from the other input models. Physiologically, 
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the results can be explained by the ECG, being the electrical signal for the contraction of the heart, thus 
better represent the dynamics of the BP, resulting in accurate BPW estimates. The better mapping of 
changes in blood volume to the BP with ANNPPG can be attributed to a higher maximum cross 
correlation of BP with the PPG signals than with the ECG signal. which could lead to a better estimation 
of the peaks.  
The present NARX model differs from other machine learning models for BP estimation in how 
much data are used for testing. In the present literature, 15% to 30% of the data are used for testing the 
model [163], [14]. Herein, 64% to 90% of the data were used for testing on different subjects; the goal 
was to build a model out of a relatively small amount of training data to estimate the BP for long time 
intervals.  
Adding hidden layers in the multilayer Perceptron [163] or using a deep recurrent neural network 
[164], can lead to longer training time and potentially better performance if sufficient training data are 
available. However, the complexity of the model in those cases was justified by the attempt of building 
a universal model, i.e., a model that could suit anyone, which was not the objective herein. In this study, 
the model was subject-specific and trained on a small amount of data, and only required one hidden 
layer of 10 neurons. Increasing the number of hidden neurons to 20 resulted in no decrease in the MAE 
of the estimated BPW. The MAE was increased when using 5 neurons in the hidden layer though. The 
NARX architecture was able to model the nonlinear behavior of the BP with only eight minutes of 
training data. It is interesting to compare training CPU time for every input and training mode as it can 
help the user in choosing the NARX configuration depending on the application. For example, the 
model is applicable for physicians, where four hours of data could be retrieved within a single visit. In 
that case, ANNECG could be preferred since the training time is significantly smaller than the others.  
The general model architecture was adapted for the MIMIC II database, in which the measurement 
locations and the sampling frequency of 125 Hz were fixed. The number of time-step delays of the 
exogenous input was then adapted such that the pulse wave delay for each input was shorter than the 
maximum input delay. Nevertheless, the size of the input can be changed to account for a different 
pulse wave delay if one is using a different peripheral location of the sensors. Similarly, the sampling 
frequency can be changed as long as all the information about the BP is within the input layer. If a 
higher sampling frequency is to be used, one must be careful in using two consecutive BP time-step 
delays as feedback for the ANN as the dynamics of the BP could become buried in the noise. 
 It was observed that adding white noise to the BP training time series improved the robustness of 
the model when being used in the recurrent fashion (estimation configuration). Although the effect of 
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noise amplitude was not extensively studied here, preliminary work showed that a 4-fold change in the 
standard deviation of the noise, ranging from half to twice, has no considerable effect on the reported 
results.  
Data corrupted by motion artifacts were removed in this study as they diminished the accuracy of 
the estimation of the NARX model. Nevertheless, the model could be used with some degree of motion 
artifact with a risk of a decline in the estimation accuracy. It is, however, not possible to quantify the 
loss of accuracy as even the ground truth BP was noisy. In order to increase the robustness to such 
noise, the model could be trained on data with motion artifact, or filters could be applied to the input 
signal [12]. 
In this study, all training windows were eight minutes long; model performance as a function of 
training window size was not assessed. The aim was to minimize the training duration and maximize 
the span between required training sessions. Eight minutes was selected as an estimate of a feasible 
window for real-world applications. The results were acceptable when compared with PAT results; in 
future work the training duration could be optimized for each subject and accuracy requirement. In this 
study, the model estimated the BP for one to 5.2 consecutive hours without recalibration, depending on 
the subject data availability, because the aim was to maximize the time span of the prediction. However, 
the accuracy of the estimation will be a function of the length of the time span between the training 
sections, i.e., a shorter testing interval will lead to a more accurate result. This is true for Predictive 
training mode, but also applicable to Interval training mode, as it would minimize the interpolation 
needed from the model. 
3.4 Conclusion 
It was shown that the complete BP waveform can be predicted from an ECG and/or PPG time series 
with an NARX model using ANN. The SBP, DBP and MAP estimation accuracy is better than a PAT 
model when compared on the same 15 subjects from the MIMIC II database. Using eight minutes of 
training data, the model was able to estimate the BP for one to 5.2 consecutive hours without 
recalibration, depending on the subject. With the availability of the complete BP waveform, this model 
can help physicians extract additional details of the physiological condition of a subject and better 
monitor changes in time. The additional information will enable the estimation of other metrics, such 





Estimation of Blood Pressure during Activities 
of Daily Living5 
In this chapter, subject-specific NARX models are trained to estimate the BP waveform time series 
from electrocardiography (ECG) and forehead photoplethysmography (PPG) input signals during 
activities of daily living. To broaden the range of BP in the training data, subjects followed a short 
procedure consisting of sitting, standing, walking, Valsalva maneuvers, and static handgrip exercises. 
This chapter evaluates two different components of the method. 
First, the efficacy of the cuffless BP method for continuous BP estimation during activities of daily 
living is evaluated when varying training data segments of the procedure to understand better the effect 
of each intervention. Second, the performance of three different NARX models are compared with three 
pulse arrival time (PAT) models.  We hypothesize that the developed method for cuffless BP estimation 
during activities of daily living can be used for continuous BP monitoring and, therefore, for acute 
hypotension and hypertension detection. 
4.1 The Training Procedure 
The main focus of this section is to investigate the effect of the various training protocol sections on 
the accuracy of the model estimations throughout the day.  
4.1.1 Method 
4.1.1.1 Measurements 
Data were collected on 3 young healthy males [age 27 ± 3.5 yr (mean ± SD)] of varied fitness levels, 
ranging from sedentary to regularly active, and free of cardiovascular and peripheral vascular disease. 
 
5 Parts of this chapter have been adapted from the following publications: 
C. Landry, E. T. Hedge, R. L. Hughson, S. D. Peterson, and A. Arami, “Cuffless Blood Pressure Estimation for 
Activities of Daily Living,” presented at the Conf Proc IEEE Eng Med Biol Soc, Jul. 2020. 
C. Landry, E. T. Hedge, R. L. Hughson, S. Peterson, and A. Arami, “Accurate Blood Pressure Estimation during 
Activities of Daily Living: A Wearable Cuffless Solution,” IEEE Journal of Biomedical and Health Informatics, 
pp. 1–1, 2021, doi: 10.1109/JBHI.2021.3054597. 
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All participants signed informed consent forms before participating in the study. Study protocols and 
procedures were approved by the University of Waterloo, Clinical Research Ethics Committee 
(ORE#41490) and conformed with the Declaration of Helsinki. 
Arterial blood pressure, see Figure 4.3, was continuously measured at 100 Hz using finger PPG 
(Portapres; Finapres Medical Systems, the Netherlands) [81]. Pressure measures were height adjusted 
to heart level and the arterial pressure waveform was calculated using BeatScope™ 1.1a software. The 
“finger to brachial: level corrected,” option was employed, which passes the finger pressure signal 
through a transfer function and a regression-based level correction to estimate the brachial artery BP 
[81].The middle finger of the non-dominant hand was used for measuring the finger BP, and the arm 
was put into a sling to minimize motion artefact. Each time the Portapres turns on, it performs a 
calibration that lasts anywhere from 3 to 11 minutes. Time points during these initial calibrations, as 
well as during periodic calibrations throughout the day, were removed from the data. 
 
Figure 4.1 – A participant with the sensors used during monitoring 
The Astroskin wearable body metrics vest (Carré Technologies Inc., Canada) was used for ECG, 
PPG, and tri-axial acceleration measurements [165], see Figure 4.3 for sample signals. Each participant 
was fitted with the correct size based on thoracic and abdominal circumference measurements. 
Astroskin hip accelerometers, recording at 64 Hz, were secured in the vest pocket as indicated by the 
manufacturer. The ECG signal was recorded at 256 Hz from 3 electrodes embedded into the vest (2 
located on the chest, and another located lower on the right side of the rib cage). The PPG was recorded 







calculated internally at 256 Hz. The sensor placement can be seen in Figure 4.1. Note that the iPhone 
SE on Figure 4.1 was not installed in this study, and only used in the next study (see Section 4.2.1.1). 
4.1.1.2 Protocol 
Testing was performed at the Schlegel-University of Waterloo Research Institute for Aging (RIA). 
Participants had access to the RIA Research Apartment to move around, take breaks, and have lunch 
while their bio-signals were continuously recorded (Figure 4.2.a-c). The participants performed their 
office work in the Vascular Aging and Brain Health Lab (Figure 4.2.d).  
 
Figure 4.2 - The a) living room, b) kitchen, and c) bedroom in the RIA Research Apartment, 
and d) office and lab space in the Vascular Aging and Brain Health Lab. 
The testing session consisted of three one-hour windows of continuous BP monitoring separated by 
one hour. When data were not being collected the Portapres was turned off to relieve pressure from the 
subject’s finger. A 15 min procedure, used as training data for the model, was performed at the 
beginning of the data collection. This procedure was designed to change the participant's BP within a 
range that is usually experienced during activities of daily living. The sequence of activities included 
in the procedure is shown in Table 4.1. Five minutes of seated rest at the end of the day was also 
recorded and included in the model training.  
Between the initial training and the seated rest at the end of the day (4.67 hours) the participants 
were free to do as they pleased, excluding vigorous exercise. There were no structured activities, though 
participants were encouraged to go for a walk from time to time, which included going up and down 





suggested to every participant that they lie down at some point during the day to increase the range of 
measured BPs. 
4.1.1.3 Model Architecture 
The NARX architecture using an Artificial Neural Network (ANN) was adapted from Chapter 3 for 
this study. The ANN used a multilayer Perceptron with one hidden layer of 20 neurons in every case. 
Hyperbolic tangent and linear activation functions were used for the hidden layer and the output layer, 
respectively. The time between the ECG peak and the DBP was set to be 0.2 seconds to synchronize 
the devices. In addition, the PPG signal was temporally shifted such that there was no delay between 
the foot of the ECG and PPG signals (see PPGd in Figure 4.3). Temporally shifting the signals with 
respect to one another (ECG, PPGd, and BP) was performed in order to minimize the ANN input layer; 
that is, phase shifting allowed the ECG and PPG peaks to be always in the data fed to the input layer 
when estimating SBP for all individuals. That approach was selected instead of having an input layer 
large enough to cover different ranges of PAT (ECG to BP and ECG to PPG phase delays) [166]. The 
specific time shifts employed were for convenience and do not impact the estimation. 
 
Table 4.1 – Duration of each activity included in the procedure 
Segment # Duration (min) Activity 
1 0.5 Sit 
2 0.25 Seated Valsalva  
3 0.75 Sit 
4 1 Stand 
5 0.25 Standing Valsalva 
6 0.75 Stand 
7 1 Walk 
8 1 Sit 
9 1 Seated handgrip 
10 1 Sit 
11 0.5 Stand 
12 1 Standing handgrip 
13 1 Stand 





Figure 4.3 - Representative ECG, PPG (dashed), delayed PPG (solid), and BP signals 
illustrating the potential temporal delays between signals. 
The input of the ANN consisted of 0 to 18 time-step delays of the ECG and the PPGd sampled at 64 
Hz. The NARX model also used the BP at time-steps k-1 and k-2 to estimate BP at time point k. The 
model architecture is summarized in Figure 4.4. A feedforward ANN was trained on the exogenous 
inputs and the BP measurements (Figure 4.4.a). Then, the trained ANN was used to estimate the BP on 
the test data, where a feedback loop with delay was implemented to provide the ANN with the estimates 
of the required delayed BPs (Figure 4.4.b).  
 
Figure 4.4 - Schematic of the NARX model used for a) training of the ANN as a feedforward 
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The delayed exogenous inputs and the delayed BP measurements of a given participant were used 
as inputs for training a personalized ANN (Figure 4.4.a). Zero mean white Gaussian noise (standard 
deviation = 1 mmHg2) was added to the BP time series to enrich the training data and improve the 
model robustness to input noise. Error backpropagation was used with the Levenberg-Marquardt 
optimization algorithm to minimize the norm of the difference between the predicted and measured 
values of the BP. A training stop condition was defined as an increase of the mean squared error on the 
validation dataset in six consecutive epochs.  
The data split for training and testing the ANN is shown in Figure 4.5, where the 15-minute protocol 
at the beginning (A) and 5-minute seated at the end of the time series (C) were used for training. To 
explore the effect of the training protocol on BP estimation fidelity, 6 different permutations of the 
training protocol were considered (other data from the training sessions were removed from the set). 
The 6 training permutations are shown in Table 4.2 with their respective included segment numbers 
from Table 4.1. Segments number 3, 8, 10, and 14 contain transitions from one activity to another at 
the beginning of the segment. Those transitions were removed (15 seconds) when investigating 
different training protocol sections. It is also noted whether the training set included the 5-minute seated 
data at the end of the day (C). 
Table 4.2 – Permutations of the training data employed 
Permutation Segment # Training on Portion (C) 
Train1 1 to 14 No 
Train 2 1 to 14 Yes  
Train 3 1, 2, 3, 8, 9, 10, 14 Yes 
Train 4 1, 3, 8, 9, 10, 14 Yes 
Train 5 1, 2, 3, 8, 10, 14 Yes 





Figure 4.5 - Schematic of data split for training and testing the models. Parts A and C were 
randomly split into training, validation, and test datasets for training the ANN, stopping the 
training, and acceptation/rejection of the trained ANN, respectively. Part B is the sub-dataset 
used for comparing the performance of the models. 
Only 70% of the training data were used for tuning the weights of the ANN, while 15% were used 
for validation (to check the training stop condition) and 15% for testing estimation performance in a 
one-step-ahead prediction. The mean square error of the 15% test data was used as a threshold for 
retraining; that is, if it was 20% higher than the mean square error on the training or the validation data, 
the ANN was retrained. 
4.1.1.5 Validation 
The portion (B) of the full dataset (see Figure 4.5) was used for testing the estimation accuracy of 
the model. Both the full data set in (B) and the dataset with the walking and lying down/sleeping 
segments removed (noWnoS) were tested to observe any difference in accuracy for different activities 
of daily living. The walking and lying down segments were detected via the Astroskin accelerometer.  
4.1.1.6 Data Analysis 
Predicted SBP and DBP time series were compared with the measured values from the Portapres. 
The SBP and DBP error time series were compared for each participant. The mean absolute errors 
(MAE) on the complete dataset (B) were used as a metric for comparing the model performance for 
each participant. The mean and the standard deviation of the MAE of the 3 participants’ noWnoS data 
were compared for the 6 training permutations and benchmarked against Train1 on the complete dataset 
(B). The 3 training permutations with the lowest MAE were then investigated more in-depth. The errors 
were separated into bins according to the distribution of the noWnoS BP data over the course of the 
day. The bins were defined for each participant as -3 to -2, -2 to -1, -1 to 0, 0 to 1, 1 to 2, and 2 to 3 
standard deviations (SD) away from the mean BP of the noWnoS data. The MAEs were then compared 
for each bin. Finally, the mean and variance of the model’s error, which describes its bias and precision, 
A B C 
15 min 5 min 280 min 
Training Validation Test 
Randomly Shuffle 
Time 
70 % 15 % 15 % 
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were assessed via scatterplots and Bland-Altman plots, where ±1.96 SD was used for a 95% confidence 
interval.  
 
Figure 4.6 - Estimated (dashed) and the measured values (solid) for SBP (top) and DBP 
(bottom). Gaps in data are when the Portapres was off. 
4.1.2 Results 
4.1.2.1 Model Performance Overview of the Full Dataset 
The extracted SBP and DBP from the predicted BP waveform are compared with the measured 
values in Figure 4.6 for one participant. The BP estimation has an error of 0.93±8.32 mmHg for the 
SBP and -1.68±6.96 mmHg for the DBP, resulting in MAEs of 6.3 and 5.2 mmHg, respectively. At the 
beginning of the third segment of data, a large discrepancy is observed between the measured and 
predicted BP. This discrepancy coincides with the person lying down, as detected by the Astroskin 
accelerometer.  
BP estimation error evolution is shown in Figure 4.7 when using Train1 for each participant. For 
the complete dataset, the MAE on the SBP estimates for each participant (BP01, BP02, and BP03) is 
11.3, 8.4, and 6.3 mmHg, respectively and the MAE on the DBP is 9.8, 6.4, and 5.2 mmHg, 
respectively. It can be observed that between 45% (see grey boxes in Figure 4.7) and 60% both BP02 
and BP03 have a large error due to the participants lying down. This is also reflected in Figure 4.6 at 
the beginning of the third estimation segement. 


















Figure 4.7 - Estimation error evolution for a) SBP and b) DBP 
 
Figure 4.8 - Mean and standard deviation of the MAE of the 3 participants for SBP and DBP. 
The comparison is made for the 6 training data splits on noWnoS data and benchmarked against 
Train1 on all data.  
4.1.2.2 Training Comparison 
Figure 4.8 compares the MAEs for different training data splits on the noWnoS data and is 
benchmarked against the MAE on the complete dataset using Train1. It can be observed that by 
removing the walking and sleeping segments, there is an average MAE reduction of 1.4 mmHg when 
using Train1. Train2, Train3 and Train6 have the lowest mean MAE, with values of 6.3, 6.4, and 6.4 
mmHg, respectively, for SBP and 5.2, 5.1, and 4.9 mmHg, respectively, for DBP. 
The MAE on the 3 participants according to the distribution on their SBP and DBP throughout the 
day is shown in Figure 4.9. The results are sorted in bins according to numbers of standard deviation 
(SD) away from the mean BP of noWnoS data.  
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Figure 4.9 - Mean and standard deviation of the MAE for the 3 participants with respect to 
the distribution of the BP throughout the day. a) SBP, and b) DBP. 
4.1.2.3 Best Estimation Results 
Figure 4.10 presents scatterplots of the measured versus estimated SBP and DBP extracted from 
Train2 noWnoS model estimates for the 3 subjects. Bland-Altman plots of the SBP and DBP are also 
presented to highlight the bias and variance in the estimates. The linear fit between the estimated and 
measured SBP and DBP have coefficients of determination of R2=0.69 and R2=0.60, respectively. SBP 
and DBP were accurately estimated, where the errors fall in 95% confidence interval of -0.8±15.34 
mmHg and 0.17±14.18 mmHg, respectively.  
Table 4.3 compares the results of the Train2 noWnoS model for the three subjects with the 
requirements according to the AAMI protocol. It shows that the model achieves the bias and precision 
requirements for DBP and is near the AAMI requirement for the SBP precision. 
Table 4.3 - Error comparison between the proposed model estimates and the AAMI 
requirements for the three subjects 
 Mean error (mmHg) Standard deviation error (mmHg) 
SBP  -0.80 8.67 
DBP  0.17 7.09 

















SBP σ range  
[-2,-1] [-1,0] [0,1] [1,2] [2,3] 
[-3,-2] 
DBP σ range  



















Figure 4.10 - Scatterplots of a) SBP and b) DBP. The solid line is the regression line through 
all data. The coefficient of determination is shown near each regression line. Bland–Altman plots 
of c) SBP and d) DBP. The solid line and dashed lines represent fixed bias (M) and M ± 1.96 
standard deviation range, respectively. Average = (estimated + measured)/2, Difference = 
measured – estimate. Subjects are color-coded. 
4.1.3 Discussion 
The model architecture used in this section enables estimating the complete BP waveform using 
information encoded in ECG and PPG signals. The NARX architecture performance using an ANN 
was shown to be dependent on inclusion of informative activities in the training data. Using a 15 min 
protocol that changes the BP over a wide range and 5 min of sitting at the end of the day as training 
data gives access to a continuous estimation of the BP for at least 280 min. Moreover, the performance 
of the model is enhanced on a larger range of BPs. It was shown that the use of MAE as a criterion for 
continuous estimation of the BP can bias the estimation as most of the time during the day the BP is 
close to an average value. It is important to have a model that can detect fluctuations in the BP even 
though they may happen briefly as short-term BP variability is often associated with cardiovascular 
risk factors [9]. 
It was shown that using a training protocol that does not incorporate the supine position of the 
participant leads to large prediction errors, up to 20 mmHg, when lying down (Figure 4.7). This may 























































function of the global body posture. This may be the case for standing and sitting as well, but the 
Astroskin accelerometers used in the experiment did not give enough information to distinguish 
between these latter body postures throughout the day. It could explain why training on the complete 
protocol (Train2) performed slightly better than using only the sitting protocol (Train3). It was only 
slightly better since the amount of data of people standing and not walking during the day was probably 
negligible. Nevertheless, it would be interesting to compare the performance on both sitting and 
standing BPs when using one model trained on the full protocol versus 2 models trained on sitting and 
standing protocols, respectively. 
The data when walking was removed because the waveform was highly variable. This variability 
was probably partially due to the acceleration of the blood in the arm and finger. Therefore, it was hard 
to judge if the reconstructed brachial BP was still accurate. Regardless, the model could not predict 
accurately the BP while walking. More details are available in Sections 4.2.2 and 4.2.3. 
A large range of BPs was tested for each individual (approximately 40 mmHg for the DBP and 70 
for the SBP). A dependency between the accuracy of the model and the magnitude of the BP was 
observed (Figure 4.9). The advantage of using a protocol that broadens the BP range when collecting 
training data is clearly observed on the high extremum values of the SBP estimates, where the Train2 
protocol has the lowest error. On the lower range of BPs, the model has a large estimation error, but 
the model has good performance on the higher range. This is aligned with the developed training 
protocol, as it was designed mostly to increase the BP. Though the participants were told to relax during 
the last 5 min of the protocol, decreasing BP is not as easy as increasing it. Relaxing while standing 
was also not part of the training protocol, which can explain the large error of Train2 protocol at low 
values of SBP. Again, for hypertension detection, the lower range of BP is not as important as the 
higher range, as long as a representative low-range BP can be estimated. 
 
Large variations of the coefficient of determination between estimated and measured BP have been 
reported (R2=0.194-0.846), which highly depends on the modelling approach [8]. Herein, the R2 values 
for the SBP (R2=0.69) and DBP (R2=0.60) indicate a high correlation between the NARX model 
predictions and the measurements (Figure 4.10), in comparison with the literature. It has to be noted 
that, herein, the measured BP comes from the Portapres device, which has its own bias and precision. 
Therefore, the model error is possibly lower than the reported one as the results are compared with a 
BP measurement that includes its own error. 
It was shown that the accuracy of the DBP estimation meets the AAMI requirements. By comparing 
with the AAMI, we find that the error of the NARX model is sufficiently accurate for the DBP 
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estimation to be classified as a medical device, but the SBP prediction needs further improvement. 
However, it must be noted that the AAMI standard was designed for intermittent blood pressure 
monitoring and may not be applicable for continuous monitoring. Nevertheless, it is suggested in The 
Handbook of Cuffless Blood Pressure Monitoring  that a preliminary study resulting in a MAE lower 
than 7 mmHg on the SBP and DBP estimates should move forward [167]. Herein, 6.3 and 5.2 mmHg 
were achieved for SBP and DBP, respectively. 
4.1.4 Conclusion  
It was shown that a NARX model using an ANN can predict the complete BP waveform using ECG 
and PPG as inputs during activities of daily living. The accuracy of the model on the estimated DBP 
meets the AAMI requirement, whereas the SBP has an error standard deviation that is slightly too large. 
The results on the 3 participants of this study indicate the potential of using a protocol that changes the 
BP over a large range during the collection of training data for the NARX model for accurately 
predicting BP during activities of daily living. The next section improves on this one by repeating the 
protocol at the end of the day to increase the performance of the NARX model and further validation 
on additional subjects. Moreover, an accelerometer on the leg is be added to classify the position of the 
participants.  
4.2 The model inputs 
In this section, the protocol designed in Section 4.1 is modified to improve the richness of the BP 
data used for training the NARX model. Different preprocessing steps on the model’s inputs (ECG and 
PPG) are explored. The BP estimates from the user-specific NARX models are compared with PAT 
models. The main contributions of this section are two-fold; first, the combination of a training 
procedure with a NARX architecture realizes accurate continuous BP estimation during activities of 
daily living, regardless of the user’s position (sitting or standing); and second, the trained model 
remains accurate over months if one-point-calibration is used for SBP and DBP. The accuracy of the 
BP estimates is demonstrated over a broad range of BPs for each user. 
4.2.1 Method 
4.2.1.1 Measurements 
Data were collected on five young healthy individuals (four males, age 28 ± 6.6 yrs) of varied fitness 
levels, ranging from sedentary to regularly active, and free of cardiovascular and peripheral vascular 
 
 67 
disease. All participants signed informed consent forms before participating in the study. Study 
protocols and procedures were approved by the University of Waterloo (ORE#41490), Clinical 
Research Ethics Committee and conformed with the Declaration of Helsinki. 
Arterial blood pressure, see Figure 4.3, was continuously measured at 100 Hz using finger PPG and 
the Astroskin wearable body metrics vest was used for ECG, PPG, and tri-axial acceleration 
measurements (see Section 4.1.1.1), see Figure 4.3 for sample signals. In this study, an iPhone SE was 
added and fixed to the thigh to record the orientation at 64 Hz to identify the body posture. The sensor 
placement can be seen in Figure 4.1. 
The data from the three measurement devices (Portapres, Astroskin and iPhone) were store in their 
respective internal memory for offline processing. 
Table 4.4 – Duration of each activity in the 15-minute training procedure 
Segment Duration (min) Activity 
1 1 Sit-to-stand and stand-to-sit every 10 s 
2 2 Stand 
3 0.25 Standing Valsalva 
4 0.75 Stand 
5 1 Standing handgrip 
6 1 Stand 
7 1 Walk 
8 1 Sit 
9 0.25 Seated Valsalva 
10 0.75 Sit 
11 1 Seated handgrip 
12 5 Sit 
4.2.1.2 Protocol 
Testing was performed at the Schlegel-University of Waterloo RIA (see Section 4.1.1.2). Testing 
sessions consisted of six consecutive 50-minute windows and a final 30-minute window of continuous 
BP monitoring. These were separated by 10-minute intervals when BP data were not being collected 
(the Portapres was turned off) to relieve pressure on the subject’s finger. A 15-minute procedure was 
performed at the beginning of the data collection (in the first 50-minute window) and again six hours 
later, at the end of the final 30-minute testing window; the two procedures were used for model training. 
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The training procedure was designed to change the participant's BP within a range usually experienced 
during activities of daily living. The sequence of activities included in the procedure is shown in Table 
4.4. During the procedures, the participants were asked not to talk, and the experimenter guided them 
using a chronometer. For the Valsalva maneuvers, the participants were asked to push as hard as they 
could for 15 seconds (though the participants were told to release if they felt dizzy; none did). The static 
handgrip exercises had the participants squeezing a rolled towel at maximum voluntary contraction for 
one minute. 
During the six hours of testing the participants were free to do as they pleased, excluding lying down 
and vigorous exercise. There were no structured activities, though participants were encouraged to walk 
at least once during each 50-minute data collection window, which included going up and down the 
stairs to ensure a wide range of BP in the testing data.  
The protocols for the five participants started between 7:00am and 9:00am, and finished between 
3:00pm and 5:00pm. The data collection steps were as follows: i) The participant read and signed the 
consent form. ii) The steps in the training procedure were thoroughly explained. iii) Thoracic and 
abdominal circumferences were measured, and the appropriate Astroskin vest size were fitted to the 
participant. Gel was applied between the skin and each ECG electrode, and elastic bands were fitted at 
the thoracic and abdominal level. iv) The Portapres was fitted to the participant’s non-dominant hand 
with an appropriate cuff size. v) The iPhone SE was fixed to the participant’s thigh. vi) Data collection 
initiated on all the equipment and the signals were individually validated (signals were synchronized 
offline). vii) The chronometer was started, and the six and a half hours of data collection protocol began. 
4.2.1.3 Model Architecture 
A NARX architecture based on a multilayer Perceptron detailed in Section 4.1.1.3. The NARX 
model used exogenous inputs and the BP at time-steps k-1 and k-2 to estimate BP at time point k. Each 
exogenous input consisted of 0 to 18 time-step delays (19 samples) of the signals sampled at 64 Hz. In 
this study, the NARX input signals are the PPGd, ECG, and their z-normalized counterparts across the 
19 time-delayed samples, denoted by PPGnorm, and ECGnorm.  Three different exogenous input 
combinations for the ANN were explored: i) ECG and PPG (NARX); ii) ECG and PPGnorm (NARX – 
PPGnorm); and iii) ECGnorm and PPGnorm (NARX – ECGnormPPGnorm).   
Estimating BP from the NARX model is a two-step process comprising training and testing. For 
training, a feedforward ANN was trained for each participant on the three sets of exogenous inputs and 
the BP measurements ((4.1).  
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BP(k) = f(BP(k-1), BP(k-2), Input(k), …, Input(k-18)) (4.1) 
where BP is the estimated BP. 
For testing, the trained ANN was used to estimate the BP on the six-hour test data, wherein a 
feedback loop with delay using BP from the previous two time steps was implemented to provide the 
ANN with the required BPs ((4.2).   
BP(k) = f(BP(k-1), BP(k-2), Input(k), …, Input(k-18)) (4.2) 
 
4.2.1.4 Training 
The delayed exogenous inputs and the delayed BP measurements were used as inputs for training a 
user-specific ANN. The training was performed on the two 15-minute procedures at the beginning and 
at the end of the six-hour data collection. Zero mean white Gaussian noise with a standard deviation 
(SD) of 1 mmHg was added to the BP time series to enrich the training data and improve the model 
robustness to input noise. Error backpropagation was used with the Levenberg-Marquardt optimization 
algorithm to minimize the norm of the difference between the estimated (BP) and measured values of 
the BP. Only 70% of the training data were used for tuning the ANN weights, while 15% were used for 
internal validation (to check the training stop condition) and 15% for testing estimation performance 
during the procedures in a one-step-ahead prediction. The mean square error of this internal test data 
was used as a threshold for retraining; if it was 20% higher than the mean square error on the training 
or the validation data, the ANN was retrained. 
4.2.1.5 Validation 
The six hours of data between the two training procedures were used for testing the estimation 
accuracy of the models. The Portapres BP waveform was distorted due to walking resulting in a large 
variability from beat to beat (Figure 4.11). The variability might have been caused in part by 
acceleration of blood in the arm and finger, and by the variations in peripheral vascular resistance with 
leg muscle contraction and relaxation. Therefore, from the six hours of test data, all the data collected 
while walking were removed for the initial comparison of the different models. The test datasets were 
then divided into three subsets: i) sitting data only, ii) standing data only, and iii) walking data only, to 
observe any differences in accuracy for those three activities of daily living. The walking segments 
were detected via the Astroskin vertical accelerometer that was virtually aligned with subjects’ torso, 
using the gravity vector measurement during upright standing. The sitting and standing data were 
detected using the orientation of the phone. 
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4.2.1.6 Pulse Arrival Time Model 
User-specific PAT models were implemented to facilitate direct comparison with an established 
cuffless BP monitoring method. According to a recent study [115], PAT models wherein BP is assumed 
to be linear with respect to PAT are the most commonly used due to their robustness, though logarithmic 
models are also common [111]. In [115], the most accurate model was found to be a quadratic inverse 
dependency between BP and PAT with a linear dependency on heart rate (HR). In order to estimate 
SBP and DBP we thus implemented three PAT models, linear PAT (PATLin) [113]: 
SBP = 𝑎 PAT + 𝑏  
DBP = 𝑎 PAT + 𝑏  
(4.3.a) 
(4.3.b) 
logarithmic PAT (PATLog), computed as [111]: 
SBP = 𝑎 ln(PAT) + 𝑏  
DBP = 𝑎 ln(PAT) + 𝑏  
(4.4.a) 
(4.4.b) 
And inverse quadratic PAT with linear HR term (PATInvHR), computed as [115]: 
SBP = 𝑎 /PAT2 + 𝑏 HR + 𝑐  
DBP = 𝑎 /PAT2 + 𝑏 HR + 𝑐  
(4.5.a) 
(4.5.b) 
where the user-specific coefficients 𝑎 , 𝑏 , and 𝑐 were determined using a least squares estimation 
for each training dataset [113]. Two PAT calculation algorithms were used; the first computed as the 
time difference between the ECG peak and the PPG peak at 64 Hz (PAT – 64 Hz); the second was 
computed using the Astroskin’s embedded algorithm, in which PAT is defined as the time difference 
between the ECG peak and the PPG 50% amplitude (50% of foot to peak), see Figure 4.3. The latter 
was post-processed at 256 Hz, and thus had improved temporal resolution (PAT – Astroskin 256 Hz).  
4.2.1.7 Mean Training Data Model 
User-specific mean training data (MTD) models were implemented for baseline comparison. In this 
case, SBP and DBP estimations were equal to their respective means in the training data. 
4.2.1.8 Data Analysis 
For each model configuration (3 NARX, 4 PAT, 1 MTD model), the mean error (μ ), the error 
SD (σ ), the mean absolute error (MAE), the Pearson correlation coefficient (r), and the estimated 
BP SD error (Errσ) were computed for the test dataset (six hours) for each participant. The Pearson 
correlation coefficient (r) between BP and the three PAT relationship (PAT, ln(PAT), 1/PAT2) were 
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computed. The NARX model and the PAT model with the lowest MAE were then investigated more 
in-depth and compared with the MTD model. To visualize how the models performed in estimating 
changes in BP (ΔP), the mean absolute value of ΔPmodel - ΔPportapres was used (MAEΔP), where ΔP is 
defined as the BP deviation from the mean. The errors were separated into bins representing the 
distribution of the BP data in the test dataset over the day. Each bin covers a range of 5 mmHg, and the 
bins indicate deviations from mean BP of the participant by 5n to 5(n+1) mmHg, where n ranged from 
-5 to 5 for SBP and -4 to 4 for DBP. The MAEs were then compared for each bin using Wilcoxon rank 
sum tests (α=0.05) with Bonferroni corrections to identify any statistical differences between the 
models.  The MAEs for the sitting data were compared with the MAEs obtained on standing and 
walking data. The MAE was also normalized by the SD of the BP of the respective user-specific dataset. 
The normalized MAE (nMAE) was used to provide a fair comparison between the datasets, as it 
represents the relative MAE with respect to the change in BP, which varies considerably across datasets. 
The MAE for sitting, standing and walking data were also binned according to the method described 
above for more in-depth comparisons. 
4.2.1.9 Long-term Validity 
User-specific cuffless BP estimation is usually more accurate than uncalibrated models, but fails to 
maintain long term validity [6]. It is crucial for long term use to have an indication of when retraining 
or recalibration is needed. Even if the NARX model is trained on compact, but rich, data (see Sec. II.B), 
we are interested in evaluating its long-term validity using one-point calibration; that is, to determine 
if the model can be periodically calibrated and remain accurate on data acquired months apart. 
Data were further collected four months apart for two of the participants and six months apart for 
one of them. The data collection protocol for these tests was identical to the one described in II.B, 
except: i) there was no monitoring of the leg position, and ii) there were three one-hour windows of BP 
monitoring separated by one hour.  
BP was estimated for these datasets using the models for the participants described in II.D. The 
estimated SBP and DBP were then one-point-calibrated using the mean of the last minute of the sitting 
data at the end of the first procedure. The estimated DBP and SBP were offset such that their estimated 
mean values matched their respective mean values of the Portapres BP measurements during the last 
minute of sitting data. The same calibration method was applied to the PAT model. The results were 
compared using the MAE, the nMAE and the μ  over different days for the NARX and the PAT 




Representative samples of estimated BP waveforms using NARX – PPGnorm are benchmarked 
against the measured BP in Figure 4.11 for the sitting, standing and walking cases for one subject. 
Figure 4.11.a,b demonstrate agreement between the measured and estimated waveforms for sitting  and 
standing, respectively. In Figure 4.11.c, the measured BP waveform looks distorted due to walking, 
which was observed in every participant’s data. Therefore, it was decided to remove the walking data 
from the analysis (otherwise mentioned). The computed MAE across the five subjects for the complete 
BP waveform are 6.18±0.73 mmHg and 5.85±0.73 mmHg with and without the walking data, 
respectively, showing the model’s good agreement in estimating the complete BP waveform. 
 
Figure 4.11 - Comparison of the actual versus estimated BP waveforms from NARX - PPGnorm 
for one representative participant during a) sitting, b) standing, and c) walking. 
The estimated and measured BPs and their filtered signals (61 datapoints centered moving average) 
during the six-hour test data are shown for one participant in Figure 4.12. In this case, with walking 
data included, the BP estimation has an error of -2.96±8.42 mmHg for the SBP and -1.99±6.70 mmHg 
for the DBP, resulting in MAEs of 6.79 and 5.31 mmHg, respectively. When removing the walking 
data, the error is -3.96±6.98 mmHg for the SBP and -2.80±5.55 mmHg for the DBP, resulting in MAEs 
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Figure 4.12 - Measured (blue) and estimated (orange; NARX - PPGnorm) SBP (top) and DBP 
(bottom) for the six-hour validation window. The original signals appear transparent and the 
filtered signals are solid lines. Gaps in data are when the Portapres was off. 
4.2.2.1 Model Comparison 
The computed Pearson correlation coefficient (r) across the five subjects between the PAT 
relationship (PAT, ln(PAT), and 1/PAT2) and BP are shown in Table 4.5. 
Table 4.5 – Pearson correlation coefficient (r) across the five subjects between the PAT 
relationship and BP 
Feature SBP DBP 
PAT – Astroskin 256 Hz -0.35±0.07 -0.12±0.07 
ln(PAT) – Astroskin 256 Hz -0.35±0.07 -0.12±0.07 
1/PAT2 – Astroskin 256 Hz 0.34±0.08 0.12±0.07 
PAT – 64 Hz 0.01±0.08 0.12±0.11 
ln(PAT) – 64 Hz 0.00±0.08 0.12±0.11 
1/PAT2 – 64 Hz 0.02±0.08 -0.11±0.11 
The expected value and SD of the MAE computed across the five subjects for SBP and DBP are 
shown in Figure 4.13.a. Included in the plot are data points presenting the respective MAE for each 
subject. The results exhibit differences in mean MAE between the models, ranging from 6.21 mmHg 
for NARX – PPGnorm (best) to 7.58 for the MTD model (worst) for SBP, and from 5.03 mmHg for 
PATLog – 64 Hz (best) to 6.16 for NARX – ECGnormPPGnorm (worst) for DBP.  The IEEE cuffless 
wearable standard limit [167] for preliminary studies is also shown in the figure. All models meet the 
standard except for the MTD model for SBP. 



















Figure 4.13 - Comparison of a) mean absolute error, b) mean error, c) SD of the error, d) 
Pearson correlation coefficient between different model estimates and the BP measurements, and 
e) the error between the daily SD of the measured BP and the estimated BP for SBP (left) and 
DBP (right). Bars represent the mean of all subjects and the error bars show ± SD. Each data 
point represents one participant. The IEEE cuffless wearable and the AAMI standard limits are 
also shown where applicable. 
The mean error, μ , (expected value and SD) computed for the five subjects is presented in Figure 
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requirement limit [153]. All models meet the AAMI requirement of less than 5 mmHg bias for SBP 
and DBP.  
The SD of the error, σ , of each model is shown in Figure 4.13.c. Only the expected SDs of the 
NARX models, PATLog, and PATInvHR – Astroskin 256 Hz meet the AAMI SD requirement of 8 mmHg 
for SBP and all models meet the standard for DBP. 
Figure 4.13.d presents the average Pearson correlation coefficient, r, between the estimated and 
measured SBP and DBP for all five participants. The correlation coefficients obtained with the NARX 
models are higher than the other models. 
Figure 4.13.e shows the difference between the actual BP SD and the estimated BP SD (Errσ). The 
three NARX models exhibit the lowest Errσ. 
 
Figure 4.14 - a) Mean and SD of the MAEΔP for all participants, and b) the distribution of the 
aggregated datasets, against the distribution of the ∆P from µSBP measured throughout the day. 
In a) bars represent the mean of all subjects and the error bars show ± SD. Each data point 
represents one participant.  Legend: (*) NARX vs PAT, (+) NARX vs MTD, and (–) PAT vs MTD 
(p<0.05/3) 
The MAEΔP as a function of BP deviation from the mean measured during the experiments is shown 
in Figure 4.14.a for SBP and Figure 4.15.a. for DBP; the data distributions when aggregating the data 
of all participants are included in Figure 4.14.b and Figure 4.15.b for SBP and DBP, respectively. The 
MAEΔP are binned in increments of 5 mmHg from -25 mmHg to 30 mmHg for SBP and -20 mmHg to 





























































NARX – PPGnorm MAE is significantly lower than PATLog – Astroskin 256 Hz MAE for large positive 
and negative ∆P for both SBP and DBP. PATLog and NARX – PPGnorm are significantly different from 
MTD model in every bin except for the NARX [-10,-5] bin (Wilcoxon p<0.05/3). The bin widths were 
selected for clarity of presentation. There is, however, sufficient data density to improve the resolution. 
For example, for a bin width of 1 mmHg, the MAE for NARX – PPGnorm is significantly lower than 
PATLog and MTD from 7 mmHg to 24 mmHg, and -10 mmHg to -21 mmHg for SBP and from 7 mmHg 
to 18 mmHg, and -6 mmHg to -12 mmHg for DBP (Wilcoxon p<0.05). This represents 24% and 23% 
of the data for SBP and DBP, respectively.  
 
Figure 4.15 - a) Mean and SD of the MAEΔP for all participants, and b) the distribution of the 
aggregated datasets, against the distribution of the ∆P from µDBP measured throughout the day. 
In a), bars represent the mean of all subjects and the error bars show ± SD. Each data point 
represents one participant.  Legend: (*) NARX vs PAT, (+) NARX vs MTD, and (–) PAT vs MTD 
(p<0.05/3) 
The MAEs obtained using NARX - PPGnorm and PATLog – Astroskin 256 Hz were compared for 
sitting, standing, and walking data in Figure 4.16.a, with SBP to the left and DBP on the right. While 
the error in BP estimation is slightly larger during standing, when normalized by the SD of the BP 
(nMAE), the error is lower for the standing data (Figure 4.16.b). This suggests larger variance of BP 
during standing postures. Figure 4.16 also shows that the NARX – PPGnorm trends towards 





























































MAE on the walking data is large in comparison with standing and sitting data. However, this is partly 
caused by the large variation in BP, which is evident in the nMAE, which is similar for walking, 
standing, and sitting, for SBP, though not for DBP.  
The MAEΔP as a function of the ∆P deviation from the mean SBP measured during the experiments 
is shown in Figure 4.17 for the sitting, standing, and walking data for NARX - PPGnorm. The bins span 
the intersection of the ranges of both datasets. The results are similar for sitting and standing; however, 
differences can be seen for the [-25,-20] bin (Wilcoxon p=0.095). There is also a significant difference 
for the [5,10] and the [10,15] bins between sitting and walking data (Wilcoxon p<.05/3). 
 
Figure 4.16 - Comparison of NARX - PPGnorm and PATLog – Astroskin 256 Hz models during 
sitting, standing, and walking for SBP (left), and DBP (right) using a) mean absolute error, and 
b) the normalized mean absolute error. Bars represent the mean of all subjects and the error bars 
show ± SD. Each data point represents one participant. 
 
Figure 4.17 - Mean and SD of the MAEΔP for the five participants for NARX - PPGnorm, plotted 
with respect to the distribution of the ∆P from µSBP measured throughout the day. Bars represent 
the mean of all subjects and the error bars show ± SD. Each data point represents one participant.  























































4.2.2.2 Long-Term Performance 
Figure 4.18 shows the SBP MAE, nMAE, and the mean error (µErr) of the NARX – PPGnorm and 
PATLog – Astroskin 256 Hz  over the span of months for two participants. Once the NARX model is 
one-point calibrated, the MAE is under 7.1 mmHg for all cases, and always lower than the PAT model. 
The nMAE is lower for 4 months and 6 months, showing more variance in the SBP data during those 
days. The MAE is largely a function of model’s bias, which is quite arbitrary, as seen in Figure 4.18.c, 
since it depends on the initial bias of the uncalibrated model. Once the bias of the model is removed, 
using the one-point calibration, the NARX - PPGnorm performs similarly over the range of ∆P for 
different days for both participants, see Figure 4.19.  
 
Figure 4.18 - Comparison of a) mean absolute error, b) normalized mean absolute error, and 
c) mean error for different days. The results are comparing NARX - PPGnorm and PATLog – 
Astroskin 256 Hz for SBP. The model was trained on Training day, and calibrated at the 
beginning of the Testing day “~ 4 months” and “~ 6 months”.  
4.2.3 Discussion 
This section presents an effective approach to continuously estimate BP over a wide range of 
variability for each individual. To the best of our knowledge, this is the first demonstration of tracking 
beat-to-beat BP during activities of daily living. Our proposed approach uses a NARX architecture 
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training data and enables accurate BP estimation during daily activity. The proposed method 
demonstrated a clear advantage over a PAT model on estimating a large range of BPs with low error. 
The NARX model requires no complex signal preprocessing, other than the normalization of the input, 
unlike in feature extraction-based procedures, where accurate and reliable physiological feature 
extraction can be difficult due to widely varying signal morphologies between individuals [22]. 
Training of the ANN used by the NARX model is quite fast due to its shallow architecture [166].  
 
 
Figure 4.19 - Mean and SD of the MAEΔP for NARX - PPGnorm and PATLog – Astroskin 256 Hz 
for different days for a) participant 1, and b) participant 2. The results are plotted with respect 
to the distribution of the ∆P from µSBP measured throughout the day. Bars represent the mean 
of all days and the error bars show ± SD. Each data point represents one day. 
Though not emphasized here, this architecture estimates the complete BP waveform (see Figure 
4.11) with an expected MAE of 5.85±0.73 mmHg, which is lower than the SBP MAE and higher than 
the DBP MAE, similar to [166].  The BP waveform contains additional information of potential interest 
to physicians [17]. Specifically in the case of hypertension, the waveform provides information on the 
underlying disease and mechanisms leading to high blood pressure [18]. For example, pulse diagnosis 
utilizes the blood pressure waveform to identify different cardiovascular diseases and follow 
pathological changes [19]. Moreover, the complete BP waveform could give access to other important 
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This study considered important parameters in developing a user-specific continuous cuffless BP 
measurement method: i) the range of BP experienced by a user, ii) the time span of estimation, iii) the 
applicability of the calibration procedure (training) in a real world application, and iv) treating each 
participant’s data separately when analyzing the results. The range of BP covered in this study 
represents a realistic range, since it was acquired during the participants’ activities of daily living. 
Although a large range of BP was covered during testing (at least ∆P of 55 mmHg for SBP and 45 
mmHg for DBP), the BP SD was relatively low (mean of 8 mmHg and 6.3 mmHg for SBP and DBP, 
respectively), which is not surprising since the participants were healthy individuals [168], most of the 
time sitting at a desk. Some models have been previously developed to estimate large ranges of BP 
using a cold pressor test [25], reporting expected μ  of 0.04 and 0.01 mmHg for SBP and DBP, 
respectively, and expected σ  of 5.0 and 3.7 mmHg for SBP and DBP, respectively. However, they 
were only tested on a short time span (13 minutes), with 10-fold cross-validation (no test data). Herein, 
each participants’ BP estimation was tested on six hours of data. Other studies have shown the potential 
of estimating BP for a long time span (months) [148], reporting expected MAEs for SBP of 6.56, 6.66, 
6.70, 6.90 mmHg for four different models (compared with 6.21 mmHg in the present study), but the 
models were trained on a complete day of data collection. Herein, six hours of BP estimation, with the 
potential of extending to months using one-point calibration, is realized by employing only 30 minutes 
of training data, acquired during a designed procedure, making our method a more practical solution. 
In contrast to PAT models, the NARX model cannot be trained with only a few heartbeats. Thirty 
minutes of training data seem to be a practical compromise between the required length of training 
samples and acceptable estimation accuracy. For practical reasons, we employed the integrated 
forehead PPG of the Astroskin vest. However, previous work has demonstrated that the NARX model 
works well with a finger PPG [166], therefore, it is likely that the model accuracy will not be affected 
much by PPG placement.  We acknowledge the small sample size of our study; nevertheless, the MAEΔP 
of the NARX architecture showed to be significantly less than the MAEΔP of the PAT approach (Figure 
4.14 and Figure 4.15). 
It was chosen not to include lying down in our definition of activities of daily living, since the model 
was previously shown to be accurate in the supine position using bed ridden patients [166]. Therefore, 
we focused on other activities to minimize the training requirement of the NARX model. Walking data 
was analyzed separately from the rest of the activities due to its highly variable waveform (Figure 
4.11.c). This variability was partially due to the acceleration of the blood in the arm and finger. 
Distorted BP waveforms caused by body motion have been observed in the literature [49]. Those 
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waveforms are much more complex due to the interaction between the heart’s pressure wave and the 
wave generated by the whole body vertical movement. A preliminary attempt to include vertical 
acceleration as input to the ANN (19 time-steps delay) showed promising results in terms of estimating 
the distorted waveform during walking, but resulted in larger error when estimating sitting and standing 
BP; furthermore, sometimes the model became unstable when the acceleration data were too different 
from the training data. The training data only covered two times one minute of walking data, which 
was likely not sufficient to cover the whole spectrum of walking frequencies and phases between 
acceleration and BP observed during the activities of daily living. Future work will include training on 
more walking data to account for the movement related variations of BP, and potentially employing 
separate NARX models for sitting/standing and walking. 
The NARX model with the ECG and PPGnorm inputs yielded the smallest MAE (Figure 4.13.a), 
indicating the relevance of relative PPG signal to the BP estimation, similar to normalized PPG 
waveforms in [25]. While the non-normalized PPG inputs should lead to the same results, due to the 
similar information content, they are more sensitive to the sensor placement and can increase the 
estimation error. This hypothesis is solidified further by the error from the NARX (non-normalized) 
model on a different day (not shown herein), which was large as a result of different sensor placement 
(difference in peak-to-peak PPG amplitude from one day to another). In contrast, NARX – 
ECGnormPPGnorm performance varied across the participants (Figure 4.13.b-c).  
We acknowledge, that the present study met neither the AAMI nor the IEEE standards in terms of 
the number of subjects and the range of tested BP. However, it should be noted that these standards are 
not directly applicable to continuous cuffless blood pressure monitors; the AAMI is designed for cuff-
based intermittent blood pressure monitors and IEEE does not cover all aspects, such as model’s 
calibration for instance, of cuffless blood pressure measurement [167]. This is further supported by this 
study, where the MTD model showed that applying the standards are likely inadequate for continuous 
BP estimation using an individualized model trained the same day (or calibrated). It would be difficult 
to think of a less predictive model than the MTD model, and still, it passes the AAMI standard and 
nearly meets the IEEE standard. This can be explained by the distribution of BP during the activities of 
daily living (Figure 4.14.b and Figure 4.15.b), where more than 50% of the daily BP lies between +/- 5 
mmHg of the mean BP (SBP and DBP). Pearson correlation coefficient was used to capture the ability 
of a model to estimate BP changes in Figure 4.13.d. From that figure, it is clear that the NARX models 
outperform the PAT and MTD models in estimating changes in BP. This is further supported by the 
estimated BP SD, which is accurately estimated by the NARX models (Figure 4.13.e).  Accurate BP 
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SD estimation is important for a BP monitoring device as it is a predictor of cardiovascular events, 
stroke, and mortality [168]. The performance of the NARX model is good at low acquisition frequency, 
which is not true for the PAT models. The Pearson correlation coefficient was practically zero between 
all PAT relationships sampled at 64 Hz and SBP, whereas it increases to about 0.35 when sampled at 
256 Hz (positive or negative depending on the relationship), see Table II. The NARX performance at 
low acquisition frequency is interesting from a wearables perspective since it would allow reducing the 
power consumption and memory requirement of the device [169]. 
The distributions of MAEΔP in Figure 4.14 and Figure 4.15 show the capability of the NARX model 
to estimate BP varying in a large range. While not observed with the MAE, the model overestimates 
low BP and underestimates high BP values. The significantly lower MAEΔP, for both high and low BP 
values, represents 24% and 23% of the data for SBP and DBP, respectively. This is in the case of 
activities of daily living (office work) where the ∆P distribution SD of the whole dataset was 7.74 
mmHg and 6.17 mmHg for SBP and DBP, respectively. These low SDs explain why the NARX benefit 
over the PAT or MTD models are not remarkable when looking at the aggregated data (Figure 4.13.a-
d). For larger BP variations, the difference between models is expected to increase. This suggests that 
the NARX architecture may be more beneficial for cuffless BP monitoring where large changes in BP 
are observed, such as in sports wearables [170], but more importantly in a population with high risk of 
cardiovascular events [168], [171]. For example, patients with a daytime SBP SD greater than 15 
mmHg are at increased risk of developing cardiovascular events, independent of their absolute BP 
levels [171]. This emphasizes the importance of capturing BP changes during activities of daily living 
as yielded by the NARX model, in contrast to the MTD and PAT models (Figure 4.13.e, Figure 4.14, 
and Figure 4.15). 
The NARX model performed well estimating BP during sitting and standing (Figure 4.16). The 
MAE was on average larger on the standing data, the nMAE showed that the larger error was due to 
more variation in BP. Comparing the performances by looking at the distribution of error as a function 
of the ∆P away from the mean (Figure 4.17), we observed that the NARX model performs similarly on 
both standing and sitting. For the lowest ∆P bin [-25,-20 mmHg], it appears the standing BP is not as 
well estimated as in the sitting. This may be due to the small size of the standing dataset, 6.8% of the 
sitting dataset size. Therefore, the standing MAE on the samples may not represent the MAE of the 
population due to its small size. For example, the MAEΔP in the [-25,-20 mmHg] bin for the five subjects 
is computed on sample sizes ranging from 3 to 15, whereas the sitting datasets MAEs are made on 
samples of 16 to 130. The NARX model showed poor MAE in estimating BP during walking (Figure 
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4.16.a). Raw data inspection suggests that DBP is largely distorted by walking, whereas SBP is less 
affected (Figure 4.11.c). This is further supported by the walking nMAE of SBP, which has similar 
values to the sitting and standing data, whereas the DBP nMAE is much larger than its counterparts 
(Figure 4.16.b). Moreover, the SBP MAEΔP is similar to the standing data showing the model capability 
to capture changes in SBP during walking (Figure 4.17). We thus postulate that the DBP measurements 
were largely distorted by the body acceleration and could not be estimated without acceleration 
information, whereas the SBP walking data, less affected by the acceleration, were difficult to estimate 
due to the large variance in BP generated by the heart’s pressure wave resulting from the exercise. 
Therefore, the large MAE of the NARX model during walking is explained by the large distribution of 
BP for the SBP and it is explained by a poor model performance for DBP as shown by the nMAE 
(Figure 4.16.b).  
Preliminary results show that the NARX model can be used to estimate BP over a long timescale if 
periodically calibrated (Figure 4.18). Within the present study, the duration over which the NARX 
model accurately predicts the BP without recalibration was not explored. However, no degradation of 
accuracy was observed over the six-hour estimation window, suggesting that the NARX model can 
accurately estimate a complete day of activities of daily living, extending this to the time scale of 
months when one-point calibrations are applied. Such calibration could be performed with an arm cuff 
in a real scenario. The calibration cannot remove the model bias completely as the bias of the 
uncalibrated model is unknown due to the variability of baseline BP on different days. Nevertheless, 
one-point-calibration resulted in a smaller bias to the uncalibrated model. This explains why in Figure 
4.18.c, the mean error µ
Err
 can be either positive or negative. This also explains why the PAT models 
result in a different mean error than the NARX models, even though the models are calibrated on the 
same data (they have different initial biases).  
Comparing the MAEΔP distribution over ∆P shows that there is no degradation of the model 
performance over months (Figure 4.19). The distribution of the data points in each bin is narrow, as 
shown by the small SD of each bin, indicating similar MAE for the different days for participant 1 
(Figure 4.19.a), whereas participant 2 model performance was better for the data 4 months apart (Figure 
4.19.b).  
It needs to be acknowledged that the “ground truth” BP measurements are from the Portapres, which 
has an inherent bias and precision error [81]. The model calibration across days may be needed to match 
the Portapres measurements and not the actual BP. Cuff placement variations may bias the 
measurements differently from one day to another [172], which requires a recalibration. Arterial 
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pressure estimates obtained via the finger volume clamp method have been reported to artificially drift 
over an extended period of monitoring due to changes in local factors induced by clamping the finger, 
such as altered finger blood flow, edema, and/or changes in finger temperature [172]. This can lead to 
erroneous BP measurements, which is usually compensated by switching fingers for the BP 
measurement [172]. However, this can also lead to a difference in BP measurement between the two 
fingers [173]. Before adopting the NARX approach for medical purposes, it should be validated with 
catheterized participants. Nevertheless, the work presented in this section shows the great potential of 
this approach in estimating BP with a relatively large variability range and demonstrates its potential 
for long-term and multi-session monitoring. 
4.2.4 Conclusion and future work 
This work demonstrated the advantage of using a NARX architecture in estimating a large range of 
SBP and DBP. BP of five participants was continuously monitored during their activities of daily living 
and the BP waveform was estimated and validated over six hours for each individual. The NARX model 
outperformed the established PAT models in estimating both low and high ranges of BP. Preliminary 
results showed the NARX model can maintain its performance for up to a 6-month horizon. Future 
steps will include monitoring more participants over months for a thorough analysis of the model 
performance on short, medium, and long timescales. Moreover, more investigations will be required 






A Fusion Approach to Improve Accuracy and 
Estimate Prediction Interval6 
In this chapter, a one-class support vector machine approach is investigated to estimate the prediction 
interval (PI) of BP estimates from three different model architectures. The PI is practical confidence 
metric concerned with the accuracy at which the observed target value itself can be predicted. 
Therefore, since continuous BP monitoring is likely to be employed outside of the clinic, the PI would 
be of high clinical value when it comes to outcome evaluation. Next, a fusion algorithm is used to 
combine BP estimates from those models using their estimated PI. We hypothesize that (1) estimation 
fusion will increase the BP estimation accuracy and (2) The PI can be used to identify high quality data 
for clinical uses. 
5.1 Method 
5.1.1 Measurements  
The data from the five healthy participants presented in Chapter 4 was used in this chapter (see 
Section 4.1.1.1 for Measurements and Section 4.2.1.2 for Protocol). 
5.1.2 BP Estimation Models 
NARX: The NARX that uses the ECG and a z-normalized PPG as input signals, the details of which, 
along with network training descriptions, can be found in Section 4.2.1.3. To reduce the estimation 
variance, five NARX models were bootstrap-ensembled [174], herein referred to as NARX.  
ANN: Using the same ANN architecture, models were developed to estimate directly the SBP 
(ANNSys) and the DBP (ANNDias) from ECG and the z-normalized PPG signal (no BP estimates in the 
input layer). A similar model architecture is employed in [22]. Again, five ANN models were bootstrap-
ensembled [174], herein referred to as ANNSys(ANNDias). 
 
6 Parts of this chapter have been adapted from the following submitted article: 
C. Landry, S. D. Peterson, A. Arami, “A Fusion Approach to Improve Cuffless Blood Pressure and Prediction 
Interval Estimation,” submitted to IEEE Journal of Biomedical and Health Informatics (August). 
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PAT: According to Chapter 4, the common logarithmic PAT model (PATLog) [111] was the most 
accurate in estimating SBP during activities of daily living. The PAT was computed using the 
Astroskin’s embedded algorithm, in which PAT is defined as the time difference between the ECG 
peak and 50% of the PPG amplitude (50% of foot-to-peak), see Section 4.2.1.6. PAT was post-
processed at 256 Hz, resulted in improved temporal resolution compared to extracting PAT from the 
outputted 64 Hz data.  
5.1.3 Prediction Interval Estimation  
A PI estimation model was trained independently for each individual’s SBP and DBP. The model 
architecture consisted of multiple one-class support vector machines (OCSVMs) [175], trained on the 
two 15-minute training sets, using Gaussian kernels and a regularization parameter ν=0.5 (0 < ν ≤ 1), 
where a small value of ν leads to fewer support vectors and, therefore, a smooth, crude decision 
boundary [107]. Each OCSVM was trained on a different percentage of outliers from 0% to 99% in 1% 
increments. The 100 OCSVM hyperplanes were used to group data into 101 clusters, each spanning 10 
hyperplanes (i.e., between the 0% and the 9% hyperplanes, between the 1% and the 10% hyperplanes, 
etc. Note that from 91% to 99%, the clusters were defined as inside the X% hyperplane, instead of from 
X% to X+9%). The data outside the 0% hyperplane was defined as the outlier cluster. A visual 
representation of the clustering method is shown in Figure 5.1 with increments of 20% outliers for an 
arbitrary 2-dimensional input. For each cluster of training data, the BP estimation (SBP or DBP) error 
distribution was calculated, and the error standard deviation (σ ) was associated with the uncertainty 
of that cluster. Therefore, any new datapoint assigned to a cluster was associated with that cluster’s 
uncertainty, herein referred to as the PI, in the testing phase. Clustering by intervals of 10 hyperplanes 
was used to increase the resolution of the estimated PI and ensure that σ  was calculated on a 
sufficient number of datapoints.  
Ten different inputs to the OCSVM were tested by varying the length of the input time series (ECG 
and PPG) in increments of 0.3s (segment lengths were τ = 0.3n seconds long, where n ∈ {1,2,3,4,5}) 
with (w/ BP) and without (w/o BP) the estimated BP waveform of length τ. The BP waveform was 





Figure 5.1 - Algorithm schematic featuring arbitrary data. The shown percentages indicate 
the number of outliers associated with the projections of the one-class support vector machine 
models’ hyperplanes on the two-dimensional input space (circles in this example). The clusters 
are upper and lower bounded by the hyperplanes (except inside 80% and outside 0%). 
5.1.4 Estimation Fusion 
The covariance intersection [150] method was used to fuse the BP estimates from the different 
models. For consistent estimates, Ai = {𝜉 , 𝑃 }, where 𝑖 = 1 to 𝑛 number of estimates, 𝜉 and 𝑃 are the 
mean and covariance of the estimate, respectively, the mean and covariance of the fused estimate C can 
then be determined as  
𝑃 = 𝜔 𝑃 + ⋯ + 𝜔 𝑃  
𝜉 = 𝑃 𝜔 𝑃 𝜉 + ⋯ + 𝜔 𝑃 𝜉  
(5.1) 
(5.2) 
where ∑ 𝜔 = 1 and 𝜔  are determined through an optimization process to minimize Pc.  
In this chapter, 𝜉 refers to the estimated BP and 𝑃 is the PI estimated by the OCSVM model. 
Covariance intersection was used to fuse NARX and ANNSys(ANNDias) (NARX + ANNSys(ANNDias)), 
PATLog with other models (NARX + PATLog and ANNSys(ANNDias) + PATLog), and for the fusion of all 
three models (NARX + ANNSys(ANNDias) + PATLog).  
5.1.5 Validation and Data Analysis 
The six hours of data between the two training procedures were used for testing the PI estimates of 
the models. For the NARX model, the estimated BP waveform was supplied to the OCSVM for 
training. For ANNSys(ANNDias) and PATLog models, only the estimated SBP/DBP was fed to the 
OCSVM. 
For each of the 10 PI model configurations, the MeRCI score [176], defined as:  
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MeRCIα = ∑ 𝜆 𝜎  (5.3) 
was computed for the test dataset for each participant, where N is the number of SBP(DBP) 
datapoints, 𝜎 is the BP estimated PI from the OCSVM model, and 𝜆  is obtained by first evaluating all 
ratios 𝜆 = |𝑦 − 𝑦 |/𝜎  and then extracting the αth percentile, in this case, 99.7%, of the 𝜆  distribution. 
The MeRCI score represents a mean scaled PI that contains α% of the data; thus, a smaller MeRCI 
score represents a better PI estimation. The MeRCI scores were calculated only for the BP estimates 
associated with a PI; i.e., if the BP estimate is classified outside the 0% hyperplane, the estimate is 
discarded. 
The PI model configurations with the lowest MeRCI scores for SBP(DBP) were further investigated 
for each of the BP models. The Pearson correlation coefficients (r) were calculated for each participant 
to examine the linear relationship between the σ  of each cluster in the training and of the test data. 
The expected σ  ± standard deviation (SD) in each cluster was also plotted against the percentage of 
outliers in the cluster.  
The performance of the three BP models and the four fused models were analyzed using the mean 
error (μ ), σ , mean absolute error (MAE), Pearson correlation coefficient, MeRCI score, and mean 
PI computed for the six-hour test data for each participant. To visualize the models’ performance in 
estimating changes in BP (ΔP), the mean absolute value of ΔPmodel - ΔPportapres was used (MAEΔP), where 
ΔP is defined as the BP deviation from the mean and the subscript indicates whether the data are from 
the model or the Portapres device. The errors were separated into bins representing the distribution of 
the BP in the test dataset over the day. Each bin spans a range of 5 mmHg, and the bins indicate 
deviations from the mean BP of the participant by 5m to 5(m+1) mmHg, where m ranged from -6 to 6 
for SBP and -4 to 4 for DBP. The difference of each bin with analogous bins from PATLog was computed 
as a function of |ΔP|. The MAEs were compared for each bin using a 2-way ANOVA test followed by 
a t-test with Bonferroni corrections to identify statistical differences across the models.   
A standard deviation threshold (σ ) was used to filter the data, such that all BP estimates associated 
with a PI higher than σ  were removed from the dataset. For the remaining BP estimates (PI < σ ), the 
percentage of data removed as a function of the absolute estimation error was computed for different 
σ . The σ  and the percentage of data kept were computed for the six-hour test data to observe the 
tradeoff between the two. To visualize the error in estimating ΔP for the remaining data (PI < σ ) in 
comparison with the initial dataset, the MAEΔP as a function of |ΔP| was computed for σ  = 8 and 9 
mmHg. To understand better the PI estimation performance, the percentage of data removed in each 
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|ΔP| bin was computed. To assess the performance of the fused models during activities of daily living, 
σ  was computed for different activities (sitting, standing, and walking), and compared with the value 
when using σ  = 8 mmHg. 
5.2 Results 
Herein only the results for SBP are presented for brevity. DBP results are included in the Appendix 
B. 
The MeRCI scores (mean±SD) across the five subjects exhibit differences between the models, 
ranging from 24.4 for τ=0.9 w/ BP (best) to 30.3 for τ=0.3 w/o BP (worst) for NARX, from 24.9 for 
τ=0.9 w/ BP (best) to 28.4 for τ=1.5 w/o BP (worst) for ANNSys, and from 28.0 for τ=0.6 w/ BP (best) 
to 33.1 for τ=0.3 w/o BP (worst) for PATLog.  
 
Figure 5.2 - The SBP training and testing data standard deviation of error in every cluster for 
a) NARX, b) ANNSys, and c) PATLog. Lines represent the mean of all subjects, and the error bars 
show ± SD. 
The MeRCI score for PATLog using the τ=0.9 w/ BP model was 28.5, only slightly higher than its 
best configuration (τ=0.6 w/ BP); therefore, we use the PI model τ=0.9 w/ BP for the three BP models 
for simplicity of comparison for the remainder of the analysis. The training and testing clusters’ σ  
as a function of the clusters’ percentage of outliers (lower bound) are shown in Figure 5.2 for the 
NARX, ANNSys, and PATLog models. Note that estimates of σ  on the training data are the model 
output on predicting the testing data σ  (in blue) compared to its real values (in red). The 
over/underestimation of σ  in each cluster reflects the bias of the three different models in predicting 
the testing data σ . The change in σ  for the training data compared to the test data was 17%, -22% 
and 82%, for NARX, ANNSys, and PATLog, respectively. Note that the training σ  at 0% of outliers 
is not defined, as there are no training data in this cluster. In the test data, the data points outside the 
0% hyperplane are outliers and represent 3.9±2.0%, 3.3±1.3% ,and 4.9±4.2% of the BP estimates for 
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the NARX, ANNSys, and PATLog models, respectively. The Pearson correlation coefficients between 
the training and testing σ  of each cluster are r=0.88±0.11, r=0.81±0.09, and r=0.86±0.13 for the 
NARX, ANNSys, and PATLog models, respectively. It can be observed in Figure 5.2 that the model 
overestimates, on average, the σ  of the test data by 21% and 68% for NARX and PATLog, 
respectively, and underestimates it by 3% for ANNSys. 
 
Figure 5.3 - Comparison of a) mean absolute error, b) mean error, c) standard deviation of 
the error, d) Pearson correlation coefficient between different model estimates and the BP 
measurements, e) MeRCI score, and f) mean estimated prediction interval. Bars represent the 
mean of all subjects, and the error bars show ± SD. Each data point represents one participant. 
The IEEE cuffless wearable and the AAMI standard limits are also shown in subplots a), and b-
c), respectively. 
The mean and SD of the MAE, μ , σ , r, MeRCI score, and mean of the PI during activities of 
daily living computed across the five subjects are shown in Figure 5.3. The results exhibit differences 
in mean MAE between the models, ranging from 5.74 mmHg for NARX + ANNSys + PATLog (best) to 
6.91 for PATLog (worst). The IEEE cuffless wearable standard limit [167], which all models meet, is 
also shown. The horizontal dashed lines in Figure 5.3.b indicate the AAMI requirement limit for μ  
[153], which is met by all models. All models meet the σ  AAMI standard except for PATLog. It is 
noted that the σ  is under 8 mmHg for all participants except for NARX, PATLog, and NARX + 
PATLog. The average Pearson correlation coefficient between the estimated and measured SBP for all 
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five participants obtained with the fusion of at least the two ANN models (NARX and ANNSys) are 
higher than the other models. The MeRCI score shows that model fusion enhances PI estimation when 
compared to the three initial non-fused models. ANNSys has the lowest mean PI, but a larger MeRCI 
score than the other fused models, indicating that it underestimates the PI. The difference between 
MAEΔP of each model and the MAEΔP of PATLog (in percentage) as a function of absolute BP deviation 
from the mean is shown in Figure 5.4.a; the data distributions when aggregating the data of all 
participants are included in Figure 5.4.b. The range of SBP shown is the minimum range spanned by 
all participants.  
 
Figure 5.4 - Mean of SBP MAEΔP relative to MAEΔP – PATLog for all participants, and b) the 
distribution of data (all participants aggregated) against the distribution of |∆P| from µSBP 
measured throughout the day. The MAEΔP are binned in increments of 5 mmHg from -30 mmHg 
to 30 mmHg then grouped according to their absolute value. 
The percentage of data removed is plotted against the absolute estimation error in Figure 5.5.a for 
the NARX + ANNSys + PATLog model. The tradeoff between the amount of data retained and the σ  
when varying σ  is shown in Figure 5.5.b.  
MAEΔP as a function of |ΔP| is plotted in Figure 5.6.a for the NARX + ANNSys + PATLog model 
using σ  = 8 and 9 mmHg. The percentages of data removed in each |ΔP| bin are plotted in Figure 5.6.b. 
When using the OCSVM model of PI to remove data with large expected error SD (PI ≥8 or 9 mmHg), 
all expected MAEΔP values are lower than their original values. In every case, the BP estimates by the 
fused model at large |ΔP| have higher expected error than BP estimates closer to the mean BP. There 
were, however, statistical differences when comparing each bin; randomly removing the same amount 





Figure 5.5 - For the NARX + ANNSys + PATLog model, a) percentage of the data removed as a 
function of the absolute error using different 𝛔𝐓. The results are calculated from all the test data 
from every participant and grouped in increments of 1 mmHg. b) Percentage of data kept as a 
function of the error standard deviation when varying the threshold on the prediction interval. 
The line was computed by varying the 𝛔𝐓, where specific values are marked with circles 
according to the legend. 
 
 
Figure 5.6 - For the NARX + ANNSys + PATLog model, a) mean and standard deviation of 
MAEΔP for all participants, and b) percentage of data removed from each bin, against the |∆P| 
from µSBP measured throughout the day. In a) lines represent the mean of all subjects and the 
error bars show ± SD. Legend: (*) Original vs 𝛔𝐓 = 9 mmHg, (-) Original vs 𝛔𝐓 = 8 mmHg, and 
(+) 𝛔𝐓 = 8 mmHg vs 𝛔𝐓 = 9 mmHg (p<0.05/3) 
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The σ  for the NARX + ANNSys + PATLog model is shown in Figure 5.7.a when estimating BP 
during sitting, standing, and walking. The σ  is shown for original beat-by-beat estimation and for 
the σ  = 8 mmHg case; the percentage of data kept for each activity is shown in Figure 5.7.b. It can be 
seen that estimating BP during walking is difficult. The expected σ  of NARX + ANNSys + PATLog is 
10.3 mmHg, which is lower by 0.6 mmHg, 1.6 mmHg, and 3.9 mmHg, than the NARX, ANNSys, and 
PATLog, models, respectively. Moreover, the expected σ  decreases to 7.95 mmHg when using a σ  
= 8 mmHg threshold on the PI, and the expected mean error is down to 1.7 mmHg. The previous results 
show that using the fusion approach presented herein results in BP estimates during walking achieving 
the AAMI standard 29% of the time (Figure 5.7.b). Using σ  = 9 mmHg increases the error SD to 8.3 
mmHg while 53% of data are kept. Estimating BP while sitting and standing is an easier task, as can 
be observed with their respectively lower σ  values in comparison with walking. However, they still 
benefit by using a σ  = 8 mmHg threshold, which decreases their σ  by 12% and 14%, respectively, 
while keeping 71% and 64% of the BP estimates, respectively. 
 
Figure 5.7 - Comparison of error standard deviation for the original NARX + ANNSys + PATLog 
model and the same model using a 𝛔𝐓 = 8 mmHg during sitting, standing, and walking, and b) 
percentage of data kept (prediction interval < 8 mmHg). Bars represent the mean of all subjects 
and the error bars show ± SD. Each data point represents a participant. 
5.3 Discussion  
This work was motivated by two needs: (1) to improve cuffless BP estimation, and (2) to provide a 
measure of the degree of confidence a practitioner should have in the BP estimates. The PI model 
architecture using OCSVM can be applied to different BP models, from simple PAT models to more 
complex NARX models. The covariance intersection fusion algorithm is also generic since it does not 
rely on any assumptions on the variables to be fused; only their means and covariances are needed. The 
method developed herein is not limited in terms of the number of models that can be fused. However, 
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the covariance intersection algorithm will become more complex to optimize as the number of models 
increases [177]. Herein, we used a small dataset specifically designed to train subject-specific BP 
models; however, the method is also applicable to population-based models. The one modification that 
would be needed for Big Data is to add kernel approximation techniques to minimize the training time 
of the OCSVMs [178]. Further studies are required to assess the fusion of population-based models. 
In this study, we have shown that the PI estimation varied depending on the inclusion of estimated 
BP as an input to the OCSVMs, and the length of the input signals (ECG, PPG, and BP). The obtained 
MeRCI scores, indicating how well the PI represented the observed error [176], demonstrate the 
importance of using estimated BP as an input to the PI model.  
High Pearson correlation coefficients for the NARX, ANNSys, and PATLog models have been 
observed between the estimated PI and the actual PI for each cluster. This shows the validity of using 
the training data clusters’ σ  as a surrogate for the PI when estimating BP, as is typically done in 
clustering-based PI computations [179]. The over/underestimation of σ  in each cluster can be 
explained by the difficulty of estimating the training dataset and by how each model is trained. The 15-
minute procedures performed by the participants to train the models were designed to create large BP 
variability in a short amount of time. This makes it a short but difficult time series to estimate for 
PATLog, which has only two tunable parameters, in comparison with the ANNSys (780 parameters) and 
NARX (820 parameters) models. NARX has more parameters, but it is trained in a feedforward fashion, 
and predicts as a recurrent ANN, which makes the prediction of the training data more difficult 
compared to ANNSys. Apart from over/underestimating, all models exhibit negative trends in Figure 
5.2, which shows that the further away from the center of the training dataset is a BP estimate, the more 
likely the estimation error will be large. This highlights the importance of using an outlier detection 
algorithm, such as OCSVM, to cluster data. 
The estimated σ  of the BP was smaller when fusing all three models (Figure 5.3.c). On average, 
the NARX + ANNSys + PATLog model decreased σ  by 1.2 mmHg, 0.8 mmHg, and 2.0 mmHg over 
the individual NARX, ANNSys, and PATLog models, respectively, with a consistent decrease for every 
participant. The μ , however, is slightly higher when compared with NARX and PATLog due to the 
fusion with ANNSys, which is more biased than other estimators (Figure 5.3.b). Nevertheless, the MAE 
is the lowest when fusing all the models (Figure 5.3.a). A simple approach to decrease the bias of the 
fused models would be to correct its mean estimation to that of the least biased model (PATLog). 
However, a larger sample size would be required to validate that PATLog is the least biased.  
 
 95 
Using PATLog in the fusion process is beneficial for the activities of daily living dataset because the 
model is good at estimating small change in BP (Figure 5.4.a); for this dataset, as observed in Figure 
5.5.b, about 50% of the BP fluctuates between ±5 mmHg of the mean BP. The NARX + ANNSys + 
PATLog model benefits from this and performed similarly to PATLog in that range of ΔP. Fusion of the 
three models is beneficial up to a ΔP of ±10 mmHg, where NARX + ANNSys + PATLog model 
outperformed the other models for 80% of the data (except PATLog for ΔP of ±5 mmHg), explaining its 
best overall MAE. This result, however, will be highly dependant on the distribution of BP that is to be 
estimated. With a larger change in BP, NARX + ANNSys might be more suited for the task. 
The estimation of the PI is best when using both NARX + ANNSys and NARX + ANNSys + PATLog 
models based upon the MeRCI scores. The mean PI is, however, lower for NARX + ANNSys. An 
estimation of how much the PI is over/underestimated can be computed by dividing the MeRCI score 
by the mean PI, which should give 3 for an ideal PI when computing the MeRCI score with 99.7% of 
the 𝜆  distribution (99.7% of the data of a normal distribution should be covered by ±3 SD). For the 
NARX + ANNSys model, this ratio is 3.5, thus, on average the PI is underestimated by 16%. For the 
NARX + ANNSys + PATLog model, the mean underestimation is 4%. This computation is only a crude 
estimation of the goodness of the PI since it only considers the mean PI and MeRCI score, and not the 
PI estimation accuracy at different ranges of PI and ΔP. Nevertheless, it was shown that the estimated 
PI could be effectively used to remove large errors from the BP estimation time series. However, it 
comes with a compromise between removing BP estimates with low and high errors for different σ , 
as shown in Figure 5.5.a. This compromise is, however, successful in decreasing σ  as σ  is decreased 
(Figure 5.5.b). Moreover, the PI model is successful in decreasing σ  for every individual. 
One might expect that OCSVMs cluster the data by range of BP, therefore, when using a σ  = 8 (or 
9) mmHg threshold on the PI it would remove only estimates at both ends of the BP range. However, 
this is not the case, as observed in Figure 5.6.a, the PI estimation model decreased the error for the 
whole range of BP, and removed data from every |ΔP| bin (Figure 5.6.b). 
An ideal PI model would, when selecting a σ , result in no individual σ  larger than σ  in every 
activity/posture. This was not the case with the NARX + ANNSys + PATLog model as it could not reach 
8 mmHg for every participant while walking, although it reaches that level of error on average and for 
every participant while sitting and standing. This shows that the approach presented herein is a viable 
solution for cuffless BP estimation to be used in clinical settings as the BP estimates with a PI lower 
than 8 mmHg will meet the AAMI standard independent from the conditions in which the BP is 
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measured. In the worst-case scenario, there are no high-quality BP estimates (PI < 8 mmHg), but at 
least erroneous estimates would not be mistakenly used for diagnosis.  
5.4 Conclusion 
This chapter examined the estimation fusion of up to three state-of-the-art models to achieve better 
cuffless BP estimation accuracy. We emphasized the importance of the prediction interval in the 
process of fusion, also in the context of clinical use of the estimated BP data, for which high quality 
estimates are essential. For that purpose, a clustering approach using one-class support vector machines 
was developed to estimate the prediction interval independent of the model architecture. 
It was shown that the prediction interval model can cluster the BP estimates in terms of their quality, 
which was quantified by the error standard deviation and used to estimate the prediction interval. The 
prediction interval model was used with the three different BP estimation models (NARX, ANNSys, and 
PATLog), and the results were fused using the covariance intersection fusion algorithm. The fusion of 





Blood Pressure Estimation During Moderate and 
Heavy Intensity Exercise 
In this chapter, the estimation of BP during moderate and heavy intensity cycling exercise is 
investigated. The performance of the estimation is studied using MAP which is a good indicator of 
perfusion in the body [180]. Population-based and subject-specific model accuracies are compared 
during exercise in which BP is changing over a wide range in a short time interval. Based on the 
observations in Chapter 4 we hypothesize that modeling the complete BP waveform will lead to a more 
precise estimation of MAP than when directly using ECG and PPG features or the entire signals. 
6.1 Methods 
6.1.1 Data Collection 
Eighteen young, healthy adults with no known musculoskeletal, respiratory, cardiovascular, or 
metabolic conditions participated in the study. The data used in this chapter are a subset of the dataset 
detailed in [181], during which BP was monitored as part of an investigation into the oxygen uptake 
kinetics in humans. Briefly, arterial BP was measured using finger PPG (NOVA; Finapres Medical 
Systems, the Netherlands), and ECG and PPG were measured via the Astroskin wearable body metrics 
vest (Carré Technologies Inc., Canada). All data were stored for processing at 64 Hz. In 6 of the 
participants the BP measurement device could not recalibrate during the exercise or automatically 
turned off and had to restart the initial calibration process. As a result, 12 participants were used for 
this study (7 males, 5 females; age: 27 ± 6 yr). The study was approved by the University of Waterloo 
Research Ethics committee (ORE #32164) and conducted in accordance with the Declaration of 
Helsinki.  
Participants visited the laboratory on four separate occasions to perform a ramp-incremental 
exercise test and two different pseudorandom binary sequence (PRBS) exercise tests [182], [183], in 
which 21 minutes of data were collected. Each exercise session was separated by at least 48 hours. 
Participants were instructed to arrive for testing at least two hours postprandial and abstain from 
alcohol, caffeine, and vigorous exercise in the 24 hours preceding each test. To ensure reliable data 
collection, each participant was fitted with the correct Astroskin vest size based on thoracic and 
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abdominal circumference measurements. The middle finger or the thumb of the left hand was used for 
measuring finger BP, and the hand and forearm were rested on a warm beanbag placed on a platform 
set at heart level to minimize both motion artefact and poor perfusion in the finger. All exercise tests 
were performed in an environmentally controlled laboratory on an electronically braked cycle 
ergometer (Lode Excalibur Sport, Lode B.V., Groningen, Netherlands). Participants were instructed to 
maintain cadence at 60 revolutions per minute for all exercise tests.  
On the first visit, 5 min of seated rest was followed by a ramp-incremental exercise test  
to exhaustion (Max test; 25 W baseline for 4 min followed by a 25 W/min ramp to exhaustion and a 
recovery period for nominally 21 minutes). The Max test was terminated when the cadence dropped 
below 55 revolutions per minute despite strong verbal encouragement.  The remainder of the 21 minute 
Max test was used as a recovery period during which data continued to be collected; the duration of the 
recovery period varied between participants depending on each individual’s time to exhaustion (ramp 
up time varied between 7.8 min and 12.1 min). The Max test was used to determine each participant’s 
ventilatory threshold (VT) [184], peak oxygen uptake (V̇O2peak), and the work rates used in the design 
of the PRBS exercise tests (Figure 6.1). V̇O2peak was defined as the highest V̇O2 computed from a 20 
s moving average during the exercise test. V̇O2 at VT was estimated by visual inspection as previously 
described in [184]. Work rates at 90% VT, and the midpoint between VT and V̇O2peak (referred to as 
Δ50%) were estimated by left-shifting the V̇O2 response by each individual’s mean response time to 
align the V̇O2 and work rate profiles [185]. In visits 2 and 3, participants performed one of two different 
PRBS exercise tests in a randomized order. Work rates systematically alternated in the two PRBS 
exercise tests between 25 W and 90% VT (low-to-moderate; L-M), and 25 W and Δ50% (low-to-heavy; 
L-H). In this study, the 90% VT WR was  106 +/- 8 W and Δ50% WR was 185 +/- 25 W. A single 
PRBS was composed of 15 units, each 30 seconds in duration, totaling 7.5 min. Each complete PRBS 
testing session consisted of a 3.5-min warmup (the last 3.5 min of the 7.5-min PRBS), and then two 
full repetitions of the PRBS for a total of 18.5 min of continuous cycling per session. Also included 
were an initial two-minute resting period and a 30 second of recovery period for a total testing time of 




Figure 6.1 - Schematic of the incremental ramp and two pseudorandom binary sequence 
(PRBS) cycling tests. PRBS protocols were designed using work rates at 90% ventilatory 
threshold (VT), and the midpoint between VT and V̇O2peak (Δ50%) using participant-specific VT 
and V̇O2peak determined from the ramp test [181]. 
6.1.2 BP Estimation Models 
NARXpop and NARXsub: A NARX architecture based on a multilayer Perceptron artificial neural 
network (ANN) was developed. The ANN was composed of two hidden layers of 40 neurons each with 
a batch normalization layer before each fully connected hidden layer. Hyperbolic tangent and linear 
activation functions were used for the hidden layers and the output layer, respectively. The NARX 
model used exogenous inputs and the estimated BP at time steps k-1 and k-2 to estimate BP at time k. 
The exogenous inputs consisted of 0 to 18 time-step delays (19 samples) of the signals sampled at 64 
Hz. The NARX input signals were ECG and a Z-normalized PPG signal, the details of which can be 
found in Chapter 4. The trained NARX model were used to estimate the BP waveform, from which 
MAP was extracted for further analysis. To reduce the estimation variance, five NARX models were 
ensemble-averaged [174], herein (depending on the model training) referred to as NARXpop or 
NARXsub, which are population-based and subject-specific models, respectively.  
ANNpop: Using the same ANN architecture as NARX, models were developed to directly estimate 
the MAP from ECG and the Z-normalized PPG signal (no BP estimates in the input layer). For this 
ANN, 64 samples from each signal were used as inputs to the ANN. The 64 samples started from the 
ECG peak (QRS peak) up to the sample 63 time steps ahead. A similar model architecture was 
employed in [22]. Again, five ANN models were ensemble-averaged [174], herein referred to as 
ANNpop. 
ANNsub: Using the same inputs as ANNpop, a single hidden layer ANN was developed to be trained 
on smaller datasets. The ANN was a multilayer Perceptron with one hidden layer of 20 neurons in every 
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case. Hyperbolic tangent and linear activation functions were used for hidden layer and output neurons, 
respectively. The ANNsub directly estimates MAP. 
PAT-HR: User-specific pulse arrival time with heart rate (PAT-HR) models were implemented to 
facilitate direct comparison with an established cuffless BP monitoring method. The inverse PAT with 
linear HR term was computed as [115]: 
MAP = 𝑎/PAT + 𝑏HR + 𝑐 (6.1.a) 
where the user-specific coefficients 𝑎, 𝑏, and 𝑐 were determined using a least-squares estimation for 
each training dataset [113]. PAT was computed as the time difference between the ECG peak and the 
PPG peak at 64 Hz ; HR was computed from the R-R interval in the ECG with resolution of 64 Hz. 
NARXcorr: Subject-specific ANN models were trained to predict the error of the NARX BP 
waveform estimation using the 0 to 18 time-step delays Z-normalized PPG signal as input. This 
estimated error was subtracted from the NARX BP estimation. The goal of this step was to understand 
better to what extent the input signals still contain information about BP. 
6.1.3 Model Training 
In this study, separate population-based and subject-specific models were trained. In the former, 
leave-one-subject-out cross-validation was performed, where a model was trained on 11 subjects and 
tested on the one left out; this process was performed iteratively for the 12 participants. In the latter, a 
model was trained for participant on one cycling exercise test with the others used for testing. 
Table 6.1 – Hyperparameters for training the different deep neural networks 
 NARXpop NARXsub ANNpop 
Number of epochs 100 500 2500 
Initial learning rate 0.01 0.01 0.01 
Learning rate drop factor 0.9 0.95 0.95 
Learning rate drop period (epochs) 1 1 100 
Minibatch size 640 640 64 
 
The NARXpop, NARXsub, and the ANNpop networks were trained using the Adam optimizer, whereas 
the ANNsub and the NARXcorr were trained using error backpropagation with the Levenberg-Marquardt 
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optimization algorithm. The hyperparameters for the Adam optimizer were different for each model 
architecture and are shown in Table 6.1. During training, the data was shuffled every epoch and each 
minibatch does not contain a sequence of data; it contains random data as for training a regular 
feedforward ANN. 
6.1.4 Validation and Data Analysis 
To compare the performance of the different architectures using population-based and subject-
specific trainings, the models were trained on the Max test and tested on the L-M and L-H exercise 
tests. To understand the effect of training data on population-based NARX models, training on different 
permutations of data were performed and tested on the L-M and L-H tests (in a leave-one-subject-out 
fashion): training on six random participants’ Max tests (NARXpop – Max 6 participants), training on 
L-M or L-H only ( NARXpop – L-M or NARXpop – L-H), and training on all the tests (Max, L-M, and 
L-H tests; NARXpop – All). Finally, to understand to what extent the performance of a model based on 
PPG and ECG can be increased, NARXsub models were trained on L-M, L-H (NARXsub – L-M (Train) 
or NARXsub – L-H (Train)) or all the tests (NARXsub – All (Train)) and validated on L-M(L-H). Here, 
the goal was to deliberately test the NARX model on its training data (or a portion of them) to see how 
well the model can learn the BP dynamics. Finally, NARXcorr was trained to estimate the NARXsub 
estimation error, which was then was subtracted from the BP estimation to observe the best BP 
estimation performance that can be obtained solely from PPG and ECG. This final step was showing 
how much BP information was left in both PPG and ECG signals after modeling BP using the NARX 
model. For instance, if the error could be modeled perfectly from the PPG and ECG signals, it would 
mean that the NARX model could not extract all the relevant information from those, whereas if none 
of the error could be modeled, the NARX extracted all the information from the input signals. 
The performance of the different models was analyzed using the mean error (μ ), error SD (σ ), 
Pearson correlation coefficient (r), coefficient of determination of the unbiased models (R2), and the 
Kullback-Leibler (KL) divergence of the unbiased models. The unbiased models were computed as 
𝑀𝐴𝑃 − μ . The equation for computing R2 is shown in equation (6.2 and the KL divergence in (6.3. 
The KL divergence was used as a metric to compare the unbiased MAP and estimated unbiased MAP 
distributions. It shows how well the model covers a large range of BP. 






KL = ln MAP + MAP −  (6.3) 
To visualize model performance in estimating changes in MAP (ΔMAP), the mean absolute value 
of ΔMAPmodel – ΔMAPNova was used (MAEΔMAP), where ΔMAP is defined as the MAP deviation from 
the mean and the subscript indicates whether the data are from the model or the Nova device. The errors 
were split into bins representing the distribution of MAP in the test dataset. Each bin spans a range of 
5 mmHg, and the bins indicate deviations from the mean MAP of the participant by 5m to 5(m+1) 
mmHg, where m ranges from -6 to 5. The MAEs were compared for each bin using a Wilcoxon signed 
rank test with Bonferroni corrections to identify statistical differences across the models.  The 
maximum cross-correlation values between the estimated BP waveform error and the input signals (rerr-
PPG, and rerr-ECG) were computed to get a sense of the unmodeled relationship between the exogenous 
input signals and BP. Group averaged BP response to the L-M(L-H) exercise test was compared with 
the group averaged BP estimation to visualize trends in the estimation error. Heart rate (HR), the peaks 
of the PPG waveform (PPGpeak), and the inverse of the pulse arrival time (1/PAT), which are all 
common BP features that correlate with BP [22], [115], were computed to visualize the trends 
throughout the tests. 
6.2 Results 
Herein only the results for L-H are presented for brevity. L-M results are included as supplementary 




Figure 6.2 - Comparison of a) mean error, b) SD of the error, c) Pearson correlation 
coefficient, and d) coefficient of determination between different model estimates and the BP 
measurements. Bars represent the mean of all subjects and the error bars show ± SD for the L-
H test. Each data point represents one participant. Legend: Wilcoxon with (*) p<0.05/10 and (†) 
p<0.01. 
The means and SDs of μ , σ , r, and R2 during the L-H test computed across the 12 subjects are 
shown in Figure 6.2 for the different models. The SD of μ  is large indicating that the BP models for 
some participants are biased. The results exhibit differences in mean σ  between the models, ranging 
from 10.91 mmHg for NARXsub (best) to 12.66 mmHg for ANNpop (worst). As a reference, the MAP 
SD across the 12 participants is 13.4±1.9 mmHg (mean±SD) during the L-H test. Due to the distribution 
of results, only the NARXpop σ  is found to be statistically lower than the ANNpop (p<0.05/10), but 
NARXsub trends toward a statistical difference (p<0.01). The average Pearson correlation coefficient 
between the estimated and measured MAP is higher for NARXpop and statistically different from PAT-
HR (p<0.05/10) and trends toward a statistical difference with ANNpop (p<0.01). Also, NARXsub is 
significantly higher r than PTT-HR. Similarly, R2 is the largest for both NARXpop and statistically 





Figure 6.3 - Comparison of actual versus estimated BP waveforms and MAP (after applying 
a moving average). The results are shown for the subject with the lowest, a) and c), and highest, 
b) and d), SD of the error for the L-H test. 
The estimated BP time series from NARXpop and NARXsub are shown for the subjects with the 
lowest and the highest σ  in Figure 6.3. In Figure 6.3.a-b, the estimated BP waveforms are shown at 
rest (2 min), during the first PRBS high intensity (Δ50%) section (9 min), during the low intensity (25 
W) section between the two PRBS (14 min), and at the last high intensity (Δ50%) section (19.5 min). 
In Figure 6.3.c-d, MAP is shown as a function of time for the complete 21 minutes, including the initial 




Figure 6.4 - Filtered BP error for the 12 subjects for the L-H cycling test. Grey lines represent 
individual subject data and the red line is the mean of all subjects. 
The NARXpop error (with removed bias) evolution over the 21-minute testing period is presented 
for all 12 participants in Figure 6.4. The red line is the mean of all participants. It can be observed that 
the model in the majority of subjects underestimates the change in MAP up to approximately the end 
of the first PRBS (13 min) and overestimates it for the rest of the test, which is consistent with 
qualitative observations in Figure 6.3.  
The means and SDs of σ , r, R2, and KL-divergence during the L-H test computed across the 12 
subjects are shown in Figure 6.5 for NARXpop trained on different data. In general, training the model 
on only half of the data (NARXpop – Max 6 participants) leads to poorer outcomes, although there is no 
statistical difference due to the large variance in the results, it trends toward statistical significance 
(p<0.05). Training on the Max tests (NARXpop) results in higher r and significantly lower KL 
divergence than training the model on L-H tests (NARXpop – L-H). On average, training on all tests 





Figure 6.5 - Comparison of a) SD of the error, b) Pearson correlation coefficient, c) coefficient 
of determination, and d) KL divergence between different model estimates and the BP 
measurements distributions. Bars represent the mean of all subjects and the error bars show ± 
SD for the L-H test. Each data point represents one participant. Legend: Wilcoxon with (*) 
p<0.05/6 and (†) p<0.05. 
The capability of predicting changes in MAP by NARXpop is shown in Figure 6.6 for the different 
training datasets. As shown by the p-values obtained from the Wilcoxon tests, using the data of all the 
tests as training data leads to lower MAE in the small range of ΔMAP without affecting the model’s 
capability to estimate BP at large ΔMAP. Similarly, training on only the L-H tests leads to significantly 
lower MAE at low ΔMAP, but the model trained on the Max tests is significantly better at estimating 
large positive ΔMAP. Even though there are no significant differences between training on six or 11 
participant’s Max tests when comparing every ΔMAP bin, the model trained on 11 participants has a 





Figure 6.6 - a) Mean of MAEΔP for all participants against the distribution of ∆MAP from 
µMAP measured throughout the L-H test. Wilcoxon tests’ p-value for b) NARXpop vs NARXpop – 
All, c) NARXpop vs NARXpop – L-H, and d) NARXpop vs NARXpop – Max 6 participants. Symbols 
represent the p-values (or MAEΔP value) and the location on the abscissa indicates the bin over 
which the statistical test was performed.  
The means and SDs of σ , r, R2, rerr-PPG, and rerr-ECG during the L-H test computed across the 12 
subjects are shown in Figure 6.7 for NARXpop, NARXsub – L-H (Train), NARXsub – All (Train), and 
NARXcorr. These results indicate that when a model can extract more information from the PPG and 
ECG signals (lower rerr-PPG and rerr-ECG) it is better at estimating BP (lower σ  and higher r). It can 
also be observed that the employed NARX architectures are not able to extract all the information from 
the PPG and ECG even when the test data are included in the training set, though this helps the 




Figure 6.7 - Comparison of a) SD of the error, and b) Pearson correlation coefficient between 
different model estimates and the BP measurements, and the maximum cross-correlation 
between c) BP and PPG, and d) BP and ECG signals. Bars represent the mean of all subjects and 
the error bars show ± SD for the L-H test. Each data point represents one participant. Legend: 
(*) Wilcoxon with p<0.05/6. 
The mean of the 12 participants’ ΔMAP during the L-H test is shown in Figure 6.8.a. It can be seen 
that the measured ΔMAP during the second PRBS is lower than the first one, which is not the case 
when BP is estimated with the NARX models. Figure 6.8.b shows HR, PPGpeak and 1/PAT, which are 
all features that keep increasing throughout the test. This can explain why the NARX models do not 




Figure 6.8 – Mean of the 12 participants a) measured and estimated ΔMAP and b) common 
features that correlate with BP for the L-H exercise test.  
6.3 Discussion 
This work looked into the generalizability of BP estimation during moderate and heavy cycling 
exercise, which, to the best of the author’s knowledge, is a physiological condition for which BP 
estimation has never previously been attempted. Most cuffless BP estimation studies have used exercise 
as a means to increase BP prior to the estimation; they only estimated BP during the recovery period 
and not during the exercise [186]–[188]. One noted exception is the estimated BP during two minutes 
of low, medium, and heavy cycling exercise [147], wherein the models were subject-specific, trained 
per specific exercise, and no cross-validation was performed (only training data was analyzed). Herein, 
the intensities of the exercise were subject-specific and based on VT and V̇O2peak, which is a reliable 
way to quantify intensity [182], [184]. 
In this work, deep neural networks were trained to estimate the complete BP waveform from PPG 
and ECG signals. Final hyperparameters were chosen based on multiple iterations. For each iteration, 
the training data was split into 70% training and 30% validation to ensure that the models were not 
overfit. Once the final configuration was chosen, the models were trained on 100% of the training data 
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and tested as explained in the Method section. It is worth mentioning that hyperparameters shown in 
Table 6.1 did not affect the results likely because 1) the PPG and ECG signals do not contain enough 
information to overfit BP (see NARXCorr in Figure 6.7), and 2) the precision of the BP measurement 
device is not perfect [189]. It was shown in [189] that the Finapres device during Max tests had error 
in SBP and DBP of -2.7±10 mmHg and -2.6±10 mmHg at 180 W (average Δ50% herein), respectively, 
and increased to 0.7±15 mmHg and -3.3±13 mmHg at maximum work rate.  
Herein, different model architectures are compared to better understand BP estimation results. For 
most cuffless BP studies, the results can be compared against the AAMI standard [153], however, it 
might be set to high since it was not intended for heavy intensity exercise. Therefore, no standard is 
directly applicable to judge the goodness of results. Instead, a well understood subject-specific PAT-
HR model is used as a baseline comparison. This model leads to relatively good BP estimates on both 
the training (not shown here) and test data, and even better results on the training data when using 
PPGpeak as a feature. However, PPGpeak is not a robust feature on a day-to-day basis, probably due, 
partly, to sensors repositioning. For that reason, it is expected that temporal features are more robust 
than amplitude features when using linear models such as PAT-HR. However, when using ANNs, the 
Z-normalized PPG input signal is the solution to track BP robustly based on the PPG (and ECG) 
waveform. This goes in hand with the observation in Chapter 4 that the Z-normalized PPG signal 
improved estimation of BP during activities of daily living on another day than the one on which the 
training data were collected.  
During cycling exercise, it is shown in Figure 6.2 that both NARXsub and ANNsub performed similarly 
at estimating BP, although mean σ , r, and R2 were lower for NARXsub than ANNsub. The fact that 
NARXpop is able to perform well in comparison to ANNpop may be due to its capacity to rely more on 
the dynamics of the BP, which are relatively similar between subjects, and less on exogenous signals 
(PPG and ECG) features that can exhibit larger inter-subject variability.  
As shown in Figure 6.3, Figure 6.4, and Figure 6.8, one factor that affects σ  the most is the 
difference in BP responses during the first and the second PRBS. For instance, the participant with the 
lowest σ  in Figure 6.3.c had approximately no change in BP response between the two PRBS (-4 
mmHg peak MAP), whereas the participant with the largest σ  in Figure 6.3.d had a drop in BP 
response of approximately 20 mmHg. This drop of BP between the large peaks of the PRBSs is on 
average 12 mmHg for the L-H test (Figure 6.8.a). This phenomenon can be explained by a decrease in 
total peripheral resistance (TPR) due to factors such as increased skin blood flow during exercise [190]. 
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The decrease in TPR was much smaller during the L-M test (see Appendix C); it was almost neglectable 
on the timescale of 21 min. This means that BP during exercise is influenced by prior exercise and is 
not predictable based on PPG and ECG alone; NARXcorr could not correct the error drift and, therefore, 
those signals do not contain enough information about the change in TPR. Moreover, previous exercise 
has different effects on future BP depending not only on intensity, but also duration [190]. The 
employed NARX architecture, which has only a short memory of two time steps at 64 Hz and, therefore, 
can only learn faster dynamics, was not able to learn these longer timescale dynamics. Though not 
predicted by the models in this study, the longer timescale variations in TPR might be learnable 
dynamics. Since the timescale is long, however, occuring over minutes and potentially even affected 
by prior activities during the course of the day (morning vs evening) [190], it may be practically 
challenging to train such model. Long short-term memory (LSTM) and gated recurrent unit (GRU) 
architectures, which are known for their temporal memory, are left for future work. 
NARXpop BP estimation improves by training on more participants’ data and also by training on 
different cycling test types (Figure 6.5). Training the population-based model on only the L-H test to 
estimate L-H test data resulted in poorer results than NARXpop (- Max) and NARXpop – All, showing 
first that the model can generalize to different types of exercise and, second, that the model benefits 
from training on Max due to the large range of BP covered within that test. The latter is shown in Figure 
6.6 where NARXpop was significantly better than NARXpop – L-H at estimating the upper range of 
ΔMAP. Based on the results shown in Figure 6.6, NARXpop can track relatively well changes in BP 
during cycling exercise, but cannot track the absolute value of BP (Figure 6.2). However, those results 
are based on a small amount of data for a population-based model. Adding more participant data for 
training the model might be a solution to tracking absolute BP values. 
Figure 6.7 shows that the NARX model architecture could not extract all the PPG and ECG 
information if provided with the necessary training data. This is shown in rerr-PPG and rerr-PPG of NARXsub 
– All (Train) and NARXcorr – All (Train), which are statistically different. Even though σ  from both 
models are statistically and meaningfully different (9.4 vs 8.5 mmHg), it is not realistic to base a model 
on the error since it cannot be known a priori.  Figure 6.7 shows instead the expected best performance 
of the NARX model architecture that could be achieved. Although it cannot be tested herein, it is 
hypothesized that NARXpop – All could reach the performance of NARXsub – All (Train) if provided 
with data of a larger and more evenly distributed demographic. Even with this best performance, 
however, the model does not track the slow change in BP dynamics observed between the two PRBSs 
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(Figure 6.8). On the other hand, BP tends to show a larger rise in BP at the onset of exercise and linearly 
decrease over time [190], [191] depending on the exercise intensity. Therefore, it might be argued that 
the NARX model could estimate BP changes during exercises in a time window where the decrease in 
TPR is small. For instance, one PRBS would be more reliable data to measure the performance of the 
model in estimating BP during heavy intensity exercise, where the time window is shorter than the 
timescale of the change in TPR. As an example, NARXpop - All σ  would drop from 10.8 mmHg to 
8.9 mmHg when considering only the second PRBS. Assuming that NARXsub – All (Train) would be 
the best achievable performance, its σ  on the second PRBS is 7.9 mmHg, which is lower than the 
requirement by the AAMI standard [153]. In the case of moderate exercise, the change in TPR is small 
during a time window of 21 min, where NARXpop – All’s σ  is already 8.1 mmHg and drops to 7.2 
mmHg with NARXsub – All (Train). Therefore, the NARX model performance is a function of the 
intensity of the exercise and would require recalibration periodically based on the exercise intensity. 
In this study PPG was measured on the forehead, which is known to provide high-quality and reliable 
signals [192]–[194]. However, PPG signals acquired from the forehead have been reported to be less 
affected by vasoconstriction than the fingers [192], [193], [195], [196], which might have limited the 
precision of the BP models herein as the change in TPR was not capture on the forehead, but might be 
measurable from the fingers. Future studies should investigate the estimation of BP during considerable 
changes in TPR using a finger or toe PPG, from which vasomotion can be clearly observed in 
comparison to the ear PPG [197]. Another study has reported a correlation between 
ballistocardiography signal and TPR [198], however, this would likely be an impractical sensor to 
employ during exercise. Moreover, changes in TPR obtained by slow breathing and breath holding are 
not in the same range as observed herein and might not correlate at that point. 
It should be noted that the ground truth BP measurements used in this study have limited the accuracy 
of the estimations. Volume clamping during high intensity exercise are not as reliable as in a resting 
posture [189]. This is clearly observed with the participants removed from this study, where the BP 
measurement device could not recalibrate during exercise or would automatically turn off and restart 
the initial calibration process. The precision of the device might, therefore, explain the relatively low 
R2 computed for the BP estimation models. For instance, if the device has a precision of 10 mmHg 
during heavy exercise conditions, assuming that the measurement error is independent of the PPG and 
ECG signals, a model estimating BP perfectly can only achieve an R2 of 0.44 when the SD of BP is 
13.4 mmHg (R2 = 1 −
∑ (MAP )
∑ (MAP )
= 1 − 
.
= 0.44, see equation (6.2). This also explains 
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why R2 is lower during L-M (see Appendix C), since the MAP SD is only 9.1 mmHg. Therefore, a 
possible improvement to this study would be an invasive BP measurement to better ground the data. 
6.4 Conclusion 
This chapter explored the feasibility of estimating BP during moderate and heavy intensity exercise. 
It was shown that the NARX model architecture can track large changes in MAP with both subject-
specific and population-based training. This architecture was shown to better model BP during 
moderate and heavy intensity cycling exercise than a PAT-HR linear model and an ANN using the 
entire PPG and ECG waveforms as input. It was shown that a limitation of estimating BP from PPG 
and ECG is the change in total peripheral resistance that happens during exercise (and is a function of 
intensity) and cannot be modeled using those signals. Although the NARX model is a dynamical model, 
it does not have sufficiently long memory to capture this change in total peripheral resistance that 
happens over a timescale on the order of minutes. Nevertheless, population-based NARX was able to 
track changes in MAP with a reasonable precision during moderate and heavy intensity exercise, which 
is increased when estimating on a smaller time window (e.g. 21 minutes for moderate and 8.5 minutes 
for heavy). Therefore, it can be concluded that the population-based NARX model can estimate BP 
during moderate and heavy intensity exercise, which was achieved by training on the data of only 11 
participants. Moreover, its precision can be improved with more data and by using finger PPG as an 





Conclusions and Recommendations 
The main findings of this thesis are summarized and recommendations for future work are given. 
7.1 Conclusions 
In this thesis, cuffless BP monitoring was explored, an approach that can give a continuous 
measurement of the BP, which is not possible with existing non-invasive tools, and therefore gives a 
more complete picture of the patient’s cardiovascular state. This approach requires a surrogate model 
of BP, which has typically relied upon pulse-wave delay between two arterial segments or other pulse 
waveform features in the estimation process.  Typical approaches provide estimates of only systolic 
and diastolic blood pressure as a function of time. However, considerable clinically-relevant data are 
lost by neglecting the BP waveform. Moreover, most efforts to date in the field of cuffless BP 
monitoring have been in validating algorithms in a laboratory setting and with little to no consideration 
to algorithm uncertainty. 
In this thesis, critical gaps in cuffless BP monitoring were studied using machine learning in the 
pursuit of several objectives, which were laid out in Section 1.1 and are repeated here: 
4. develop a data-driven model of BP dynamics to enable estimation of the complete BP 
waveform; 
5. validate the model architecture in real-world scenarios;  
6. incorporate an uncertainty measure into the modeling scheme. 
The main findings, as they relate to these objectives, are summarized as follows. 
In Chapter 3, a NARX model was introduced; this is the first BP estimation model that gives access 
to the full BP waveform (compared to just SBP, DBP, and mean BP), which can provide clinicians with 
additional salient information (Objective 1), such as cardiac output, stroke volume, and arterial 
stiffness. Moreover, the proposed model improved the accuracy of SBP, DBP, and mean BP estimations 
when compared to state-of-the-art pulse arrival time models. This NARX approach is the first to 
consider BP as a dynamical system instead of the typical approach where static features are used to 
model the BP, which leads to a more accurate model. 
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In Chapter 4, the first validation of a cuffless BP method during activities of daily living was 
presented. A 15-minute training procedure was introduced, which captures a wide range of BP observed 
during activities of daily living that, combined with the NARX model, showed accurate continuous BP 
estimation, regardless of the user’s position (Objective 2). Moreover, the trained NARX model remains 
accurate over months if a one-point calibration is employed prior to each use. A major contribution of 
this chapter is the validation and the applicability of the protocol used for the developed cuffless BP 
monitoring system. The developed solution was validated as a wearable system, which could potentially 
be prescribed by clinicians. With only a 30-minute training session and a daily calibration, accurate 
continuous BP estimation up to 6 months is realizable. This is attractive in comparison to the majority 
of the methods in the literature that either require several days of data collection to be able to build a 
model or cannot track BP changes due to the lack of model complexity. Moreover, the accuracy of the 
BP estimates over a broad range of BPs for each user in an uncontrolled environment validates the 
method as a truly viable wearable solution. 
In Chapter 5, it is argued that it is imperative to assign a confidence metric to cuffless BP estimates 
for outcome evaluation, since it is likely to be employed outside of the clinic. As such, the prediction 
interval (PI), which is a practical confidence metric concerned with the prediction accuracy of the target 
value, would be of high clinical relevance. In Chapter 5, a method for estimating PI independently of 
the BP model architecture was developed. A fusion algorithm was then used to combine three 
established BP models (using their estimated PI). The results showed (1) the benefit of estimation fusion 
on the BP and the PI estimations accuracy, and (2) how PI can be used to identify high-quality data. 
This shows that the approach presented is a viable solution for cuffless BP estimation to be used outside 
the clinic as the BP estimates with a PI higher than a predetermined quality level can be discarded. In 
the worst-case scenario, there are no high-quality BP estimates, but at least erroneous estimates would 
not be mistakenly used for diagnosis. 
In Chapter 6, the first attempt to estimate BP during low and heavy intensity exercise is presented. 
Even though the experiments were performed in an environmentally controlled laboratory on an 
electronically braked cycle ergometer, they should be representative of real-life exercises where motion 
artefacts are not dominant such as cycling, cross-country skiing, or aerobic weightlifting. In Chapter 6, 
it was shown that the NARX model could track large changes in BP precisely when both trained in a 
subject-specific or population-based manner. The largest source of error that could not be tracked by 
the NARX model using PPG and ECG as input was the change in BP due to a decrease in peripheral 
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resistance over the course of the exercise. This might limit the time window on which the model can 
be used without drifting too much. It was shown that within a 21-minute moderate pseudorandom 
binary sequence (PRBS) exercise test or within one heavy PRBS exercise test of 8.5 minutes, the change 
in BP due to the decrease in peripheral resistance was small enough and led to acceptable model 
precision. Since this change in peripheral resistance depends on the intensity of the exercise, the model 
could be precise continuously for low intensity exercise or if periodically calibrated for moderate and 
heavy intensity exercise.  
7.2 Recommendations 
Validation protocols for cuffless BP monitoring are lacking. IEEE is working on a standard for 
validating cuffless approaches, but it is still an ongoing process [167]. For that reason, the results 
reported in the literature are difficult to compare. The main reasons are inhomogeneity in the 
calibrations used (Section 2.4), datasets employed (database versus in-house data collection), and 
methods for reporting the results.  
The results from population-based models are easier to report since cuff-based measurement 
standards, such as the AAMI, are readily applicable. However, most results reported in the literature 
used the AAMI protocol’s mean and standard deviation of error criteria (see Section 2.2.1.2), but do 
not apply the requirements in terms of number of participants and range of BP that should be covered 
by the validation protocol. Therefore, the results are only applicable to the dataset on which the model 
has been validated. I suggest that future work on cuffless BP estimation should use data in a different 
setting to validate models. For instance, if training a model on the MIMIC database, one should collect 
data in a different environment to validate the applicability of the model in a realistic environment. 
The problems with person-specific and hybrid calibrations are the same. First and foremost, the 
calibration of those models has an expiry date, that is not covered by the AAMI protocol. When 
validating one of those models, the error needs to be reported along with a time frame for which the 
periodic calibration is needed. This, along with testing different models with different data, makes it 
difficult to compare results. The last problem that will be covered herein is the assessment of results 
for person-specific and hybrid calibrations. Many different studies report their results by aggregating 
data from all participants. This leads to a high correlation between estimated and measured BP (ρ > 
0.9). However, this is an artefact coming from the different BP levels across individuals; the correlation 
only reflects the difference in the initial BP calibration measurement between the different individuals 
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and not the capacity of a model in tracking change in BP in a given individual. This is applicable to this 
thesis work as well. For instance, in Chapter 3, high correlation coefficients between estimated and 
measured BP were presented in Figure 3.8, in order to be comparable to other studies, but then the study 
went on with subject-specific results instead of aggregated results. Cuffless BP studies should at least 
compare with other models on the same data. This, however, has limitations as far as all models from 
the literature cannot be reproduced in each study. Future standards for evaluating calibrated cuffless 
BP model should include a definition to normalize the reported error by the difficulty of estimating a 
given dataset. This would facilitate comparisons between different studies. 
The main limitation of the collected data used in Chapters 4, 5, and 6 is the moderate accuracy of BP 
reference signal. As explained in Section 2.2.1.3, a finger cuff BP measurement system (Portapres and 
NOVA; Finapres Medical Systems, the Netherlands) has its own bias and variance, which does not 
meet the AAMI standard requirement (although the NOVA system uses RTF calibration, which 
improves the precision; see Section 2.2.1.3). Therefore, the developed model estimation error can 
reflect not only the error in estimating BP, but also the error of the measurement device itself. In future 
work, catheterization of participants should be performed and compared with finger cuff measures. 
Since training subject-specific models using catheterization is not a viable solution, the study should 
focus on the impact of the accuracy of the training data on the estimation of the BP model. 
The precision of the estimation of BP during exercise was limited by the change in peripheral 
resistance, which could not be captured by the NARX model based on PPG and ECG. Although we 
suggested in Chapter 6 to use a deep neural network architecture with longer memory (e.g., LSTM), it 
is in the author’s opinion that the timescale in question is too long and variable for such network to 
learn the underlying dynamics caused by the changing peripheral resistance. Future studies should 
investigate integrating a physiological measure that correlates with peripheral resistance or change in 
peripheral resistance. For instance, measuring skin blood flow with a doppler probe might lead to good 
results [190], however, this is not a convenient sensor to use. Skin temperature is a more practical sensor 
that would easily be integrated into a cuffless BP monitoring system, and, based on the data of a few 
participants in Chapter 6, the temperature measured with some models of the Astroskin vest (Carré 
Technologies Inc., Canada) increased throughout the exercise and might be inversely correlated with 
the change in peripheral resistance. This is left for future work. 
Chapters 4 and 5 were limited to estimating BP during fairly sedentary activities of daily living, 
which are applicable to office work, for instance. However, the performance of the NARX model in 
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estimating BP for a more active daily life, such as during a day of a construction worker, will drastically 
decrease (expected by the performance during walking). Nevertheless, it is in the author’s opinion that, 
by using the PI, good BP estimation data could be selected, which would be representative of the actual 
BP distribution and, therefore, useful to a clinician. Future work should investigate the performance of 
the NARX and PI models during more active daily lives. 
The current approach to diagnose hypertension uses cuff-based BP measurements every 20 minutes 
for 24 hours. Therefore, future studies should explore estimating BP during the night to close the loop, 
such that the current approach can be replaced by cuffless continuous measurement of the BP to give a 
more accurate picture of a patient's state. It was shown in Chapter 3 that estimating BP using NARX is 
feasible in the supine position (bed-ridden patients). However, practical challenges need to be addressed 
for nighttime estimation using the NARX model. There is a well-known drop in BP while sleeping, so 
collecting data to train the NARX model that contains a similar drop without disturbing sleep might be 
challenging. Ideally, the 15-minute training protocol developed in Chapter 4 could be enhanced such 
that it encompasses such BP drop, leading to a 24-h estimation based solely on this training protocol. 
One potential solution would be to add deep breathing in the supine position to reach a lower BP level 
to the protocol [109]. 
This thesis covered a large range of inter-individual BP from hypo- to hypertensive cases in Chapter 
3. However, Chapter 3 was limited to bed-ridden patients and, therefore, only small BP variabilities 
had to be estimated. Future studies should investigate the effect of inter-individual BP level on the 
accuracy of the NARX model in predicting BP variability during activities of daily living. It will be of 
high importance to assess the NARX model performance on different sex and ethnicities before the 
deployment of such a cuffless BP monitoring system for clinical uses. 
In this thesis, PI was used as a confidence metric for the BP estimation. Future work should 
investigate explainable AI [199]–[201] as a means to increase confidence in BP models. Physiological 
models, such as PTT-based models, have gained a lot of attention over the years because of their 
simplicity and interpretability. Extracting physiological parameters using explainable AI would be an 
interesting way to gain confidence in BP models without sacrificing accuracy. Another interesting 
approach that could be used for the NARX model specifically is using interpretable nonlinear functions 
instead of ANN. This way, the interpretability of the relationship from input to output would not be lost 
in the ANN weights and could be interpreted using nonlinear dynamics techniques. 
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This thesis was certainly limited in terms of participants. Nevertheless, it is in the author’s opinion 
the methodology expressed by this thesis in terms of validation protocols and using PI (or other 
confidence metrics) for such health monitoring application should be pursued by other scholars. 
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Appendix A7 - Subjects from MIMIC II Database 
Table A.1 details of the NARX model performance on the 15 subjects from MIMIC II database used 
in Chapter 3. 
 
Table A.1: List of the MIMIC II Clinical Database Public Subset (mimic2cdb) subjects used 
in the paper. The initial and final time included A, B, and C sections of the data. The absolute 
error on the waveform estimation is given for both training modes and all inputs. 
Subject 
Number 
Absolute Error for Interval 
Training  
(mean ± SD mmHg) 
Absolute Error for  
Predictive mode training 





 ANNECG ANNPPG ANNECG+PPG ANNECG ANNPPG ANNECG+PPG   
3000397m 2.8±3.2 3.0±3.4 2.5±3.2 5.8±7.4 3.9±4.2 4.5±4.6 20:17:00 1:45:00 
3000480m 3.7±3.4 3.3±3.5 2.6±2.5 6.3±5.7 6.9±5.7 5.2±4.6 19:33:42 20:48:22 
3000860m 2.6±2.3 3.9±3.3 2.4±2.2 8.0±4.9 9.5±5.0 8.7±5.0 14:50:47 16:01:27 
3000989m 1.8±1.7 2.1±2.3 1.5±1.4 2.1±2.0 2.2±2.4 1.6±1.5 22:59:54 23:42:34 
3001689m 3.6±4.0 3.7±4.5 2.9±3.2 5.1±5.1 4.1±5.0 3.6±3.9 6:25:03 8:34:23 
3002090m 3.0±3.7 4.2±5.3 2.7±3.2 3.9±4.3 5.9±6.0 3.6±3.8 8:02:56 10:12:16 
3900975m 3.4±2.9 4.5±4.9 3.1±2.6 4.9±3.6 5.4±5.1 4.8±3.6 12:05:11 14:26:31 
3901254m 2.4±2.0 2.8±2.8 2.3±2.0 2.2±2.2 3.1±3.0 2.5±2.4 23:48:30 2:23:10 
3901339m 2.8±2.9 3.2±3.6 2.4±2.4 3.3±3.7 4.1±5.7 2.6±2.7 14:06:44 16:24:04 
3902929m 4.3±4.5 5.7±6.8 4.1±4.5 10.1±7.3 9.6±8.6 10.2±6.8 19:31:03 2:04:23 
3902994m 4.2±3.9 4.3±4.8 3.7±3.8 5.3±4.5 5.4±6.2 5.5±5.3 16:48:44 21:23:24 
3903771m 2.0±1.5 2.2±2.3 1.9±1.4 2.7±1.8 3.4±2.4 3.1±1.9 2:20:29 5:08:29 
3903773m 3.0±3.9 3.5±3.6 2.5±2.5 4.7±5.3 4.8±4.4 4.1±3.8 1:27:10 3:37:50 
3903867m 3.4±2.7 2.5±2.5 2.2±2.5 2.6±3.0 2.3±3.1 2.1±2.2 22:13:07 0:47:47 




7 Parts of Appendix A have been adapted from the following publication: 
C. Landry, S. D. Peterson, and A. Arami, “Nonlinear Dynamic Modeling of Blood Pressure Waveform: Towards 




Appendix B8 - Fusion Results for Diastolic Blood Pressure 
Chapter 5 presents the results for SBP. Herein are supplemented the results with analogous findings for 
diastolic blood pressure (DBP). 
The training and testing clusters’ error standard deviation (σ ) for the NARX, ANNDias, and 
PATLog models are shown in Figure B.1 as a function of the clusters’ percentage of outliers (lower 
bound). Note that the training σ  at 0% of outliers is not defined, as there are no training data in this 
cluster. In the test data, those are outliers and represent 3.1±1.3%, 4.3±1.7%, and 4.8±3.4% of the BP 
estimates for the NARX, ANNDias, and PATLog models, respectively. The Pearson correlation 
coefficients between the training and testing σ  of each cluster are r = 0.80±0.24, 0.72±0.23, and 
0.78±0.11 for the NARX, ANNDias, and PATLog models, respectively. It can be observed in Figure  that 
the model overestimates on average the σ  of the test data by 43%, 13%, and 57% for NARX, 
ANNDias, and PATLog, respectively. 
 
Figure B.1 - The diastolic blood pressure training and testing data standard deviation of error 
in every cluster for a) NARX, b) ANNDias, and c) PATLog. Lines represent the mean of all subjects 
and the shaded region show ± SD. 
The mean and standard deviation (SD) of the MAE, mean error (μ ), σ , r, MeRCI score, and 
mean of the prediction interval (PI) during activities of daily living computed across the five subjects 
are shown in Figure B.2.  
 
 
8 Parts of Appendix B have been adapted from the following submitted article: 
C. Landry, S. D. Peterson, A. Arami, “A Fusion Approach to Improve Cuffless Blood Pressure and Prediction 




Figure B.2 - Comparison of a) mean absolute error, b) mean error, c) standard deviation of 
the error, d) Pearson correlation coefficient between different model estimates and the BP 
measurements, e) MeRCI score, and f) the mean estimated prediction interval. Bars represent 
the mean of all subjects and the error bars show ± SD. Each data point represents one participant. 
The IEEE cuffless wearable and the AAMI standard limits are also shown in subplots a), and b-
c), respectively. 
 
Figure B.3 - a) Mean of the DBP MAEΔP relative to MAEΔP – PATLog for all participants, and 
b) the distribution of data of all participants aggregated against the distribution of |∆P| from µSBP 
measured throughout the day. The MAEΔP are binned in increments of 5 mmHg from -20 mmHg 
to 20 mmHg then grouped together according to their absolute value. 
Figure B.3.a depicts the difference in MAEΔP of each bin with analogous bins from PATLog was 
computed as a function of |ΔP|; the data distributions when aggregating the data of all participants are 
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included in Figure B.3.b. The range of DBP shown is the minimum range spanned by all the 
participants.  
The percentage of data removed is plotted against the absolute estimation error in Figure B.4.a for 
the NARX + ANNDias + PATLog model. The tradeoff between amount of data kept and σ  when 
varying threshold values σ  for NARX + ANNDias + PATLog is shown in Figure B.4.b.  
 
 
Figure B.4 - a) Percentage of the data removed as a function of the absolute error using 
different thresholds 𝛔𝐓. The results are calculated from all the test data from every participant 
and grouped in increments of 1 mmHg. b) Percentage of data kept as a function of the error SD 
when varying the threshold on the PI. The line was computed by varying the 𝛔𝐓, where specific 
values are marked with circles according to the legend. 
The MAEΔP as a function of |ΔP| is plotted in Figure B.5.a for the NARX + ANNDias + PATLog model 
using σ  = 8 and 9 mmHg. The percentage of data removed in each |ΔP| bin is plotted in Figure B.5.b. 
All the expected MAEΔP values are lower when using the OCSVM model PI to remove data with large 
expected error SD (PI ≥8 or 9 mmHg). In every case, the BP estimations at large |ΔP| by the fused 
model have a higher expected error than BP estimations closer to the mean BP.  
The error SD for the NARX + ANNDias + PATLog model is shown in Fig S6.a when estimating BP 
during sitting, standing, and walking. The σ  is shown for original beat-by-beat estimation and for 
the SD threshold σ  = 8 mmHg case. The percentage of data kept for each activity when using  σ  = 8 






Figure B.5 - a) Mean and SD of MAEΔP for all participants, and b) percentage of data removed 
from each bin, against the |∆P| from µDBP measured throughout the day. In a) bars represent the 
mean of all subjects and the error bars show ± SD. Legend: (*) Original vs 𝛔𝐓 = 9 mmHg, (-) 
Original vs 𝛔𝐓 = 8 mmHg, and (+) 𝛔𝐓 = 8 mmHg vs 𝛔𝐓 = 9 mmHg (p<0.05/3) 
   
 
 
Figure B.6 - a) Comparison of the 𝛔𝑬𝒓𝒓 for the original NARX + ANNDias + PATLog model and 
the same model using 𝛔𝐓 = 8 mmHg during sitting, standing, and walking, and b) the percentage 
of data kept (PI < 8 mmHg). Bars represent the mean of all subjects and the error bars show ± 





Appendix C – Results for Low-to-Moderate Cycling Exercise Test 
Chapter 6 presents the results for the L-H test. Herein the analogous results for the L-M test are 
presented. In this section, one participant was removed from the analysis (out of 12) due to a poor PPG 
signal biasing the results. The PPG signal was found to have small signal to noise ratio, making it 
difficult to extract the PPG peak. 
 
Figure C.1 - Comparison of a) mean error, b) SD of the error, c) Pearson correlation 
coefficient and d) coefficient of determination between different model estimates and the BP 
measurements. Bars represent the mean of all subjects and the error bars show ± SD for the L-
M test. Each data point represents one participant. Legend: Wilcoxon with (*) p<0.05/10 and (†) 
p<0.01. 
The mean and SD of μ , σ , r, and R2 during the L-M test computed across the 11 subjects are 
shown in Figure C.1 for the different models. The SD of μ  is relatively large, showing that all BP 
models can be largely biased for some participants. The results exhibit differences in mean σ  
between the models, ranging from 8.19 mmHg for NARXpop (best) to 9.58 mmHg for ANNsub (worst). 
As a reference, the MAP SD across the 11 participants is 9.1±1.6 mmHg (mean±SD) during the L-M 
test. Due to the distribution of results, only the NARXpop σ  is found to be statistically lower than 
ANNpop (p<0.05/10), and trends toward a statistical difference with ANNsub (p<0.01). The average 
Pearson correlation coefficient between the estimated and measured MAP is higher for NARXpop and 
statistically different from ANNpop(ANNsub) (p<0.05/10). Similarly, R2 is the largest for both NARXpop 
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and statistically different from ANNpop(ANNsub) (p<0.05/10) and PAT-HR is statistically different from 
ANNsub (p<0.01). 
The estimated BP time series from NARXpop and NARXsub are shown for the subjects with the 
lowest and highest σ  in Figure 6.3. In Figure 6.3.a-b, the estimated BP waveforms are shown at rest 
(2 min), during the first PRBS moderate intensity (90%VT) section (9 min), during the low intensity 
(25 W) section between the two PRBS (14 min), and at the last moderate intensity (90%VT) section 
(19.5 min). In Figure 6.3.c-d, MAP is shown, as a function of time, for the complete 21 minutes, 
including the initial resting portion and the complete L-M exercise test.  
 
Figure C.2 - Comparison of actual versus estimated BP waveforms and MAP (after applying 
a moving average). The results are shown for the subject with the lowest, a) and c), and highest, 
b) and d), SD of the error for the L-M test. 
The NARXpop error (with removed bias) evolution over the 21-minute testing period is presented 
for all 11 participants in Figure 6.4. The red line is the mean of all participants. It can be observed that 
the model in the majority of subjects underestimates the change in MAP up to the end of the first PRBS 
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(13 min) and error slowly increases throughout the test, which is consistent with qualitative 
observations in Figure 6.3.  
 
Figure C.3 - Filtered BP error for the 11 subjects for the L-M cycling test. Grey lines represent 
individual subject data and the red line is the mean of all subjects. 
 
Figure C.4 - Comparison of a) SD of the error, b) Pearson correlation coefficient, c) coefficient 
of determination, and d) KL divergence between different model estimates and the BP 
measurements distributions. Bars represent the mean of all subjects and the error bars show ± 
SD for the L-M test. Each data point represents one participant. Legend: Wilcoxon with (*) 
p<0.05/6 and (†) p<0.05. 
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The means and SDs of σ , r, R2, and KL-divergence during the L-M test computed across the 11 
subjects are shown in Figure 6.5 for NARXpop trained on different data . In general, training the model 
on only the L-M test (NARXpop – L-M) leads to poorer outcomes, with statistical difference observed 
between r of NARXpop. Training on the Max tests (NARXpop) resulted in higher r, and significantly 
lower KL-divergence than training the model on L-M tests. On average, training on all tests (NARXpop 
– All) leads to larger R2 and smaller σ  compared to the other models. 
 
Figure C.5 - a) Mean of MAEΔP for all participants against the distribution of ∆MAP from 
µMAP measured throughout the L-M test. Wilcoxon tests’ p-value for b) NARXpop vs NARXpop 
– All, c) NARXpop vs NARXpop – L-M, and d) NARXpop vs NARXpop – Max 6 participants. Symbols 
represent the p-values (or MAEΔP value) and the location on the abscissa indicates the bin over 
which the statistical test was performed. 
The capability of predicting changes in MAP by NARXpop is shown in Figure 6.6 for the different 
training datasets. As shown by the p-values obtained from the  Wilcoxon tests, using the data of all the 
tests as training data leads to lower MAE in the small range of ΔMAP without affecting the model’s 
capability to estimate BP at large ΔMAP. The model trained on the Max tests is significantly better at 
estimating large positive ΔMAP than the training only on L-M. There were no significant differences 
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between training on six or 11 participants Max tests when comparing every ΔMAP bin, so nothing 
appears on the figure. 
The means and SDs of the σ , r, R2, rerr-PPG, and rerr-ECG during the L-M test computed across the 
11 subjects are shown in Figure 6.7 for NARXpop, NARXsub – L-M (Train), NARXsub – All (Train), and 
NARXcorr. The results indicate that when a model can extract more information from the PPG and ECG 
signals (lower rerr-PPG and rerr-ECG), it is better at estimating BP (lower σ  and higher r). It can also be 
observed that the employed NARX architectures are not able to extract all the information from the 
PPG and ECG even when the test data are included in the training set, though this helps the estimation 
for the moderate exercise case (NARXsub – All (Train)). 
 
 
Figure C.6 - Comparison of a) SD of the error, and b) Pearson correlation coefficient between 
different model estimates and the BP measurements, and the maximum cross-correlation 
between c) BP and PPG, and d) BP and ECG signals. Bars represent the mean of all subjects and 
the error bars show ± SD for the L-M test. Each data point represents one participant. Legend: 
(*) Wilcoxon with p<0.05/6. 
The mean of the 11 participants’ ΔMAP during the L-M test is shown in Figure 6.8.a. It can be seen 
that the measured ΔMAP during the second PRBS is lower than the first one, but the difference is much 
smaller compared to the L-H test. Figure 6.8.b shows HR, PPGpeak and 1/PAT, which are all features 




Figure C.7 – Mean of the 11 participants a) measured and estimated ΔMAP and b) common 
features that correlate with BP for the L-M exercise test.  
 
 
 
